--
-- PostgreSQL database dump
--

-- Dumped from database version 9.5.1
-- Dumped by pg_dump version 9.5.1

SET statement_timeout = 0;
SET lock_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SET check_function_bodies = false;
SET client_min_messages = warning;
SET row_security = off;

SET search_path = public, pg_catalog;

--
-- Data for Name: amino_acids; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY amino_acids (id, name) FROM stdin;
1	p.Q61H
2	p.Q61L
3	p.Q61*
4	p.Q61E
5	p.Q61K
6	p.G13V
7	p.G13A
8	p.G13D
9	p.G13C
10	p.G13R
11	p.G12V
12	p.G12A
13	p.G12D
14	p.G12C
15	p.G12R
16	p.G12S
17	p.S768R
18	p.T618I
19	p.M918T
20	p.R130G
21	p.R130*
22	p.R130Q
23	p.R159S
24	p.R233*
25	p.K267fs
26	p.A382fs
27	p.Q61R
28	p.A146V
29	p.A146P
30	p.A146T
31	p.K117N
32	p.Q61P
33	p.G13S
34	p.D839G
35	p.I836M
36	p.I836L
37	p.D835E
38	p.D835V
39	p.D835A
40	p.D835Y
41	p.D835H
42	p.D835N
43	p.E17K
44	p.DTKH759in_frame_delEPNT
45	p.L755S
46	p.A309G
47	p.F53L
48	p.Q56P
49	p.K57N
50	p.D67N
51	p.I111S
52	p.C121S
53	p.P124S
54	p.P124L
55	p.E203K
56	p.P264S
57	p.N382H
58	p.R172S
59	p.R172M
60	p.R172K
61	p.R140L
62	p.R140Q
63	p.R140W
64	p.G309A
65	p.LREN755in_frame_del*
66	p.D769H
67	p.D769Y
68	p.V777L
69	p.779in_frame_insLPS
70	p.V842I
71	p.R896C
72	p.R273H
73	p.R273C
74	p.R249T
75	p.R249W
76	p.R248Q
77	p.Y220C
78	p.V173G
79	p.V173A
80	p.E330A
81	p.D351N
82	p.D351H
83	p.D355E
84	p.R361S
85	p.R361C
86	p.R361H
87	p.D537Y
88	p.Q209P
89	p.Q209L
90	p.K700N
91	p.K700I
92	p.K700R
93	p.K700T
94	p.K700*
95	p.K700E
96	p.K700Q
97	p.K666N
98	p.K666R
99	p.K666T
100	p.K666E
101	p.R132L
102	p.R132P
103	p.R132H
104	p.R132C
105	p.R132G
106	p.R132S
107	p.R882L
108	p.R882P
109	p.R882H
110	p.R882C
111	p.R882G
112	p.R882S
113	p.Y1278S
114	p.R1275Q
115	p.F1245L
116	p.F1245C
117	p.F1245V
118	p.D1225N
119	p.F1174L
120	p.F1174C
121	p.F1174V
122	p.F1174I
123	p.I1171N
124	p.T1151M
125	p.D1091N
126	p.R201*
127	p.R162S
128	p.R162K
129	p.R162G
130	p.Q157R
131	p.Q157P
132	p.S34F
133	p.S34Y
134	p.R398W
135	p.T354M
136	p.E542K
137	p.E545K
138	p.E545Q
139	p.E545A
140	p.E545G
141	p.E545V
142	p.Q546K
143	p.Q546E
144	p.Q546P
145	p.Q546R
146	p.Q546L
147	p.D549N
148	p.H1047R
149	p.H1047L
150	p.S37Y
151	p.S37F
152	p.S45P
153	p.S45Y
154	p.S45F
155	p.V561D
156	p.N659K
157	p.D842V
158	p.E490K
159	p.F504L
160	p.K550N
161	p.Y553N
162	p.EVQW554in_frame_delKYSG
163	p.Q556in_frame_insPK
164	p.556in_frame_insP
165	p.Q556in_frame_insPE
166	p.QWKV556in_frame_insP*
167	p.Q556in_frame_insLK
168	p.Q556in_frame_insLE
169	p.W557R
170	p.K558N
171	p.V560in_frame_del
172	p.V559D
173	p.V559A
174	p.V559G
175	p.VEEI560in_frame_delLRR
176	p.V560D
177	p.V560A
178	p.V560G
179	p.G565V
180	p.N566D
181	p.NNYVYI566in_frame_del
182	p.NNYVYIDPT566in_frame_del
183	p.V569G
184	p.Q575in_frame_insPRK
185	p.Q575in_frame_insPRE
186	p.Q575in_frame_insPGK
187	p.Q575in_frame_insPGE
188	p.QLPY575in_frame_insP*
189	p.L576P
190	p.PYDH577in_frame_delLMIT
191	p.D579in_frame_del
192	p.R634W
193	p.K642E
194	p.V654E
195	p.V654A
196	p.N655S
197	p.N655K
198	p.H697Y
199	p.D816H
200	p.D816Y
201	p.D816I
202	p.D816V
203	p.D820H
204	p.D820Y
205	p.D820V
206	p.D820E
207	p.N822Y
208	p.N822I
209	p.N822K
210	p.Y823D
211	p.A829P
212	p.I841V
213	p.S864F
214	p.W288fs
215	p.S463P
216	p.V534E
217	p.P535H
218	p.L536R
219	p.Y537N
220	p.Y537S
221	p.Y537C
222	p.D538G
223	p.A68V
224	p.R199W
225	p.T349I
226	p.D473H
227	p.R485W
228	p.L515F
229	p.W535L
230	p.R562Q
231	p.A652V
232	p.P755F
233	p.K601E
234	p.V600D
235	p.V600G
236	p.V600E
237	p.V600R
238	p.V600K
239	p.L597R
240	p.D594E
241	p.D594V
242	p.D594G
243	p.D594A
244	p.D594Y
245	p.D594H
246	p.D594N
247	p.Y472C
248	p.E77*
249	p.G469A
250	p.G469E
251	p.LEQ76F*
252	p.G466V
253	p.G719S
254	p.G719C
255	p.G719A
256	p.T790M
257	p.L858R
258	p.L861Q
259	p.V617F
260	p.R683G
261	p.R683T
262	p.R683S
263	p.Q209R
264	p.F232C
265	p.R2505P
266	p.E2419K
267	p.Q2223K
268	p.S2215Y
269	p.E2014K
270	p.L1460P
271	p.G391R
272	p.T615A
273	p.S505C
274	p.S505N
275	p.W515L
276	p.V658F
277	p.S646F
278	p.A18T
279	p.L63V
280	p.L239R
281	p.G253C
282	p.G505S
283	p.I638F
284	p.G774V
285	p.G1269A
286	p.S1206Y
287	p.G1202R
288	p.L1196M
289	p.R1192P
290	p.L1152R
291	p.G1128A
292	p.E872K
293	p.R544W
294	p.E452K
295	p.R393W
296	p.E317K
297	p.P81S
298	p.L85P
299	p.L89H
300	p.L158Q
301	p.R161*
302	p.R167W
303	p.W388S
304	p.S257P
305	p.V384D
306	p.L273P
307	p.A13T
308	p.A21T
309	p.VSHWQQQSYLDSGIHSG22in_frame_del
310	p.V22A
311	p.WQQQSYLD25in_frame_del
312	p.D32N
313	p.D32H
314	p.D32Y
315	p.D32A
316	p.D32G
317	p.D32V
318	p.S33Y
319	p.S33C
320	p.G34R
321	p.G34E
322	p.G34V
323	p.S37P
324	p.S37A
325	p.S37C
326	p.T40P
327	p.T40A
328	p.T40S
329	p.T40I
330	p.S45A
331	p.S45C
332	p.R88Q
333	p.N345K
334	p.C420R
335	p.P539R
336	p.E542Q
337	p.E545D
338	p.H701P
339	p.Y1021C
340	p.M1043I
341	p.H1047Y
342	p.G1049S
343	p.G1049R
344	p.R248C
345	p.S249C
346	p.G372C
347	p.S373C
348	p.Y375C
349	p.V555M
350	p.K652Q
351	p.G699C
352	p.P577S
353	p.V658A
354	p.RD841in_frame_del
355	p.R841K
356	p.D842Y
357	p.D842I
358	p.DIM842in_frame_del
359	p.IMHD843in_frame_del
360	p.H845Y
361	p.D846Y
362	p.G853D
363	p.D52N
364	p.V559I
365	p.T670I
366	p.V825A
367	p.E839K
368	p.S185C
369	p.G376R
370	p.EDN439in_frame_delKI
371	p.R461*
372	p.D560Y
373	p.DKRMNS560in_frame_del
374	p.N564D
375	p.N564K
376	p.T576in_frame_del
377	p.WLTQ583in_frame_delG*
378	p.R876*
379	p.R1114*
380	p.E1306*
381	p.K1310fs
382	p.Q1338*
383	p.Q1367*
384	p.Q1378*
385	p.E1379*
386	p.Q1429*
387	p.R1450*
388	p.G1466fs
389	p.I1557fs
390	p.Y969*
391	p.Y969F
392	p.Y969C
393	p.Y969H
394	p.Y571D
395	p.L301S
396	p.L301*
397	p.N535K
398	p.V550E
399	p.G2032R
400	p.E380Q
401	p.P29S
402	p.R108K
403	p.T263P
404	p.A289V
405	p.S492G
406	p.P546S
407	p.G598V
408	p.E690K
409	p.G719D
410	p.W731*
411	p.P733L
412	p.E734K
413	p.G735S
414	p.V742A
415	p.K745R
416	p.E746K
417	p.L747S
418	p.A750P
419	p.S752Y
420	p.P753S
421	p.D761N
422	p.D761Y
423	p.S768I
424	p.H773R
425	p.G810S
426	p.G810D
427	p.V843I
428	p.L858M
429	p.L858Q
430	p.L861P
431	p.L861R
432	p.R988C
433	p.T1010I
434	p.V1110I
435	p.H1112Y
436	p.H1112R
437	p.Y1248H
438	p.Y1248C
439	p.Y1253D
440	p.M1268T
441	p.M1268I
442	p.S605N
443	p.S605F
444	p.K601N
445	p.K601in_frame_del
446	p.K601R
447	p.V600A
448	p.V600L
449	p.V600M
450	p.Q207*
451	p.L597Q
452	p.L597S
453	p.L597V
454	p.G596R
455	p.F595L
456	p.L203*
457	p.F595S
458	p.I592M
459	p.I592V
460	p.D587E
461	p.D587A
462	p.E586K
463	p.N581S
464	p.V471F
465	p.G469S
466	p.G469R
467	p.G466A
468	p.G466E
469	p.G466R
470	p.G464V
471	p.G464E
472	p.G464R
473	p.R444W
474	p.A682G
475	p.Y646F
476	p.Y646S
477	p.Y646H
478	p.Y646N
479	p.P283T
480	p.S158L
481	p.P57S
482	p.A59V
483	p.T73I
484	p.S77F
485	p.N101T
486	p.P260A
487	p.P114L
488	p.W110*
489	p.R163L
490	p.E88*
491	p.R139L
492	p.A138V
493	p.R80*
494	p.E69*
495	p.E61*
496	p.R58*
497	p.E255K
498	p.E255V
499	p.M263V
500	p.L267V
501	p.G269E
502	p.Q271H
503	p.Y272H
504	p.Y272F
505	p.E274K
506	p.E274V
507	p.F302V
508	p.V318L
509	p.T334A
510	p.T334I
511	p.F336I
512	p.F336V
513	p.F336C
514	p.F336L
515	p.M370T
516	p.E374G
517	p.F378I
518	p.F378L
519	p.F378V
520	p.F378C
521	p.H415R
522	p.FPEEEKCFC612in_frame_del
523	p.D631G
524	p.EL632in_frame_del
525	p.C634R
526	p.C634Y
527	p.C634W
528	p.E768D
529	p.A883F
530	p.DVYE898in_frame_del
531	p.R173C
532	p.R173H
533	p.R234W
534	p.R335*
535	p.K660E
536	p.N639K
537	p.L618M
538	p.E566G
539	p.V565I
540	p.N550K
541	p.N550H
542	p.I548V
543	p.M538I
544	p.M536I
545	p.Y382H
546	p.Y376C
547	p.S320C
548	p.K310R
549	p.W290C
550	p.P253R
551	p.S252W
552	p.Y371H
553	p.C384R
554	p.A59T
555	p.Q22K
556	p.L19F
557	p.P262H
558	p.G284R
559	p.Q809R
560	p.R24H
561	p.Y842C
562	p.Y842H
563	p.I836in_frame_del
564	p.D835in_frame_del
565	p.D835F
566	p.F691L
567	p.I687F
568	p.N676K
569	p.N676D
570	p.D651G
571	p.G619C
572	p.Y572C
573	p.E137*
574	p.L199*
575	p.R320*
576	p.R358*
577	p.R455*
578	p.R552*
579	p.R556*
580	p.R579*
581	p.C706F
582	p.E748*
583	p.Q79K
584	p.K57E
585	p.I99T
586	p.I103N
587	p.I111N
588	p.H119P
589	p.E120D
590	p.G128D
591	p.F129L
592	p.V211D
593	p.L215P
594	p.R665W
595	p.L845F
596	p.R306*
597	p.R248W
598	p.G245S
599	p.R175H
600	p.G309E
601	p.S310Y
602	p.S310F
603	p.G776S
604	p.G776in_frame_insVC
605	p.L785P
606	p.Q37*
607	p.Q170*
608	p.D194N
609	p.D194V
610	p.D194E
611	p.G196V
612	p.E199K
613	p.E199*
614	p.P281L
615	p.W332*
616	p.N126D
617	p.C125S
618	p.Q60P
619	p.L46F
620	p.V35M
621	p.V722I
622	p.R657Q
623	p.A572V
624	p.Q501H
625	p.P132T
626	p.I87T
627	p.N561D
628	p.R368S
629	p.S302G
630	p.Q537*
631	p.R202C
632	p.R202H
633	p.R202L
634	p.Q228L
635	p.S214C
636	p.C481S
\.


--
-- Name: amino_acids_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('amino_acids_id_seq', 636, true);


--
-- Data for Name: data_versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY data_versions (id, version) FROM stdin;
1	7
\.


--
-- Name: data_versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('data_versions_id_seq', 1, true);


--
-- Data for Name: diseases; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY diseases (id, name, doid) FROM stdin;
1	melanoma	1909
2	acute myeloid leukemia	9119
3	non-small cell lung carcinoma	3908
4	thyroid cancer	1781
5	colorectal cancer	9256
6	squamous cell carcinoma	1749
7	ovarian cancer	2394
8	breast cancer	1612
9	neuroblastoma	769
10	rhabdomyosarcoma	3247
11	gastrointestinal stromal tumor	9253
12	thymic carcinoma	3284
13	progesterone-receptor positive breast cancer	0060077
14	basal cell carcinoma	2513
15	medulloblastoma	0050902
16	lung cancer	1324
17	lymphoblastic leukemia	1037
18	renal carcinoma	4451
19	bladder transitional cell carcinoma	4006
20	lung squamous cell carcinoma	3907
21	chronic myeloid leukemia	8552
22	chronic myeloproliferative disease	2226
23	hemorrhagic thrombocythemia	2224
24	myelofibrosis	4971
25	hematologic cancer	2531
26	polycythemia vera	8997
27	acute lymphocytic leukemia	9952
28	cancer	162
29	stomach cancer	10534
30	brain cancer	1319
31	lung adenocarcinoma	3910
32	astrocytoma	3069
33	renal clear cell carcinoma	4467
34	gastric adenocarcinoma	3717
35	lymphoma	0060058
36	esophagus squamous cell carcinoma	3748
37	endometrial carcinoma	2871
38	craniopharyngioma	3840
39	parathyroid carcinoma	1540
40	pilomatrixoma	5374
41	hepatocellular carcinoma	684
42	adrenal cortical adenoma	0050891
43	head and neck cancer	11934
44	oral squamous cell carcinoma	0050866
45	bladder carcinoma	4007
46	myeloma	0070004
47	mast-cell leukemia	9254
48	systemic mastocytosis	349
49	endometrial adenocarcinoma	2870
50	prostate cancer	10283
51	head and neck squamous cell carcinoma	5520
52	esophageal carcinoma	1107
53	tongue squamous cell carcinoma	0050865
54	colon cancer	219
55	chronic lymphocytic leukemia	1040
56	uveal melanoma	6039
57	thyroid medullary carcinoma	3973
58	skin squamous cell carcinoma	3151
59	angiosarcoma	0001816
60	retinoblastoma	768
61	lung small cell carcinoma	5409
62	meningioma	3565
63	osteosarcoma	3347
64	pancreatic cancer	1793
65	megakaryocytic leukemia	8761
\.


--
-- Data for Name: genes; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY genes (id, name, ensembl_id, entrez_id) FROM stdin;
1	NRAS	ENSG00000213281	\N
2	DDR2	ENSG00000162733	\N
3	CSF3R	ENSG00000119535	\N
4	RET	ENSG00000165731	\N
5	PTEN	ENSG00000171862	\N
6	WT1	ENSG00000184937	\N
7	HRAS	ENSG00000174775	\N
8	KRAS	ENSG00000133703	\N
9	FLT3	ENSG00000122025	\N
10	AKT1	ENSG00000142208	\N
11	HERC2	ENSG00000128731	\N
12	MAP2K1	ENSG00000169032	\N
13	IDH2	ENSG00000182054	\N
14	ERBB2	ENSG00000141736	\N
15	TP53	ENSG00000141510	\N
16	SMAD4	ENSG00000141646	\N
17	GNA11	ENSG00000088256	\N
18	SF3B1	ENSG00000115524	\N
19	IDH1	ENSG00000138413	\N
20	DNMT3A	ENSG00000119772	\N
21	ALK	ENSG00000171094	\N
22	RUNX1	ENSG00000159216	\N
23	U2AF1	ENSG00000160201	\N
24	GATA2	ENSG00000179348	\N
25	PIK3CA	ENSG00000121879	\N
26	CTNNB1	ENSG00000168036	\N
27	PDGFRA	ENSG00000134853	\N
28	KIT	ENSG00000157404	\N
29	NPM1	ENSG00000181163	\N
30	ESR1	ENSG00000091831	\N
31	SMO	ENSG00000128602	\N
32	BRAF	ENSG00000157764	\N
33	EGFR	ENSG00000146648	\N
34	JAK2	ENSG00000096968	\N
35	GNAQ	ENSG00000156052	\N
36	CRLF2	ENSG00000205755	\N
37	MTOR	\N	\N
38	EPHA2	\N	\N
39	CSF3R	\N	\N
40	MPL	\N	\N
41	JAK1	\N	\N
42	NRAS	\N	\N
43	DDR2	\N	\N
44	DNMT3A	\N	\N
45	ALK	\N	\N
46	SF3B1	\N	\N
47	IDH1	\N	\N
48	ERBB4	\N	\N
49	VHL	\N	\N
50	RAF1	\N	\N
51	MLH1	\N	\N
52	MYD88	\N	\N
53	CTNNB1	\N	\N
54	GATA2	\N	\N
55	PIK3CA	\N	\N
56	FGFR3	\N	\N
57	PDGFRA	\N	\N
58	KIT	\N	\N
59	IL7R	\N	\N
60	PIK3R1	\N	\N
61	APC	\N	\N
62	CSF1R	\N	\N
63	NPM1	\N	\N
64	FGFR4	\N	\N
65	ROS1	\N	\N
66	ESR1	\N	\N
67	RAC1	\N	\N
68	EGFR	\N	\N
69	MET	\N	\N
70	SMO	\N	\N
71	BRAF	\N	\N
72	EZH2	\N	\N
73	FGFR1	\N	\N
74	MYC	\N	\N
75	JAK2	\N	\N
76	CDKN2A	\N	\N
77	GNAQ	\N	\N
78	ABL1	\N	\N
79	RET	\N	\N
80	PTEN	\N	\N
81	FGFR2	\N	\N
82	HRAS	\N	\N
83	WT1	\N	\N
84	CBL	\N	\N
85	KRAS	\N	\N
86	ERBB3	\N	\N
87	CDK4	\N	\N
88	FLT3	\N	\N
89	RB1	\N	\N
90	AKT1	\N	\N
91	HERC2	\N	\N
92	MAP2K1	\N	\N
93	IDH2	\N	\N
94	PLCG2	\N	\N
95	TP53	\N	\N
96	ERBB2	\N	\N
97	SMAD4	\N	\N
98	STK11	\N	\N
99	GNA11	\N	\N
100	MAP2K2	\N	\N
101	JAK3	\N	\N
102	PIK3R2	\N	\N
103	AKT2	\N	\N
104	SRC	\N	\N
105	GNAS	\N	\N
106	RUNX1	\N	\N
107	U2AF1	\N	\N
108	CRLF2	\N	\N
109	ARAF	\N	\N
110	BTK	\N	\N
\.


--
-- Data for Name: locations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY locations (id, chromosome, reference_build, reference_read, start, stop, previous_reference_base, reference_sequence_version) FROM stdin;
1	1	\N	T	115256528	115256528	\N	GRCh37
2	1	\N	T	115256529	115256529	\N	GRCh37
3	1	\N	G	115256530	115256530	\N	GRCh37
4	1	\N	C	115258744	115258744	\N	GRCh37
5	1	\N	C	115258745	115258745	\N	GRCh37
6	1	\N	C	115258747	115258747	\N	GRCh37
7	1	\N	C	115258748	115258748	\N	GRCh37
8	1	\N	T	162748390	162748390	\N	GRCh37
9	1	\N	G	36933434	36933434	\N	GRCh37
10	10	\N	T	43617416	43617416	\N	GRCh37
11	10	\N	C	89692904	89692904	\N	GRCh37
12	10	\N	G	89692905	89692905	\N	GRCh37
13	10	\N	G	89692993	89692993	\N	GRCh37
14	10	\N	C	89717672	89717672	\N	GRCh37
17	11	\N	T	533874	533874	\N	GRCh37
18	11	\N	C	534286	534286	\N	GRCh37
19	11	\N	C	534288	534288	\N	GRCh37
20	11	\N	C	534289	534289	\N	GRCh37
21	12	\N	G	25378561	25378561	\N	GRCh37
22	12	\N	C	25378562	25378562	\N	GRCh37
23	12	\N	T	25378647	25378647	\N	GRCh37
24	12	\N	T	25380275	25380275	\N	GRCh37
25	12	\N	T	25380276	25380276	\N	GRCh37
26	12	\N	G	25380277	25380277	\N	GRCh37
27	12	\N	C	25398281	25398281	\N	GRCh37
28	12	\N	C	25398282	25398282	\N	GRCh37
29	12	\N	C	25398284	25398284	\N	GRCh37
30	12	\N	C	25398285	25398285	\N	GRCh37
31	13	\N	T	28592629	28592629	\N	GRCh37
32	13	\N	G	28592637	28592637	\N	GRCh37
33	13	\N	T	28592639	28592639	\N	GRCh37
34	13	\N	A	28592640	28592640	\N	GRCh37
35	13	\N	T	28592641	28592641	\N	GRCh37
36	13	\N	C	28592642	28592642	\N	GRCh37
37	14	\N	C	105246551	105246551	\N	GRCh37
39	15	\N	A	28505975	28505975	\N	GRCh37
40	15	\N	G	28517518	28517518	\N	GRCh37
41	15	\N	T	66727441	66727441	\N	GRCh37
42	15	\N	A	66727451	66727451	\N	GRCh37
43	15	\N	G	66727455	66727455	\N	GRCh37
44	15	\N	G	66727483	66727483	\N	GRCh37
45	15	\N	T	66729124	66729124	\N	GRCh37
46	15	\N	G	66729154	66729154	\N	GRCh37
47	15	\N	C	66729162	66729162	\N	GRCh37
48	15	\N	C	66729163	66729163	\N	GRCh37
49	15	\N	G	66774131	66774131	\N	GRCh37
50	15	\N	C	66777424	66777424	\N	GRCh37
51	15	\N	A	66782915	66782915	\N	GRCh37
52	15	\N	C	90631837	90631837	\N	GRCh37
53	15	\N	C	90631838	90631838	\N	GRCh37
54	15	\N	C	90631934	90631934	\N	GRCh37
55	15	\N	G	90631935	90631935	\N	GRCh37
56	17	\N	G	37868205	37868205	\N	GRCh37
58	17	\N	T	37880220	37880220	\N	GRCh37
59	17	\N	G	37880261	37880261	\N	GRCh37
60	17	\N	G	37881000	37881000	\N	GRCh37
62	17	\N	G	37881332	37881332	\N	GRCh37
63	17	\N	C	37881616	37881616	\N	GRCh37
64	17	\N	C	7577120	7577120	\N	GRCh37
65	17	\N	G	7577121	7577121	\N	GRCh37
66	17	\N	C	7577535	7577535	\N	GRCh37
67	17	\N	T	7577536	7577536	\N	GRCh37
68	17	\N	C	7577538	7577538	\N	GRCh37
69	17	\N	T	7578190	7578190	\N	GRCh37
70	17	\N	A	7578412	7578412	\N	GRCh37
71	18	\N	A	48591826	48591826	\N	GRCh37
72	18	\N	G	48591888	48591888	\N	GRCh37
73	18	\N	C	48591902	48591902	\N	GRCh37
74	18	\N	C	48591918	48591918	\N	GRCh37
75	18	\N	G	48591919	48591919	\N	GRCh37
76	18	\N	G	48604787	48604787	\N	GRCh37
77	19	\N	A	3118942	3118942	\N	GRCh37
78	2	\N	T	198266832	198266832	\N	GRCh37
79	2	\N	T	198266833	198266833	\N	GRCh37
80	2	\N	T	198266834	198266834	\N	GRCh37
81	2	\N	C	198267359	198267359	\N	GRCh37
82	2	\N	T	198267360	198267360	\N	GRCh37
83	2	\N	T	198267361	198267361	\N	GRCh37
84	2	\N	C	209113112	209113112	\N	GRCh37
85	2	\N	G	209113113	209113113	\N	GRCh37
86	2	\N	C	25457242	25457242	\N	GRCh37
87	2	\N	G	25457243	25457243	\N	GRCh37
88	2	\N	T	29432655	29432655	\N	GRCh37
89	2	\N	C	29432664	29432664	\N	GRCh37
90	2	\N	G	29436858	29436858	\N	GRCh37
91	2	\N	A	29436859	29436859	\N	GRCh37
92	2	\N	A	29436860	29436860	\N	GRCh37
93	2	\N	C	29436920	29436920	\N	GRCh37
94	2	\N	G	29443695	29443695	\N	GRCh37
95	2	\N	A	29443696	29443696	\N	GRCh37
96	2	\N	A	29443697	29443697	\N	GRCh37
97	2	\N	A	29445213	29445213	\N	GRCh37
98	2	\N	G	29445273	29445273	\N	GRCh37
99	2	\N	C	29446296	29446296	\N	GRCh37
100	21	\N	G	36231783	36231783	\N	GRCh37
101	21	\N	C	36252876	36252876	\N	GRCh37
102	21	\N	C	36252877	36252877	\N	GRCh37
103	21	\N	T	36252878	36252878	\N	GRCh37
104	21	\N	T	44514777	44514777	\N	GRCh37
105	21	\N	G	44524456	44524456	\N	GRCh37
106	3	\N	G	128200113	128200113	\N	GRCh37
107	3	\N	G	128200744	128200744	\N	GRCh37
108	3	\N	G	178936082	178936082	\N	GRCh37
109	3	\N	G	178936091	178936091	\N	GRCh37
110	3	\N	A	178936092	178936092	\N	GRCh37
111	3	\N	C	178936094	178936094	\N	GRCh37
112	3	\N	A	178936095	178936095	\N	GRCh37
113	3	\N	G	178936103	178936103	\N	GRCh37
114	3	\N	A	178952085	178952085	\N	GRCh37
115	3	\N	C	41266113	41266113	\N	GRCh37
116	3	\N	T	41266136	41266136	\N	GRCh37
117	3	\N	C	41266137	41266137	\N	GRCh37
118	4	\N	T	55141036	55141036	\N	GRCh37
119	4	\N	C	55144148	55144148	\N	GRCh37
120	4	\N	A	55152093	55152093	\N	GRCh37
121	4	\N	G	55592144	55592144	\N	GRCh37
122	4	\N	T	55592186	55592186	\N	GRCh37
123	4	\N	A	55593584	55593584	\N	GRCh37
124	4	\N	T	55593591	55593591	\N	GRCh37
128	4	\N	T	55593603	55593603	\N	GRCh37
129	4	\N	G	55593608	55593608	\N	GRCh37
131	4	\N	T	55593610	55593610	\N	GRCh37
133	4	\N	T	55593613	55593613	\N	GRCh37
134	4	\N	G	55593628	55593628	\N	GRCh37
135	4	\N	A	55593630	55593630	\N	GRCh37
138	4	\N	T	55593640	55593640	\N	GRCh37
140	4	\N	T	55593661	55593661	\N	GRCh37
143	4	\N	C	55594197	55594197	\N	GRCh37
144	4	\N	A	55594221	55594221	\N	GRCh37
145	4	\N	T	55594258	55594258	\N	GRCh37
146	4	\N	A	55594261	55594261	\N	GRCh37
147	4	\N	T	55594262	55594262	\N	GRCh37
148	4	\N	C	55595599	55595599	\N	GRCh37
149	4	\N	G	55599320	55599320	\N	GRCh37
150	4	\N	GA	55599320	55599321	\N	GRCh37
151	4	\N	A	55599321	55599321	\N	GRCh37
152	4	\N	G	55599332	55599332	\N	GRCh37
153	4	\N	A	55599333	55599333	\N	GRCh37
154	4	\N	T	55599334	55599334	\N	GRCh37
155	4	\N	A	55599338	55599338	\N	GRCh37
156	4	\N	A	55599339	55599339	\N	GRCh37
157	4	\N	T	55599340	55599340	\N	GRCh37
158	4	\N	T	55599341	55599341	\N	GRCh37
159	4	\N	G	55602664	55602664	\N	GRCh37
160	4	\N	A	55602700	55602700	\N	GRCh37
161	4	\N	C	55602770	55602770	\N	GRCh37
163	6	\N	T	152415537	152415537	\N	GRCh37
164	6	\N	T	152419914	152419914	\N	GRCh37
165	6	\N	C	152419917	152419917	\N	GRCh37
166	6	\N	T	152419920	152419920	\N	GRCh37
167	6	\N	T	152419922	152419922	\N	GRCh37
168	6	\N	A	152419923	152419923	\N	GRCh37
169	6	\N	A	152419926	152419926	\N	GRCh37
170	7	\N	CC	128829195	128829196	\N	GRCh37
171	7	\N	C	128845101	128845101	\N	GRCh37
172	7	\N	CC	128846116	128846117	\N	GRCh37
173	7	\N	G	128849189	128849189	\N	GRCh37
174	7	\N	CC	128849224	128849225	\N	GRCh37
175	7	\N	CC	128850279	128850280	\N	GRCh37
176	7	\N	G	128850341	128850341	\N	GRCh37
177	7	\N	G	128850838	128850838	\N	GRCh37
178	7	\N	C	128851883	128851883	\N	GRCh37
179	7	\N	CC	128852191	128852192	\N	GRCh37
180	7	\N	T	140453134	140453134	\N	GRCh37
181	7	\N	CA	140453135	140453136	\N	GRCh37
182	7	\N	A	140453136	140453136	\N	GRCh37
183	7	\N	AC	140453136	140453137	\N	GRCh37
184	7	\N	A	140453145	140453145	\N	GRCh37
185	7	\N	A	140453153	140453153	\N	GRCh37
186	7	\N	T	140453154	140453154	\N	GRCh37
187	7	\N	C	140453155	140453155	\N	GRCh37
188	7	\N	CA	140453155	140453156	\N	GRCh37
189	7	\N	T	140481393	140481393	\N	GRCh37
190	7	\N	C	140481402	140481402	\N	GRCh37
191	7	\N	CC	140481402	140481403	\N	GRCh37
192	7	\N	C	140481411	140481411	\N	GRCh37
193	7	\N	G	55241707	55241707	\N	GRCh37
194	7	\N	G	55241708	55241708	\N	GRCh37
195	7	\N	C	55249071	55249071	\N	GRCh37
196	7	\N	T	55259515	55259515	\N	GRCh37
197	7	\N	T	55259524	55259524	\N	GRCh37
198	9	\N	G	5073770	5073770	\N	GRCh37
199	9	\N	A	5078360	5078360	\N	GRCh37
200	9	\N	G	5078361	5078361	\N	GRCh37
201	9	\N	A	5078362	5078362	\N	GRCh37
202	9	\N	T	80409488	80409488	\N	GRCh37
203	X	\N	A	1314966	1314966	\N	GRCh37
15	10	\N	A	89717775	89717775	A	GRCh37
16	11	\N	-	32417909	32417910	C	GRCh37
38	15	\N	CAGGTCAGGACCGTT	28505962	28505962	T	GRCh37
57	17	\N	TTGAGGGAAAACACA	37880219	37880219	G	GRCh37
61	17	\N	-	37881003	37881004	G	GRCh37
125	4	\N	GAAGTACAGTGGAAG	55593594	55593594	T	GRCh37
126	4	\N	GAAGTACAGTGGAAGGTT	55593594	55593594	T	GRCh37
208	1	\N	C	11187857	11187857	\N	GRCh37
209	1	\N	A	11217299	11217299	\N	GRCh37
210	1	\N	C	16464489	16464489	\N	GRCh37
211	1	\N	T	36933444	36933444	\N	GRCh37
212	1	\N	A	43814978	43814978	\N	GRCh37
127	4	\N	-	55593600	55593601	A	GRCh37
130	4	\N	GTT	55593609	55593611	G	GRCh37
132	4	\N	GTT	55593612	55593612	T	GRCh37
136	4	\N	AACAATTATGTTACAGAC	55593630	55593647	A	GRCh37
137	4	\N	AACAATTATGTTACAGACCCAACA	55593630	55593656	A	GRCh37
213	1	\N	G	43814979	43814979	\N	GRCh37
214	1	\N	G	43815009	43815009	\N	GRCh37
215	1	\N	C	65312347	65312347	\N	GRCh37
216	1	\N	G	65312382	65312382	\N	GRCh37
217	1	\N	TT	115256528	115256529	\N	GRCh37
218	1	\N	TG	115256529	115256530	\N	GRCh37
219	1	\N	C	115258730	115258730	\N	GRCh37
139	4	\N	-	55593657	55593658	A	GRCh37
141	4	\N	CTTATGATC	55593664	55593664	C	GRCh37
142	4	\N	GAT	55593669	55593671	T	GRCh37
220	1	\N	C	162724415	162724415	\N	GRCh37
221	1	\N	T	162729630	162729630	\N	GRCh37
222	1	\N	G	162729671	162729671	\N	GRCh37
162	5	\N	-	170837546	170837547	C	GRCh37
204	1	\N	C	11169361	11169361	\N	GRCh37
205	1	\N	C	11174420	11174420	\N	GRCh37
206	1	\N	G	11182179	11182179	\N	GRCh37
207	1	\N	G	11184573	11184573	\N	GRCh37
223	1	\N	G	162741822	162741822	\N	GRCh37
224	1	\N	A	162745497	162745497	\N	GRCh37
225	1	\N	G	162748407	162748407	\N	GRCh37
226	2	\N	C	29432682	29432682	\N	GRCh37
227	2	\N	G	29443600	29443600	\N	GRCh37
228	2	\N	C	29443613	29443613	\N	GRCh37
229	2	\N	G	29443631	29443631	\N	GRCh37
230	2	\N	C	29443642	29443642	\N	GRCh37
231	2	\N	A	29445270	29445270	\N	GRCh37
232	2	\N	C	29445450	29445450	\N	GRCh37
233	2	\N	C	212295699	212295699	\N	GRCh37
234	2	\N	G	212537975	212537975	\N	GRCh37
235	2	\N	C	212537981	212537981	\N	GRCh37
236	2	\N	C	212566827	212566827	\N	GRCh37
237	2	\N	G	212570064	212570064	\N	GRCh37
238	2	\N	C	212578308	212578308	\N	GRCh37
239	3	\N	C	10183772	10183772	\N	GRCh37
240	3	\N	T	10183785	10183785	\N	GRCh37
241	3	\N	T	10183797	10183797	\N	GRCh37
242	3	\N	T	10191480	10191480	\N	GRCh37
243	3	\N	C	10191488	10191488	\N	GRCh37
244	3	\N	C	10191506	10191506	\N	GRCh37
245	3	\N	C	12641195	12641195	\N	GRCh37
246	3	\N	A	12645700	12645700	\N	GRCh37
247	3	\N	T	37067240	37067240	\N	GRCh37
248	3	\N	T	38182641	38182641	\N	GRCh37
249	3	\N	G	41266040	41266040	\N	GRCh37
250	3	\N	G	41266064	41266064	\N	GRCh37
252	3	\N	T	41266068	41266068	\N	GRCh37
254	3	\N	G	41266097	41266097	\N	GRCh37
255	3	\N	A	41266098	41266098	\N	GRCh37
256	3	\N	C	41266101	41266101	\N	GRCh37
257	3	\N	G	41266103	41266103	\N	GRCh37
258	3	\N	G	41266104	41266104	\N	GRCh37
259	3	\N	T	41266112	41266112	\N	GRCh37
260	3	\N	A	41266121	41266121	\N	GRCh37
261	3	\N	C	41266122	41266122	\N	GRCh37
262	3	\N	G	178916876	178916876	\N	GRCh37
263	3	\N	T	178921553	178921553	\N	GRCh37
264	3	\N	T	178927980	178927980	\N	GRCh37
265	3	\N	C	178936074	178936074	\N	GRCh37
266	3	\N	G	178936093	178936093	\N	GRCh37
267	3	\N	A	178938860	178938860	\N	GRCh37
268	3	\N	A	178952007	178952007	\N	GRCh37
269	3	\N	G	178952074	178952074	\N	GRCh37
270	3	\N	C	178952084	178952084	\N	GRCh37
271	3	\N	G	178952090	178952090	\N	GRCh37
272	4	\N	C	1803564	1803564	\N	GRCh37
273	4	\N	C	1803568	1803568	\N	GRCh37
274	4	\N	G	1806089	1806089	\N	GRCh37
275	4	\N	A	1806092	1806092	\N	GRCh37
276	4	\N	A	1806099	1806099	\N	GRCh37
277	4	\N	G	1807488	1807488	\N	GRCh37
278	4	\N	A	1807889	1807889	\N	GRCh37
279	4	\N	G	1808331	1808331	\N	GRCh37
280	4	\N	C	55141083	55141083	\N	GRCh37
281	4	\N	T	55144144	55144144	\N	GRCh37
283	4	\N	G	55152090	55152090	\N	GRCh37
284	4	\N	G	55152092	55152092	\N	GRCh37
285	4	\N	GA	55152092	55152093	\N	GRCh37
289	4	\N	C	55152101	55152101	\N	GRCh37
290	4	\N	G	55152104	55152104	\N	GRCh37
291	4	\N	G	55152126	55152126	\N	GRCh37
292	4	\N	G	55561764	55561764	\N	GRCh37
293	4	\N	G	55593603	55593603	\N	GRCh37
294	4	\N	G	55593609	55593609	\N	GRCh37
295	4	\N	C	55595519	55595519	\N	GRCh37
296	4	\N	T	55599348	55599348	\N	GRCh37
297	4	\N	G	55602694	55602694	\N	GRCh37
298	5	\N	A	35873597	35873597	\N	GRCh37
299	5	\N	G	67589138	67589138	\N	GRCh37
301	5	\N	C	67589618	67589618	\N	GRCh37
302	5	\N	G	67591085	67591085	\N	GRCh37
304	5	\N	A	67591097	67591097	\N	GRCh37
305	5	\N	C	67591099	67591099	\N	GRCh37
308	5	\N	C	112173917	112173917	\N	GRCh37
309	5	\N	C	112174631	112174631	\N	GRCh37
310	5	\N	G	112175207	112175207	\N	GRCh37
313	5	\N	C	112175303	112175303	\N	GRCh37
314	5	\N	C	112175390	112175390	\N	GRCh37
315	5	\N	C	112175423	112175423	\N	GRCh37
316	5	\N	G	112175426	112175426	\N	GRCh37
317	5	\N	C	112175576	112175576	\N	GRCh37
318	5	\N	C	112175639	112175639	\N	GRCh37
321	5	\N	A	149433644	149433644	\N	GRCh37
322	5	\N	T	149433645	149433645	\N	GRCh37
323	5	\N	A	149433646	149433646	\N	GRCh37
324	5	\N	A	149441328	149441328	\N	GRCh37
325	5	\N	A	149453044	149453044	\N	GRCh37
326	5	\N	C	176522416	176522416	\N	GRCh37
327	5	\N	T	176522552	176522552	\N	GRCh37
328	6	\N	C	117638347	117638347	\N	GRCh37
329	6	\N	G	152332832	152332832	\N	GRCh37
330	7	\N	C	6426892	6426892	\N	GRCh37
331	7	\N	G	55211080	55211080	\N	GRCh37
332	7	\N	A	55221743	55221743	\N	GRCh37
333	7	\N	C	55221822	55221822	\N	GRCh37
334	7	\N	A	55228007	55228007	\N	GRCh37
335	7	\N	C	55231430	55231430	\N	GRCh37
336	7	\N	G	55233043	55233043	\N	GRCh37
337	7	\N	G	55241620	55241620	\N	GRCh37
338	7	\N	G	55242423	55242423	\N	GRCh37
339	7	\N	C	55242428	55242428	\N	GRCh37
340	7	\N	G	55242430	55242430	\N	GRCh37
341	7	\N	G	55242433	55242433	\N	GRCh37
342	7	\N	T	55242455	55242455	\N	GRCh37
343	7	\N	A	55242464	55242464	\N	GRCh37
344	7	\N	G	55242466	55242466	\N	GRCh37
345	7	\N	T	55242470	55242470	\N	GRCh37
346	7	\N	G	55242478	55242478	\N	GRCh37
347	7	\N	C	55242485	55242485	\N	GRCh37
348	7	\N	C	55242487	55242487	\N	GRCh37
349	7	\N	G	55242511	55242511	\N	GRCh37
350	7	\N	G	55249005	55249005	\N	GRCh37
351	7	\N	A	55249020	55249020	\N	GRCh37
352	7	\N	G	55249130	55249130	\N	GRCh37
353	7	\N	G	55249131	55249131	\N	GRCh37
354	7	\N	G	55259469	55259469	\N	GRCh37
355	7	\N	C	55259514	55259514	\N	GRCh37
356	7	\N	CT	55259514	55259515	\N	GRCh37
357	7	\N	TG	55259515	55259516	\N	GRCh37
358	7	\N	C	116411923	116411923	\N	GRCh37
359	7	\N	C	116411990	116411990	\N	GRCh37
360	7	\N	G	116417457	116417457	\N	GRCh37
361	7	\N	C	116417463	116417463	\N	GRCh37
362	7	\N	A	116417464	116417464	\N	GRCh37
363	7	\N	T	116423413	116423413	\N	GRCh37
364	7	\N	A	116423414	116423414	\N	GRCh37
365	7	\N	T	116423428	116423428	\N	GRCh37
366	7	\N	T	116423474	116423474	\N	GRCh37
367	7	\N	G	116423475	116423475	\N	GRCh37
368	7	\N	C	140453121	140453121	\N	GRCh37
369	7	\N	CT	140453121	140453122	\N	GRCh37
370	7	\N	T	140453132	140453132	\N	GRCh37
372	7	\N	T	140453133	140453133	\N	GRCh37
373	7	\N	C	140453137	140453137	\N	GRCh37
374	7	\N	G	140453139	140453139	\N	GRCh37
375	7	\N	AG	140453145	140453146	\N	GRCh37
376	7	\N	G	140453146	140453146	\N	GRCh37
377	7	\N	C	140453149	140453149	\N	GRCh37
378	7	\N	A	140453150	140453150	\N	GRCh37
379	7	\N	A	140453151	140453151	\N	GRCh37
380	7	\N	A	140453152	140453152	\N	GRCh37
381	7	\N	T	140453159	140453159	\N	GRCh37
382	7	\N	T	140453161	140453161	\N	GRCh37
383	7	\N	G	140453174	140453174	\N	GRCh37
384	7	\N	T	140453175	140453175	\N	GRCh37
385	7	\N	C	140453179	140453179	\N	GRCh37
386	7	\N	T	140453193	140453193	\N	GRCh37
387	7	\N	C	140481397	140481397	\N	GRCh37
388	7	\N	C	140481403	140481403	\N	GRCh37
389	7	\N	C	140481412	140481412	\N	GRCh37
390	7	\N	C	140481417	140481417	\N	GRCh37
391	7	\N	C	140481418	140481418	\N	GRCh37
392	7	\N	G	140481478	140481478	\N	GRCh37
393	7	\N	G	148506467	148506467	\N	GRCh37
394	7	\N	T	148508727	148508727	\N	GRCh37
395	7	\N	A	148508728	148508728	\N	GRCh37
396	8	\N	G	38282209	38282209	\N	GRCh37
397	8	\N	G	38285938	38285938	\N	GRCh37
398	8	\N	C	128750632	128750632	\N	GRCh37
399	8	\N	C	128750639	128750639	\N	GRCh37
400	8	\N	C	128750681	128750681	\N	GRCh37
401	8	\N	C	128750693	128750693	\N	GRCh37
402	8	\N	A	128750765	128750765	\N	GRCh37
403	8	\N	C	128751241	128751241	\N	GRCh37
404	9	\N	G	21971017	21971017	\N	GRCh37
405	9	\N	C	21971028	21971028	\N	GRCh37
406	9	\N	C	21971029	21971029	\N	GRCh37
407	9	\N	C	21971036	21971036	\N	GRCh37
408	9	\N	C	21971096	21971096	\N	GRCh37
409	9	\N	C	21971108	21971108	\N	GRCh37
410	9	\N	G	21971111	21971111	\N	GRCh37
411	9	\N	G	21971120	21971120	\N	GRCh37
412	9	\N	C	21971153	21971153	\N	GRCh37
413	9	\N	C	21971177	21971177	\N	GRCh37
414	9	\N	G	21971186	21971186	\N	GRCh37
415	9	\N	TG	80409488	80409489	\N	GRCh37
416	9	\N	G	133738306	133738306	\N	GRCh37
417	9	\N	A	133738307	133738307	\N	GRCh37
418	9	\N	A	133738330	133738330	\N	GRCh37
419	9	\N	C	133738342	133738342	\N	GRCh37
420	9	\N	G	133738349	133738349	\N	GRCh37
421	9	\N	G	133738356	133738356	\N	GRCh37
422	9	\N	T	133738357	133738357	\N	GRCh37
423	9	\N	A	133738358	133738358	\N	GRCh37
424	9	\N	G	133738363	133738363	\N	GRCh37
425	9	\N	A	133738364	133738364	\N	GRCh37
426	9	\N	A	133747540	133747540	\N	GRCh37
427	9	\N	G	133747588	133747588	\N	GRCh37
428	9	\N	A	133748282	133748282	\N	GRCh37
429	9	\N	C	133748283	133748283	\N	GRCh37
430	9	\N	T	133748288	133748288	\N	GRCh37
431	9	\N	T	133748289	133748289	\N	GRCh37
432	9	\N	C	133748290	133748290	\N	GRCh37
433	9	\N	T	133748391	133748391	\N	GRCh37
434	9	\N	A	133748403	133748403	\N	GRCh37
435	9	\N	T	133748414	133748414	\N	GRCh37
436	9	\N	T	133748415	133748415	\N	GRCh37
437	9	\N	A	133750356	133750356	\N	GRCh37
439	10	\N	A	43609940	43609940	\N	GRCh37
441	10	\N	T	43609948	43609948	\N	GRCh37
442	10	\N	G	43609949	43609949	\N	GRCh37
443	10	\N	C	43609950	43609950	\N	GRCh37
444	10	\N	G	43613840	43613840	\N	GRCh37
445	10	\N	GC	43615568	43615569	\N	GRCh37
447	10	\N	C	89711899	89711899	\N	GRCh37
448	10	\N	G	89711900	89711900	\N	GRCh37
449	10	\N	C	89717675	89717675	\N	GRCh37
450	10	\N	C	89720852	89720852	\N	GRCh37
451	10	\N	T	123247516	123247516	\N	GRCh37
452	10	\N	A	123247577	123247577	\N	GRCh37
453	10	\N	A	123256060	123256060	\N	GRCh37
454	10	\N	T	123256215	123256215	\N	GRCh37
455	10	\N	C	123256219	123256219	\N	GRCh37
456	10	\N	A	123258034	123258034	\N	GRCh37
457	10	\N	T	123258036	123258036	\N	GRCh37
458	10	\N	T	123258042	123258042	\N	GRCh37
459	10	\N	C	123258070	123258070	\N	GRCh37
460	10	\N	C	123258076	123258076	\N	GRCh37
461	10	\N	A	123274777	123274777	\N	GRCh37
462	10	\N	T	123274794	123274794	\N	GRCh37
463	10	\N	G	123274803	123274803	\N	GRCh37
464	10	\N	G	123278324	123278324	\N	GRCh37
465	10	\N	T	123279503	123279503	\N	GRCh37
466	10	\N	C	123279562	123279562	\N	GRCh37
467	10	\N	G	123279674	123279674	\N	GRCh37
468	10	\N	G	123279677	123279677	\N	GRCh37
469	11	\N	C	533873	533873	\N	GRCh37
470	11	\N	CT	533873	533874	\N	GRCh37
471	11	\N	G	533875	533875	\N	GRCh37
472	11	\N	C	534285	534285	\N	GRCh37
473	11	\N	T	119148891	119148891	\N	GRCh37
474	11	\N	T	119148930	119148930	\N	GRCh37
475	12	\N	C	25380283	25380283	\N	GRCh37
476	12	\N	G	25398255	25398255	\N	GRCh37
477	12	\N	C	25398262	25398262	\N	GRCh37
478	12	\N	C	56481857	56481857	\N	GRCh37
479	12	\N	G	56481922	56481922	\N	GRCh37
480	12	\N	A	56490980	56490980	\N	GRCh37
481	12	\N	C	58145430	58145430	\N	GRCh37
482	13	\N	T	28592620	28592620	\N	GRCh37
483	13	\N	A	28592621	28592621	\N	GRCh37
486	13	\N	TC	28592641	28592642	\N	GRCh37
487	13	\N	A	28601359	28601359	\N	GRCh37
488	13	\N	T	28601373	28601373	\N	GRCh37
489	13	\N	G	28602340	28602340	\N	GRCh37
490	13	\N	T	28602342	28602342	\N	GRCh37
491	13	\N	T	28602416	28602416	\N	GRCh37
492	13	\N	C	28608111	28608111	\N	GRCh37
493	13	\N	T	28608341	28608341	\N	GRCh37
494	13	\N	G	48919244	48919244	\N	GRCh37
495	13	\N	T	48923148	48923148	\N	GRCh37
496	13	\N	C	48941648	48941648	\N	GRCh37
497	13	\N	C	48942685	48942685	\N	GRCh37
498	13	\N	C	48953760	48953760	\N	GRCh37
499	13	\N	C	48955538	48955538	\N	GRCh37
500	13	\N	C	48955550	48955550	\N	GRCh37
501	13	\N	C	49027168	49027168	\N	GRCh37
502	13	\N	G	49037877	49037877	\N	GRCh37
503	13	\N	G	49039164	49039164	\N	GRCh37
504	14	\N	G	105243048	105243048	\N	GRCh37
505	15	\N	A	66727453	66727453	\N	GRCh37
506	15	\N	T	66729088	66729088	\N	GRCh37
507	15	\N	T	66729100	66729100	\N	GRCh37
508	15	\N	A	66729148	66729148	\N	GRCh37
509	15	\N	G	66729152	66729152	\N	GRCh37
510	15	\N	T	66729153	66729153	\N	GRCh37
511	15	\N	G	66729175	66729175	\N	GRCh37
512	15	\N	T	66729177	66729177	\N	GRCh37
513	15	\N	T	66774156	66774156	\N	GRCh37
514	15	\N	T	66774168	66774168	\N	GRCh37
515	16	\N	C	81946260	81946260	\N	GRCh37
516	16	\N	A	81962183	81962183	\N	GRCh37
517	17	\N	G	7577022	7577022	\N	GRCh37
518	17	\N	G	7577539	7577539	\N	GRCh37
519	17	\N	C	7577548	7577548	\N	GRCh37
520	17	\N	C	7578406	7578406	\N	GRCh37
521	17	\N	C	37868208	37868208	\N	GRCh37
522	17	\N	G	37880997	37880997	\N	GRCh37
524	17	\N	T	37881025	37881025	\N	GRCh37
525	19	\N	C	1207021	1207021	\N	GRCh37
526	19	\N	C	1220415	1220415	\N	GRCh37
527	19	\N	G	1220487	1220487	\N	GRCh37
528	19	\N	A	1220488	1220488	\N	GRCh37
529	19	\N	C	1220489	1220489	\N	GRCh37
530	19	\N	G	1220494	1220494	\N	GRCh37
531	19	\N	G	1220502	1220502	\N	GRCh37
532	19	\N	C	1221319	1221319	\N	GRCh37
533	19	\N	G	1223059	1223059	\N	GRCh37
534	19	\N	T	4110581	4110581	\N	GRCh37
535	19	\N	A	4110584	4110584	\N	GRCh37
536	19	\N	T	4117541	4117541	\N	GRCh37
537	19	\N	G	4117584	4117584	\N	GRCh37
538	19	\N	C	4117617	4117617	\N	GRCh37
539	19	\N	C	17945696	17945696	\N	GRCh37
540	19	\N	C	17945969	17945969	\N	GRCh37
541	19	\N	G	17948009	17948009	\N	GRCh37
542	19	\N	C	17949138	17949138	\N	GRCh37
543	19	\N	G	17954215	17954215	\N	GRCh37
544	19	\N	A	17954634	17954634	\N	GRCh37
545	19	\N	A	18278061	18278061	\N	GRCh37
546	19	\N	C	40741870	40741870	\N	GRCh37
547	19	\N	T	40742220	40742220	\N	GRCh37
548	20	\N	C	36031762	36031762	\N	GRCh37
549	20	\N	C	57484420	57484420	\N	GRCh37
550	20	\N	G	57484421	57484421	\N	GRCh37
551	20	\N	A	57484596	57484596	\N	GRCh37
552	X	\N	C	47426121	47426121	\N	GRCh37
553	X	\N	C	100611164	100611164	\N	GRCh37
554	X	\N	A	100611165	100611165	\N	GRCh37
300	5	\N	GAA	67589552	67589552	A	GRCh37
438	10	\N	TTCCCTGAGGAGGAGAAGTGCTTCTGC	43609078	43609104	C	GRCh37
251	3	\N	GTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	41266067	41266117	T	GRCh37
253	3	\N	TGGCAGCAACAGTCTTACCTGGAC	41266076	41266099	C	GRCh37
282	4	\N	AGAGAC	55152089	55152094	C	GRCh37
286	4	\N	GACATCATG	55152092	55152100	A	GRCh37
287	4	\N	GACATCATGCAT	55152092	55152103	A	GRCh37
288	4	\N	ATCATGCATGAT	55152095	55152106	C	GRCh37
303	5	\N	GACAAACGTATGAACAGC	67591085	67591102	T	GRCh37
306	5	\N	ACG	67591133	67591135	G	GRCh37
307	5	\N	TGG	67591249	67591249	G	GRCh37
311	5	\N	AAGATTGGAAC	112175219	112175229	A	GRCh37
312	5	\N	AAGATTGGAACTAGGTCAGC	112175219	112175238	A	GRCh37
319	5	\N	GGACC	112175687	112175691	T	GRCh37
320	5	\N	ATTGATTC	112175960	112175967	T	GRCh37
371	7	\N	TTT	140453132	140453134	A	GRCh37
440	10	\N	GAGCTG	43609942	43609947	C	GRCh37
446	10	\N	GATGTTTATGAA	43615613	43615624	A	GRCh37
484	13	\N	GAT	28592637	28592639	T	GRCh37
485	13	\N	ATC	28592640	28592642	T	GRCh37
523	17	\N	-	37880997	37880998	T	GRCh37
\.


--
-- Data for Name: mutation_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY mutation_types (id, name) FROM stdin;
1	missense
2	nonsense
3	frame_shift_del
4	frame_shift_ins
5	in_frame_del
6	in_frame_ins
\.


--
-- Data for Name: sources; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY sources (id, name, pubmed_id, citation) FROM stdin;
386	\N	2674680	van 't Veer et al., 1989, Mol. Cell. Biol.
387	\N	23414587	Ascierto et al., 2013, Lancet Oncol.
388	\N	18390968	Adjei et al., 2008, J. Clin. Oncol.
389	\N	23538902	Haarberg et al., 2013, Mol. Cancer Ther.
390	\N	23569304	Trunzer et al., 2013, J. Clin. Oncol.
391	\N	8120410	Ball et al., 1994, J. Invest. Dermatol.
392	\N	16291983	Curtin et al., 2005, N. Engl. J. Med.
393	\N	20130576	Hatzivassiliou et al., 2010, Nature
394	\N	20179705	Poulikakos et al., 2010, Nature
395	\N	22761467	Martinez-Garcia et al., 2012, Clin. Cancer Res.
396	\N	23076151	Kaplan et al., 2012, J. Biol. Chem.
397	\N	20149136	Halaban et al., 2010, Pigment Cell Melanoma Res
398	\N	20406486	Søndergaard et al., 2010, J Transl Med
399	\N	17384584	Schubbert et al., 2007, Nat. Rev. Cancer
400	\N	19255327	Kloos et al., 2009, J. Clin. Oncol.
401	\N	19773371	Hoftijzer et al., 2009, Eur. J. Endocrinol.
402	\N	21107323	Nazarian et al., 2010, Nature
403	\N	23406027	Ho et al., 2013, N. Engl. J. Med.
404	\N	24918823	Carlino et al., 2014, Br. J. Cancer
405	\N	23431193	Posch et al., 2013, Proc. Natl. Acad. Sci. U.S.A.
406	\N	22962325	Wilmott et al., 2012, Mol. Cancer Ther.
407	\N	22144181	Xu et al., 2012, Blood
408	\N	24553387	Misale et al., 2014, Sci Transl Med
409	\N	23134356	Callahan et al., 2012, N. Engl. J. Med.
410	\N	18938156	Day et al., 2008, Eur. J. Pharmacol.
411	\N	23932362	Pitini et al., 2013, Lung Cancer
412	\N	19798509	Capper et al., 2009, Acta Neuropathol.
413	\N	19818334	Kato et al., 2009, Biochem. Biophys. Res. Commun.
414	\N	23558169	Rohle et al., 2013, Science
415	\N	21352804	Kaneko et al., 2011, Biochem. Biophys. Res. Commun.
416	\N	19718025	Prickett et al., 2009, Nat. Genet.
417	\N	11921283	Kondo et al., 2002, Genes Chromosomes Cancer
418	\N	7660122	Duan et al., 1995, Science
419	\N	23737487	Antony et al., 2013, Cancer Res.
420	\N	25823662	Chiu et al., 2015, Oncotarget
421	\N	21179087	Ngo et al., 2011, Nature
422	\N	19234609	Halaban et al., 2009, PLoS ONE
423	\N	9065403	Rubinfeld et al., 1997, Science
424	\N	10027390	Rimm et al., 1999, Am. J. Pathol.
425	\N	11351304	Omholt et al., 2001, Int. J. Cancer
426	\N	11930117	Pollock et al., 2002, Melanoma Res.
427	\N	11950921	Demunter et al., 2002, Mod. Pathol.
428	\N	12124804	Reifenberger et al., 2002, Int. J. Cancer
429	\N	15133491	Worm et al., 2004, Oncogene
430	\N	24788118	Hamada et al., 2014, PLoS ONE
431	\N	15805248	Saal et al., 2005, Cancer Res.
432	\N	18676830	Stemke-Hale et al., 2008, Cancer Res.
433	\N	23066039	Janku et al., 2013, Cancer Res.
434	\N	23408298	Fury et al., 2013, Cancer
435	\N	24265155	Shi et al., 2014, Cancer Discov
436	\N	15930273	Ikenoue et al., 2005, Cancer Res.
437	\N	21824802	Cohen et al., 2011, Oral Oncol.
438	\N	19381019	Qing et al., 2009, J. Clin. Invest.
439	\N	19331127	Guan et al., 2009, Anticancer Res.
1	\N	18615627	Jones et al., 2008, Cancer
2	\N	11853795	von Bubnoff et al., 2002, Lancet
3	\N	25157968	MacConaill et al., 2014, J Mol Diagn
4	\N	11861307	Hofmann et al., 2002, Blood
5	\N	22772060	Giles et al., 2013, Leukemia
6	\N	19907440	Chapiro et al., 2010, Leukemia
7	\N	19965641	Hertzberg et al., 2010, Blood
8	\N	20018760	Yoda et al., 2010, Proc. Natl. Acad. Sci. U.S.A.
9	\N	22368272	Chen et al., 2012, Blood
10	\N	22897847	Roberts et al., 2012, Cancer Cell
11	\N	22955920	Maude et al., 2012, Blood
12	\N	21680795	Zhang et al., 2011, Blood
13	\N	19470474	Mullighan et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
14	\N	19838194	Mullighan et al., 2009, Nat. Genet.
15	\N	19139102	Hornakova et al., 2009, J. Biol. Chem.
16	\N	22368270	Man et al., 2012, Blood
17	\N	18805579	Bercovich et al., 2008, Lancet
18	\N	23700467	Han et al., 2013, PLoS ONE
19	\N	23934607	Neumann et al., 2013, Virchows Arch.
20	\N	17611497	Carpten et al., 2007, Nature
21	\N	24651453	Drew et al., 2014, Mol. Cancer Res.
22	\N	8187091	Miyaki et al., 1994, Cancer Res.
23	\N	1528264	Powell et al., 1992, Nature
24	\N	2281069	Steinbrugger et al., 1990, Pneumologie
25	\N	21901162	Vasovcak et al., 2011, PLoS ONE
26	\N	24861525	Palacio-Rúa et al., Rev Gastroenterol Mex
27	\N	22810696	2012, Nature
28	\N	23204322	Nikolaev et al., 2012, Cancer Res.
29	\N	1338904	Miyoshi et al., 1992, Hum. Mol. Genet.
30	\N	10737795	Rowan et al., 2000, Proc. Natl. Acad. Sci. U.S.A.
31	\N	24518971	Hasanpour et al., 2014, Cell J
32	\N	17704924	Jeon et al., 2008, Int J Colorectal Dis
33	\N	18992635	Bougatef et al., 2008, Cancer Genet. Cytogenet.
34	\N	22848674	Voorham et al., 2012, PLoS ONE
35	\N	12374230	De Filippo et al., 2002, Scand. J. Gastroenterol.
36	\N	20233444	Fumagalli et al., 2010, BMC Cancer
37	\N	18392055	Kim et al., 2008, Br. J. Cancer
38	\N	19537845	De Roock et al., 2009, Mol Diagn Ther
39	\N	21129611	Rizzo et al., 2010, Cancer Treat. Rev.
40	\N	20350999	Tejpar et al., 2010, Oncologist
41	\N	12068308	Davies et al., 2002, Nature
42	\N	21163703	De Roock et al., 2011, Lancet Oncol.
43	\N	20857202	Mao et al., 2011, Mol. Biol. Rep.
44	\N	20413299	Tol et al., 2010, Eur. J. Cancer
45	\N	21426297	Dienstmann et al., 2011, Anticancer Agents Med Chem
46	\N	22281684	Prahallad et al., 2012, Nature
47	\N	22448344	Corcoran et al., 2012, Cancer Discov
48	\N	22180495	Yang et al., 2012, Cancer Res.
49	\N	20619739	De Roock et al., 2010, Lancet Oncol.
50	\N	23325582	Peeters et al., 2013, Clin. Cancer Res.
51	\N	22608338	Falchook et al., 2012, Lancet
52	\N	23251002	Mao et al., 2013, Clin. Cancer Res.
53	\N	23549875	Coffee et al., 2013, Clin. Cancer Res.
54	\N	24107445	Zecchin et al., 2013, Mol. Cancer Ther.
55	\N	24163374	Faber et al., 2014, Cancer Discov
56	\N	22310681	Bardelli et al., 2012, Nat. Med.
57	\N	14678966	Ikenoue et al., 2003, Cancer Res.
58	\N	15035987	Wan et al., 2004, Cell
59	\N	12438234	Yuen et al., 2002, Cancer Res.
60	\N	18186519	Bentivegna et al., 2008, Hum. Mutat.
61	\N	22270724	Montagut et al., 2012, Nat. Med.
62	\N	18316791	Amado et al., 2008, J. Clin. Oncol.
63	\N	19679400	Neumann et al., 2009, Pathol. Res. Pract.
64	\N	16361624	Rothenberg et al., 2005, J. Clin. Oncol.
65	\N	19114683	Bokemeyer et al., 2009, J. Clin. Oncol.
66	\N	21228335	Bokemeyer et al., 2011, Ann. Oncol.
67	\N	20921465	Douillard et al., 2010, J. Clin. Oncol.
68	\N	16618717	Lièvre et al., 2006, Cancer Res.
69	\N	20921462	Peeters et al., 2010, J. Clin. Oncol.
70	\N	22734028	Tejpar et al., 2012, J. Clin. Oncol.
71	\N	20978259	De Roock et al., 2010, JAMA
72	\N	22392911	Migliardi et al., 2012, Clin. Cancer Res.
73	\N	20736745	Irahara et al., 2010, Diagn. Mol. Pathol.
74	\N	21829508	Janku et al., 2011, PLoS ONE
75	\N	21305640	Vaughn et al., 2011, Genes Chromosomes Cancer
76	\N	21729679	De Mattos-Arruda et al., 2011, Clin Colorectal Cancer
77	\N	17699718	Davies et al., 2007, Mol. Cancer Ther.
78	\N	16273091	Solit et al., 2006, Nature
79	\N	15016963	Samuels et al., 2004, Science
80	\N	15647370	Kang et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
81	\N	15254419	Bachman et al., 2004, Cancer Biol. Ther.
82	\N	20453058	O'Brien et al., 2010, Clin. Cancer Res.
83	\N	18725974	She et al., 2008, PLoS ONE
84	\N	22162589	Bendell et al., 2012, J. Clin. Oncol.
85	\N	22162582	Clarke et al., 2012, J. Clin. Oncol.
86	\N	19903786	He et al., 2009, Clin. Cancer Res.
87	\N	19366826	Prenen et al., 2009, Clin. Cancer Res.
88	\N	14715079	De Bosscher et al., 2004, Biochem. J.
89	\N	10479724	Koyama et al., 1999, Mutat. Res.
90	\N	12821112	Miyaki et al., 2003, Biochem. Biophys. Res. Commun.
91	\N	8898652	Takagi et al., 1996, Gastroenterology
92	\N	9679244	Hata et al., 1998, Mol Med Today
93	\N	17994767	Prokova et al., 2007, Biochemistry
94	\N	10775259	Massagué et al., 2000, EMBO J.
95	\N	19561230	Agaimy et al., 2009, J. Clin. Pathol.
96	\N	20818844	Flaherty et al., 2010, N. Engl. J. Med.
97	\N	21639808	Chapman et al., 2011, N. Engl. J. Med.
98	\N	23470635	Falchook et al., 2013, Oncotarget
99	\N	23582185	Todd et al., 2013, Pigment Cell Melanoma Res
100	\N	21689725	Wasag et al., 2011, Exp. Hematol.
101	\N	17259998	Nakagomi et al., 2007, Lab. Invest.
102	\N	16751810	Tamborini et al., 2006, Oncogene
103	\N	24687822	Serrano et al., 2015, J. Clin. Oncol.
104	\N	19164557	Gajiwala et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
105	\N	14645423	Heinrich et al., 2003, J. Clin. Oncol.
106	\N	15928335	Corless et al., 2005, J. Clin. Oncol.
107	\N	22718859	Cassier et al., 2012, Clin. Cancer Res.
108	\N	16638875	Prenen et al., 2006, Clin. Cancer Res.
109	\N	18794084	Dewaele et al., 2008, Clin. Cancer Res.
110	\N	22745105	Heinrich et al., 2012, Clin. Cancer Res.
111	\N	23634996	2013, N. Engl. J. Med.
112	\N	22160010	Döhner et al., 2011, Hematology Am Soc Hematol Educ Program
113	\N	22898540	McCarthy, 2012, Nat. Rev. Cancer
114	\N	21067377	Ley et al., 2010, N. Engl. J. Med.
115	\N	22898541	Vogt, 2012, Nat. Rev. Cancer
116	\N	22898539	Shih et al., 2012, Nat. Rev. Cancer
117	\N	24656771	Russler-Germain et al., 2014, Cancer Cell
118	\N	24606448	Ahmad et al., 2014, Asian Pac. J. Cancer Prev.
119	\N	22744846	Li et al., 2012, Int. J. Hematol.
120	\N	21518476	Qiao et al., 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi
121	\N	22504184	Smith et al., 2012, Nature
122	\N	23430109	Smith et al., 2013, Blood
123	\N	24619500	Zhang et al., 2014, Clin. Cancer Res.
124	\N	15667533	Smith et al., 2005, Br. J. Haematol.
125	\N	23261068	Martelli et al., 2013, Blood Rev.
126	\N	23783394	Allen et al., 2013, Leukemia
127	\N	23321257	Jourdan et al., 2013, Blood
128	\N	23714533	Smith et al., 2013, Am Soc Clin Oncol Educ Book
129	\N	22504186	Connors et al., 2012, Ann. Surg.
130	\N	22504183	Eisenhoffer et al., 2012, Nature
131	\N	15256420	Clark et al., 2004, Blood
132	\N	11290608	Yamamoto et al., 2001, Blood
133	\N	19657110	Mardis et al., 2009, N. Engl. J. Med.
134	\N	20733134	Fischer et al., 2010, J. Clin. Oncol.
135	\N	16857985	Knapper et al., 2006, Blood
136	\N	22504185	Wang et al., 2012, Gastroenterology
137	\N	23878140	Opatz et al., 2013, Blood
138	\N	22147895	Kazenwadel et al., 2012, Blood
139	\N	21765025	Dickinson et al., 2011, Blood
140	\N	22417203	Patel et al., 2012, N. Engl. J. Med.
141	\N	22397365	Chotirat et al., 2012, J Hematol Oncol
142	\N	20946881	Zou et al., 2010, Biochem. Biophys. Res. Commun.
143	\N	23949315	Ashraf et al., 2013, Ann. Hematol.
144	\N	23815907	Shang et al., 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi
145	\N	21436584	Wartman et al., 2011, J. Clin. Invest.
146	\N	24404189	Nagao et al., 2014, PLoS ONE
147	\N	23115274	Paschka et al., 2013, Blood
148	\N	22829971	Novotny-Diermayr et al., 2012, Blood Cancer J
149	\N	22818858	Malak et al., Blood Cells Mol. Dis.
150	\N	22571758	Ismael et al., 2012, Br. J. Haematol.
151	\N	22041374	Yoshiki et al., 2011, Intern. Med.
152	\N	21689158	Roug et al., 2011, Eur. J. Haematol.
153	\N	21120162	Jekarl et al., 2010, Korean J Hematol
154	\N	20339092	Wang et al., 2010, Blood
155	\N	20631743	Passamonti et al., 2010, Leukemia
156	\N	22422826	Eghtedar et al., 2012, Blood
157	\N	24045550	Johnson et al., 2013, Am. J. Clin. Pathol.
158	\N	18986703	Ustun et al., 2009, Leuk. Res.
159	\N	23149070	Mpakou et al., 2013, Leuk. Res.
160	\N	22407852	Sano et al., 2012, Int. J. Hematol.
161	\N	19075190	Tyner et al., 2009, Blood
162	\N	16434492	Bacher et al., 2006, Blood
163	\N	2278970	Vogelstein et al., 1990, Genes Chromosomes Cancer
164	\N	3122217	Janssen et al., 1987, Proc. Natl. Acad. Sci. U.S.A.
165	\N	10508512	Song et al., 1999, Nat. Genet.
166	\N	24659740	Renneville et al., 2014, Oncotarget
167	\N	24616160	Duployez et al., 2014, Am. J. Hematol.
168	\N	24374719	Ismael et al., 2014, Int. J. Hematol.
169	\N	19357396	Preudhomme et al., 2009, Blood
170	\N	23395771	Yang et al., 2013, Clin. Biochem.
171	\N	24641375	Zeichner et al., 2014, Asian Pac. J. Cancer Prev.
172	\N	24487413	Kihara et al., 2014, Leukemia
173	\N	24381225	Stoddart et al., 2014, Blood
174	\N	22158538	Graubert et al., 2012, Nat. Genet.
175	\N	24498085	Brooks et al., 2014, PLoS ONE
176	\N	24671364	Christopeit et al., 2014, Ann. Hematol.
177	\N	24667279	Lyu et al., 2014, PLoS ONE
178	\N	24521058	Rein et al., 2014, Expert Opin Investig Drugs
179	\N	24422723	Uttenthal et al., 2014, Br. J. Haematol.
180	\N	24374862	Ujj et al., 2014, Pathol. Oncol. Res.
181	\N	16239216	Staerk et al., 2005, J. Biol. Chem.
182	\N	18397343	Sato et al., 2008, Br. J. Haematol.
183	\N	23676790	Chahardouli et al., 2013, Hematology
184	\N	21895409	Strhakova et al., 2011, Neoplasma
185	\N	21888027	Bagadi et al., 2011, Clin. Lab.
186	\N	20367437	Sharma et al., 2010, Leuk. Lymphoma
187	\N	18223278	Ernst et al., 2008, Haematologica
188	\N	12623848	Branford et al., 2003, Blood
189	\N	12576318	Corbin et al., 2003, Blood
190	\N	12399961	Hochhaus et al., 2002, Leukemia
191	\N	17008892	Gruber et al., 2006, Leukemia
192	\N	21221851	Gruber et al., 2012, Med. Oncol.
193	\N	18354488	Sherbenou et al., 2008, Leukemia
194	\N	21505103	Eide et al., 2011, Cancer Res.
195	\N	11964322	Branford et al., 2002, Blood
196	\N	22870928	Ferri et al., 2013, Leuk. Lymphoma
197	\N	15256422	O'Hare et al., 2004, Blood
198	\N	24109527	McCarron et al., 2013, Case Rep Hematol
199	\N	19652056	Hughes et al., 2009, J. Clin. Oncol.
200	\N	19466505	Doi et al., 2009, Int. J. Hematol.
201	\N	15381060	Sorel et al., 2004, Biochem. Biophys. Res. Commun.
202	\N	14745431	Al-Ali et al., 2004, Hematol. J.
203	\N	14559829	von Bubnoff et al., 2003, Cancer Res.
204	\N	24456693	Elias et al., 2014, Leuk. Res.
205	\N	20697894	Qin et al., 2011, Ann. Hematol.
206	\N	22210874	Parker et al., 2012, Blood
207	\N	24236021	Tanneeru et al., 2013, PLoS ONE
208	\N	22912393	Cai et al., 2012, Clin. Cancer Res.
209	\N	15194504	Yamamoto et al., 2004, Biochem. Biophys. Res. Commun.
210	\N	21562040	Soverini et al., 2011, Blood
211	\N	11423618	Gorre et al., 2001, Science
212	\N	11567109	Barthe et al., 2001, Science
213	\N	21509757	Jabbour et al., 2011, Cancer
214	\N	18757400	Cramer et al., 2008, Cancer Res.
215	\N	11569495	Hochhaus et al., 2001, Science
216	\N	19264234	Park et al., 2009, Cancer Genet. Cytogenet.
217	\N	19164531	Iacob et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
218	\N	15510211	Piazza et al., 2005, Leukemia
219	\N	23540562	Chahardouli et al., 2013, Hematology
220	\N	23355941	Elias et al., 2012, Hematol Rep
221	\N	22306673	Yin et al., 2012, Diagn. Mol. Pathol.
222	\N	21762985	Soverini et al., 2011, Leuk. Res.
223	\N	20512393	Manrique Arechavaleta et al., 2011, Clin. Exp. Med.
224	\N	20963643	Minami et al., 2010, Int. J. Hematol.
225	\N	12130516	Roche-Lestienne et al., 2002, Blood
226	\N	21872826	Paquette et al., 2011, Cancer Genet
227	\N	21489624	Oyekunle et al., 2011, Leuk. Res.
228	\N	17114651	Soverini et al., 2006, J. Clin. Oncol.
229	\N	18828913	Cang et al., 2008, J Hematol Oncol
230	\N	21605905	Eskazan et al., 2011, Leuk. Res.
231	\N	19768693	Kim et al., 2010, Hematol Oncol
232	\N	19557636	Mascarenhas et al., 2009, Leuk. Lymphoma
233	\N	20607847	Schnittger et al., 2010, Genes Chromosomes Cancer
234	\N	20557306	Yin et al., 2010, Cancer Sci.
235	\N	12783380	Roche-Lestienne et al., 2003, Semin. Hematol.
236	\N	17189410	Soverini et al., 2006, Clin. Cancer Res.
237	\N	20702476	Bennour et al., 2010, J. Clin. Pathol.
238	\N	20010464	Lewandowski et al., 2009, Pol. Arch. Med. Wewn.
239	\N	25152116	Gao et al., 2014, Zhonghua Xue Ye Xue Za Zhi
240	\N	23575252	Cho et al., 2013, Int J Lab Hematol
241	\N	19811824	Faber et al., 2010, Leuk. Res.
242	\N	23656643	Maxson et al., 2013, N. Engl. J. Med.
243	\N	22072639	Bresler et al., 2011, Sci Transl Med
244	\N	21838707	Schönherr et al., 2011, Biochem. J.
245	\N	24657128	Wakuda et al., 2014, Lung Cancer
246	\N	24986690	Rumi et al., 2014, Blood
247	\N	20151976	Boyd et al., 2010, Br. J. Haematol.
248	\N	18528423	Chaligné et al., 2008, Leukemia
249	\N	23213094	Choueiri et al., 2013, J. Clin. Oncol.
250	\N	23610116	Diamond et al., 2013, J. Clin. Oncol.
251	\N	24631838	Grabiner et al., 2014, Cancer Discov
252	\N	24622468	Voss et al., 2014, Clin. Cancer Res.
253	\N	24625776	Wagle et al., 2014, Cancer Discov
254	\N	22980975	Imielinski et al., 2012, Cell
255	\N	18948947	Ding et al., 2008, Nature
256	\N	22277784	Katayama et al., 2012, Sci Transl Med
257	\N	24670165	Shaw et al., 2014, N. Engl. J. Med.
258	\N	24327273	Chen et al., 2014, Clin. Cancer Res.
259	\N	24569458	Imielinski et al., 2014, J. Clin. Invest.
260	\N	22773810	Ohashi et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
261	\N	22908275	Greulich et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
262	\N	23724914	Awad et al., 2013, N. Engl. J. Med.
263	\N	23728071	Trigka et al., 2013, Oncol. Rep.
264	\N	21479466	Sasaki et al., Mol Med Rep
265	\N	18504432	Bleeker et al., 2008, Oncogene
266	\N	18611285	Do et al., 2008, BMC Res Notes
267	\N	18256540	Malanga et al., 2008, Cell Cycle
268	\N	15118073	Lynch et al., 2004, N. Engl. J. Med.
269	\N	15118125	Paez et al., 2004, Science
270	\N	15329413	Pao et al., 2004, Proc. Natl. Acad. Sci. U.S.A.
271	\N	19922469	Mitsudomi et al., 2010, FEBS J.
272	\N	15710947	Han et al., 2005, J. Clin. Oncol.
273	\N	16011858	Rosell et al., 2005, Lung Cancer
274	\N	16115929	Taron et al., 2005, Clin. Cancer Res.
275	\N	20479403	Sequist et al., 2010, J. Clin. Oncol.
276	\N	22753918	Ramalingam et al., 2012, J. Clin. Oncol.
277	\N	23102728	Huang et al., 2013, Mol Oncol
278	\N	16912157	Inukai et al., 2006, Cancer Res.
279	\N	15728811	Kobayashi et al., 2005, N. Engl. J. Med.
280	\N	15737014	Pao et al., 2005, PLoS Med.
281	\N	21430269	Sequist et al., 2011, Sci Transl Med
282	\N	21194487	Watanabe et al., 2011, BMC Cancer
283	\N	21531810	Wu et al., 2011, Clin. Cancer Res.
284	\N	20068085	Girard et al., 2010, Clin. Cancer Res.
285	\N	16258541	Bell et al., 2005, Nat. Genet.
286	\N	22588155	Oxnard et al., 2012, J Thorac Oncol
287	\N	22452896	Miller et al., 2012, Lancet Oncol.
288	\N	23816963	Katakami et al., 2013, J. Clin. Oncol.
289	\N	24729716	Li et al., 2014, Onco Targets Ther
290	\N	21670455	Fukuoka et al., 2011, J. Clin. Oncol.
291	\N	20573926	Maemondo et al., 2010, N. Engl. J. Med.
292	\N	20022809	Mitsudomi et al., 2010, Lancet Oncol.
293	\N	19692680	Mok et al., 2009, N. Engl. J. Med.
294	\N	19692684	Rosell et al., 2009, N. Engl. J. Med.
295	\N	22285168	Rosell et al., 2012, Lancet Oncol.
296	\N	23816960	Sequist et al., 2013, J. Clin. Oncol.
297	\N	22452895	Yang et al., 2012, Lancet Oncol.
298	\N	21783417	Zhou et al., 2011, Lancet Oncol.
299	\N	19096302	Kosaka et al., 2009, J Thorac Oncol
300	\N	18303429	Marks et al., 2008, J Thorac Oncol
301	\N	23948351	Shi et al., 2013, Lancet Oncol.
302	\N	12460918	Brose et al., 2002, Cancer Res.
303	\N	18794081	Riely et al., 2008, Clin. Cancer Res.
304	\N	18632602	Marks et al., 2008, Cancer Res.
305	\N	7651428	Bottorff et al., 1995, Mol. Cell. Biol.
306	\N	18060073	Estep et al., 2007, PLoS ONE
307	\N	23515407	Ohashi et al., 2013, Clin. Cancer Res.
308	\N	24370118	Bar et al., 2014, Clin Lung Cancer
309	\N	16930767	Kawano et al., 2006, Lung Cancer
310	\N	19513541	Zou et al., 2009, Int. J. Mol. Med.
311	\N	19029981	Engelman et al., 2008, Nat. Med.
312	\N	16906227	Engelman et al., 2006, J. Clin. Invest.
313	\N	20018398	Jin et al., 2010, Lung Cancer
314	\N	9598803	Kohno et al., 1998, Genes Chromosomes Cancer
315	\N	20881644	Lee et al., 2010, J Thorac Oncol
316	\N	10555148	Lee et al., 1999, Cell
317	\N	20085938	Courtney et al., 2010, J. Clin. Oncol.
318	\N	11504908	Neshat et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
319	\N	19351834	Sos et al., 2009, Cancer Res.
320	\N	22328973	Hammerman et al., 2011, Cancer Discov
321	\N	20360610	Faoro et al., 2010, J. Biol. Chem.
322	\N	23786770	Liao et al., 2013, Cancer Res.
323	\N	23348505	Clark et al., 2013, Science
324	\N	18559612	Verstovsek et al., 2008, Clin. Cancer Res.
325	\N	24190505	Joseph et al., 2014, Genes Chromosomes Cancer
326	\N	22357254	Schirosi et al., 2012, Ann. Oncol.
327	\N	21325067	Kong et al., 2011, Clin. Cancer Res.
328	\N	21969494	Buti et al., 2011, J. Clin. Oncol.
329	\N	23375402	Rossi et al., 2013, Lung Cancer
330	\N	12960119	Antonescu et al., 2003, Clin. Cancer Res.
331	\N	20736294	Rossi et al., 2010, Mol. Cancer Res.
332	\N	19861435	Girard et al., 2009, Clin. Cancer Res.
333	\N	15201427	Ströbel et al., 2004, N. Engl. J. Med.
334	\N	17372901	Antonescu et al., 2007, Int. J. Cancer
335	\N	15930355	Antonescu et al., 2005, Clin. Cancer Res.
336	\N	18448188	Yoh et al., 2008, Lung Cancer
337	\N	20970876	Dişel et al., 2011, Lung Cancer
338	\N	19461405	Bisagni et al., 2009, J Thorac Oncol
339	\N	17699867	Guo et al., 2007, Clin. Cancer Res.
340	\N	22184391	van Gaal et al., 2012, J. Clin. Oncol.
341	\N	24124571	Li et al., 2013, PLoS ONE
342	\N	19853286	Cohen et al., 2010, Gynecol. Oncol.
343	\N	22885469	Leslie et al., 2012, Gynecol. Oncol.
344	\N	23908597	Byron et al., 2013, Neoplasia
345	\N	18552176	Dutt et al., 2008, Proc. Natl. Acad. Sci. U.S.A.
346	\N	22238366	Gozgit et al., 2012, Mol. Cancer Ther.
347	\N	23002168	Guagnano et al., 2012, Cancer Discov
348	\N	21984976	Cheung et al., 2011, Cancer Discov
349	\N	23696637	Javadi et al., 2013, J. Biol. Chem.
350	\N	18971950	Chase et al., 2009, Leukemia
351	\N	16834459	Pikman et al., 2006, PLoS Med.
352	\N	19726788	Yauch et al., 2009, Science
353	\N	22679179	Rudin, 2012, Clin. Cancer Res.
354	\N	21683865	Kurman et al., 2011, Hum. Pathol.
355	\N	21975775	Haldar et al., 2011, Cochrane Database Syst Rev
356	\N	19018267	Nakayama et al., 2008, Br. J. Cancer
357	\N	22798288	Dahlman et al., 2012, Cancer Discov
358	\N	22271473	Janku et al., 2012, J. Clin. Oncol.
359	\N	18767981	Chalhoub et al., 2009, Annu Rev Pathol
360	\N	18451306	Beer et al., 2008, Blood
361	\N	23970983	Morrell et al., 2013, Case Rep Hematol
362	\N	21228032	Pietra et al., 2011, Haematologica
363	\N	19608689	Liu et al., 2009, Haematologica
364	\N	23680147	Jaiswal et al., 2013, Cancer Cell
365	\N	24265152	Shi et al., 2014, Cancer Discov
366	\N	23248257	Kim et al., 2013, J. Clin. Oncol.
367	\N	14679157	Maldonado et al., 2003, J. Natl. Cancer Inst.
368	\N	22356324	Sosman et al., 2012, N. Engl. J. Med.
369	\N	22663011	Flaherty et al., 2012, N. Engl. J. Med.
370	\N	22805292	Falchook et al., 2012, Lancet Oncol.
371	\N	22048237	Kirkwood et al., 2012, Clin. Cancer Res.
372	\N	22972589	Patel et al., 2013, Cancer
373	\N	20630094	Rubinstein et al., 2010, J Transl Med
374	\N	23020132	Flaherty et al., 2012, N. Engl. J. Med.
375	\N	22735384	Hauschild et al., 2012, Lancet
376	\N	20551065	Yang et al., 2010, Cancer Res.
377	\N	22536370	Lovly et al., 2012, PLoS ONE
378	\N	19404918	Boulalas et al., Int. J. Biol. Markers
379	\N	22389471	Greger et al., 2012, Mol. Cancer Ther.
380	\N	21156289	Villanueva et al., 2010, Cancer Cell
381	\N	22351686	Paraiso et al., 2012, Clin. Cancer Res.
382	\N	22997239	Jalili et al., 2012, J. Natl. Cancer Inst.
383	\N	23614898	Morris et al., 2013, Cancer Discov
384	\N	23237741	Klein et al., 2013, Eur. J. Cancer
385	\N	0	
440	\N	22869148	Chell et al., 2013, Oncogene
441	\N	21273588	Otsuka et al., 2011, Anticancer Res.
442	\N	16954519	Heinrich et al., 2006, J. Clin. Oncol.
443	\N	17087936	Weisberg et al., 2006, Gastroenterology
444	\N	24132921	Dai et al., 2013, Clin. Cancer Res.
445	\N	15685537	Debiec-Rychter et al., 2005, Gastroenterology
446	\N	21131919	Langer et al., 2011, Mod. Pathol.
447	\N	24531699	Bello et al., 2014, Ann. Surg. Oncol.
448	\N	24661573	de Jel et al., 2014, Pigment Cell Melanoma Res
449	\N	7530509	Kitayama et al., 1995, Blood
450	\N	9438854	Hirota et al., 1998, Science
451	\N	11276010	Hirota et al., 2001, J. Pathol.
452	\N	15790786	Growney et al., 2005, Blood
453	\N	18421059	Hodi et al., 2008, J. Clin. Oncol.
454	\N	18510589	Lutzky et al., 2008, Pigment Cell Melanoma Res
455	\N	18936790	Quintás-Cardama et al., 2008, Nat Clin Pract Oncol
456	\N	18980976	Beadling et al., 2008, Clin. Cancer Res.
457	\N	19671763	Woodman et al., 2009, Mol. Cancer Ther.
458	\N	19812602	Terheyden et al., 2010, J. Invest. Dermatol.
459	\N	21642685	Carvajal et al., 2011, JAMA
460	\N	21690468	Guo et al., 2011, J. Clin. Oncol.
461	\N	22261812	Minor et al., 2012, Clin. Cancer Res.
462	\N	22160160	Knösel et al., 2012, J. Cancer Res. Clin. Oncol.
463	\N	19175693	Tefferi, 2009, J. Cell. Mol. Med.
464	\N	16046538	Carter et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
465	\N	16908931	Curtin et al., 2006, J. Clin. Oncol.
466	\N	21159146	McDonnell et al., 2011, Pigment Cell Melanoma Res
467	\N	24755198	Xia et al., 2014, Mol. Cancer Ther.
468	\N	16624552	Debiec-Rychter et al., 2006, Eur. J. Cancer
469	\N	16397263	Schittenhelm et al., 2006, Cancer Res.
470	\N	19737976	Bougherara et al., 2009, Mol. Cancer Res.
471	\N	19996579	Satzger et al., 2010, Dermatology (Basel)
472	\N	11526490	Tuveson et al., 2001, Oncogene
473	\N	17824795	Graham et al., 2007, Arch. Pathol. Lab. Med.
474	\N	20545949	Yamaguchi et al., 2011, Clin. Exp. Dermatol.
475	\N	22932406	Hong et al., 2012, Zhonghua Bing Li Xue Za Zhi
476	\N	17363509	Roberts et al., 2007, Mol. Cancer Ther.
477	\N	22355224	Tutone et al., 2011, Bioinformation
478	\N	21569090	Yun et al., 2011, APMIS
479	\N	15236194	Tamborini et al., 2004, Gastroenterology
480	\N	18955458	Heinrich et al., 2008, J. Clin. Oncol.
481	\N	20147452	DiNitto et al., 2010, J. Biochem.
482	\N	16741525	Willmore-Payne et al., 2006, Mod. Pathol.
483	\N	15972446	Gotlib et al., 2005, Blood
484	\N	16912224	Pan et al., 2007, Blood
485	\N	18024392	Gleixner et al., 2007, Haematologica
486	\N	20088873	Handolias et al., 2010, Pigment Cell Melanoma Res
487	\N	23775962	Hodi et al., 2013, J. Clin. Oncol.
488	\N	19962457	Gabelli et al., 2010, Biochim. Biophys. Acta
489	\N	24459181	Liu et al., 2014, Cancer Res.
490	\N	24185510	Robinson et al., 2013, Nat. Genet.
491	\N	24185512	Toy et al., 2013, Nat. Genet.
492	\N	24398047	Jeselsohn et al., 2014, Clin. Cancer Res.
493	\N	24217577	Merenbakh-Lamin et al., 2013, Cancer Res.
494	\N	25656898	Dienstmann et al., 2015, Cancer Discov
495	\N	17177598	Lee et al., 2006, PLoS Med.
496	\N	23578570	Bahassi et al., 2013, Eur. J. Cancer
497	\N	16187797	Greulich et al., 2005, PLoS Med.
498	\N	16204070	Jiang et al., 2005, Cancer Res.
499	\N	18199554	Gilmer et al., 2008, Cancer Res.
500	\N	19671738	Tam et al., 2009, Mol. Cancer Ther.
501	\N	23945392	Berge et al., 2013, J Thorac Oncol
502	\N	2302402	Schick et al., 1990, Biochim. Biophys. Acta
503	\N	18458038	Sequist et al., 2008, J. Clin. Oncol.
504	\N	23242437	Kobayashi et al., 2013, J Thorac Oncol
505	\N	23485129	Massarelli et al., 2013, Lung Cancer
506	\N	19455431	Rajasekaran et al., 2010, Appl. Biochem. Biotechnol.
507	\N	19147750	Kancha et al., 2009, Clin. Cancer Res.
508	\N	20415598	Cassell et al., 2010, Expert Opin Investig Drugs
509	\N	21531084	Uribe et al., 2011, Pathol. Res. Pract.
510	\N	22622260	Lee et al., 2012, Lung Cancer
511	\N	18089823	Engelman et al., 2007, Cancer Res.
512	\N	24934779	Ganesan et al., 2016, J. Clin. Oncol.
513	\N	23800712	Wheler et al., 2013, Oncotarget
514	\N	16730855	Tokumo et al., 2006, Lung Cancer
515	\N	17545553	Toyooka et al., 2007, Clin. Cancer Res.
516	\N	16707764	Guo et al., 2006, N. Engl. J. Med.
517	\N	17653080	Fu et al., 2008, Oncogene
518	\N	18628075	González Manzano et al., 2008, Clin Transl Oncol
519	\N	20033049	Zhou et al., 2009, Nature
520	\N	21233402	Rosell et al., 2011, Clin. Cancer Res.
521	\N	22215752	Su et al., 2012, J. Clin. Oncol.
522	\N	21274259	Murray et al., 2010, J Oncol
523	\N	21718596	Chen et al., 2011, Chin J Cancer
524	\N	17483355	Zou et al., 2007, Cancer Res.
525	\N	18829470	Toschi et al., 2008, Clin. Cancer Res.
526	\N	11750879	Maulik et al., 2002, Cytokine Growth Factor Rev.
527	\N	24121490	Miyajima et al., 2013, Cancer Res.
528	\N	23317446	Gentilcore et al., 2013, BMC Cancer
529	\N	23031422	Ponti et al., 2012, J Hematol Oncol
530	\N	23918947	Ascierto et al., 2013, J. Clin. Oncol.
531	\N	24508103	McArthur et al., 2014, Lancet Oncol.
532	\N	22241789	Hayes et al., 2012, Clin. Cancer Res.
533	\N	23524406	Rudin et al., 2013, J Thorac Oncol
534	\N	22743296	Gautschi et al., 2012, J Thorac Oncol
535	\N	19010912	Pratilas et al., 2008, Cancer Res.
536	\N	12460919	Naoki et al., 2002, Cancer Res.
537	\N	18541894	Gupta-Abramson et al., 2008, J. Clin. Oncol.
538	\N	19238210	Gandhi et al., 2009, PLoS ONE
539	\N	20368568	Lam et al., 2010, J. Clin. Oncol.
540	\N	21483012	Paik et al., 2011, J. Clin. Oncol.
541	\N	22038996	Nicolaides et al., 2011, Clin. Cancer Res.
542	\N	22586120	Huillard et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
543	\N	22649091	Sen et al., 2012, Sci Transl Med
544	\N	23489023	Kim et al., 2013, Thyroid
545	\N	23612012	Andrulis et al., 2013, Cancer Discov
546	\N	23833300	Cardarella et al., 2013, Clin. Cancer Res.
547	\N	21750866	Buery et al., 2011, Oncol. Rep.
548	\N	23715574	Bahadoran et al., 2013, J. Clin. Oncol.
549	\N	2493360	Müller-Gärtner et al., 1989, Chirurg
550	\N	24345920	Hutchinson et al., 2013, Clin. Cancer Res.
551	\N	18794803	Smalley et al., 2009, Oncogene
552	\N	2872605	Rees et al., Neurobehav Toxicol Teratol
553	\N	20141835	Heidorn et al., 2010, Cell
554	\N	24710085	Chiappetta et al., 2015, Appl. Immunohistochem. Mol. Morphol.
555	\N	24926260	Shackelford et al., 2014, Case Rep Oncol
556	\N	24446311	Zhang et al., 2014, Am. J. Hematol.
557	\N	24035431	Gautschi et al., 2013, Lung Cancer
558	\N	16096377	Libra et al., 2005, Cell Cycle
559	\N	23273605	Greaves et al., 2013, J Mol Diagn
560	\N	22538770	Santarpia et al., 2012, Breast Cancer Res. Treat.
561	\N	23023262	Knutson et al., 2012, Nat. Chem. Biol.
562	\N	24563539	Knutson et al., 2014, Mol. Cancer Ther.
563	\N	16293597	Campbell et al., 2006, Blood
564	\N	21609436	Niehr et al., 2011, J Transl Med
565	\N	1328859	Kalinec et al., 1992, Mol. Cell. Biol.
566	\N	22733540	Khalili et al., 2012, Clin. Cancer Res.
567	\N	22653968	Wu et al., 2012, Mol. Cancer Ther.
568	\N	2549426	Landis et al., 1989, Nature
569	\N	18719078	Onken et al., 2008, Invest. Ophthalmol. Vis. Sci.
570	\N	19078957	Van Raamsdonk et al., 2009, Nature
571	\N	21083380	Van Raamsdonk et al., 2010, N. Engl. J. Med.
572	\N	22253748	Wu et al., 2012, PLoS ONE
573	\N	22808163	Ho et al., 2012, PLoS ONE
574	\N	15184865	Carlomagno et al., 2004, Oncogene
575	\N	20065189	Wells et al., 2010, J. Clin. Oncol.
576	\N	21470995	Verbeek et al., 2011, J. Clin. Endocrinol. Metab.
577	\N	23056499	Couto et al., 2012, PLoS ONE
578	\N	20943719	Vitagliano et al., 2011, Endocr. Relat. Cancer
579	\N	22025146	Wells et al., 2012, J. Clin. Oncol.
580	\N	9681850	Santoro et al., 1998, J. Intern. Med.
581	\N	11351254	Frisk et al., 2001, Int. J. Oncol.
582	\N	20847059	Carr et al., 2010, Clin. Cancer Res.
583	\N	21455200	Sherman, 2011, Mod. Pathol.
584	\N	11274365	Wen et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
585	\N	24721394	Xu et al., 2014, Transl Oncol
586	\N	21367659	Greulich et al., 2011, Trends Mol Med
587	\N	22256804	Su et al., 2012, N. Engl. J. Med.
588	\N	22726224	Anforth et al., 2012, Pigment Cell Melanoma Res
589	\N	20859122	Girard, 2010, J Thorac Oncol
590	\N	16478791	Park et al., 2006, J. Cell. Sci.
591	\N	21398618	Lee et al., 2011, J. Natl. Cancer Inst.
592	\N	22722830	Misale et al., 2012, Nature
593	\N	24740626	Jeng et al., 2014, Pediatr Blood Cancer
594	\N	24628546	Isham et al., 2014, J. Clin. Endocrinol. Metab.
595	\N	23182985	Peeters et al., 2013, J. Clin. Oncol.
596	\N	24558511	Kumar et al., 2014, Gastrointest Cancer Res
597	\N	19881948	Oikonomou et al., 2009, Neoplasia
598	\N	22235099	Doebele et al., 2012, Clin. Cancer Res.
599	\N	22897852	Maraver et al., 2012, Cancer Cell
600	\N	22282465	Miranda et al., 2012, Clin. Cancer Res.
601	\N	25044103	Chaft et al., 2014, Clin Lung Cancer
602	\N	18594010	Koivunen et al., 2008, Clin. Cancer Res.
603	\N	15374878	Brown et al., 2005, Blood
604	\N	14604974	Bagrintseva et al., 2004, Blood
605	\N	17606455	Mathews et al., 2007, Haematologica
606	\N	24046014	Zimmerman et al., 2013, Blood
607	\N	17889720	Kancha et al., 2007, Exp. Hematol.
608	\N	17047150	Piloto et al., 2007, Blood
609	\N	25754945	Sagi et al., 2015, Fam. Cancer
610	\N	21464312	Jo et al., 2011, Proc. Natl. Acad. Sci. U.S.A.
611	\N	19418217	Dunlap et al., 2010, Breast Cancer Res. Treat.
612	\N	19487299	Ricarte-Filho et al., 2009, Cancer Res.
613	\N	21512767	Boyault et al., 2012, Breast Cancer Res. Treat.
614	\N	22610119	Barbieri et al., 2012, Nat. Genet.
615	\N	22722201	Stephens et al., 2012, Nature
616	\N	22722839	Grasso et al., 2012, Nature
617	\N	23237847	Yi et al., 2013, Oncotarget
618	\N	16397024	Lee et al., 2006, Clin. Cancer Res.
619	\N	23220880	Bose et al., 2013, Cancer Discov
620	\N	22197931	Nikolaev et al., 2012, Nat. Genet.
621	\N	19915144	Emery et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
622	\N	23444215	Catalanotti et al., 2013, Clin. Cancer Res.
623	\N	22588879	Shi et al., 2012, Cancer Discov
624	\N	21383288	Wagle et al., 2011, J. Clin. Oncol.
625	\N	24448821	Narita et al., 2014, Mol. Cancer Ther.
626	\N	21107320	Johannessen et al., 2010, Nature
627	\N	22622578	Berger et al., 2012, Nature
628	\N	21250968	Pichler et al., 2011, Br. J. Haematol.
629	\N	23558173	Wang et al., 2013, Science
630	\N	24869598	Woyach et al., 2014, N. Engl. J. Med.
631	\N	15004724	Chan et al., 2004, Cancer Chemother. Pharmacol.
632	\N	24651012	Muller et al., 2014, Cancer Cell
633	\N	20013323	Ikezoe et al., 2010, Int. J. Hematol.
634	\N	17015838	Joerger et al., 2006, Proc. Natl. Acad. Sci. U.S.A.
635	\N	11101847	Stiewe et al., 2000, Nat. Genet.
636	\N	18391940	Kawauchi et al., 2008, Nat. Cell Biol.
637	\N	18413839	Trowe et al., 2008, Clin. Cancer Res.
638	\N	22046346	Kancha et al., 2011, PLoS ONE
639	\N	24516025	Ali et al., 2014, J. Clin. Oncol.
640	\N	21189378	Klümpen et al., 2011, J. Clin. Oncol.
641	\N	21444680	Patel et al., 2011, Clin. Cancer Res.
642	\N	24141786	Chen et al., 2014, Oncogene
643	\N	24265153	Van Allen et al., 2014, Cancer Discov
644	\N	24265154	Wagle et al., 2014, Cancer Discov
645	\N	20372971	Quintás-Cardama et al., 2011, Invest New Drugs
646	\N	20385788	Tyner et al., 2010, Blood
647	\N	22271575	Weigert et al., 2012, J. Exp. Med.
648	\N	16094359	Parsons et al., 2005, Nature
649	\N	21835143	Nault et al., 2012, J. Hepatol.
\.


--
-- Data for Name: transcripts; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY transcripts (id, name, source, version) FROM stdin;
1	ENST00000369535	ensembl	74_37
2	ENST00000367921	ensembl	74_37
3	ENST00000373103	ensembl	74_37
4	ENST00000355710	ensembl	74_37
5	ENST00000371953	ensembl	74_37
6	ENST00000332351	ensembl	74_37
7	ENST00000311189	ensembl	74_37
8	ENST00000256078	ensembl	74_37
9	ENST00000380982	ensembl	74_37
10	ENST00000349310	ensembl	74_37
11	ENST00000261609	ensembl	74_37
12	ENST00000307102	ensembl	74_37
13	ENST00000330062	ensembl	74_37
14	ENST00000269571	ensembl	74_37
15	ENST00000269305	ensembl	74_37
16	ENST00000342988	ensembl	74_37
17	ENST00000078429	ensembl	74_37
18	ENST00000335508	ensembl	74_37
19	ENST00000345146	ensembl	74_37
20	ENST00000264709	ensembl	74_37
21	ENST00000389048	ensembl	74_37
22	ENST00000300305	ensembl	74_37
23	ENST00000291552	ensembl	74_37
24	ENST00000341105	ensembl	74_37
25	ENST00000263967	ensembl	74_37
26	ENST00000349496	ensembl	74_37
27	ENST00000257290	ensembl	74_37
28	ENST00000288135	ensembl	74_37
29	ENST00000296930	ensembl	74_37
30	ENST00000206249	ensembl	74_37
31	ENST00000249373	ensembl	74_37
32	ENST00000288602	ensembl	74_37
33	ENST00000496384	ensembl	74_37
34	ENST00000275493	ensembl	74_37
35	ENST00000381652	ensembl	74_37
36	ENST00000286548	ensembl	74_37
37	ENST00000381567	ensembl	74_37
38	ENST00000361445	ensembl	74_37
39	ENST00000358432	ensembl	74_37
40	ENST00000372470	ensembl	74_37
41	ENST00000342505	ensembl	74_37
42	ENST00000342788	ensembl	74_37
43	ENST00000256474	ensembl	74_37
44	ENST00000442415	ensembl	74_37
45	ENST00000231790	ensembl	74_37
46	ENST00000417037	ensembl	74_37
47	ENST00000340107	ensembl	74_37
48	ENST00000303115	ensembl	74_37
49	ENST00000396611	ensembl	74_37
50	ENST00000257430	ensembl	74_37
51	ENST00000286301	ensembl	74_37
52	ENST00000292408	ensembl	74_37
53	ENST00000368508	ensembl	74_37
54	ENST00000356142	ensembl	74_37
55	ENST00000318493	ensembl	74_37
56	ENST00000320356	ensembl	74_37
57	ENST00000425967	ensembl	74_37
58	ENST00000377970	ensembl	74_37
59	ENST00000446177	ensembl	74_37
60	ENST00000361570	ensembl	74_37
61	ENST00000372348	ensembl	74_37
62	ENST00000457416	ensembl	74_37
63	ENST00000264033	ensembl	74_37
64	ENST00000267101	ensembl	74_37
65	ENST00000257904	ensembl	74_37
66	ENST00000267163	ensembl	74_37
67	ENST00000359376	ensembl	74_37
68	ENST00000326873	ensembl	74_37
69	ENST00000262948	ensembl	74_37
70	ENST00000458235	ensembl	74_37
71	ENST00000222254	ensembl	74_37
72	ENST00000392038	ensembl	74_37
73	ENST00000360723	ensembl	74_37
74	ENST00000354359	ensembl	74_37
75	ENST00000377045	ensembl	74_37
76	ENST00000308731	ensembl	74_37
\.


--
-- Data for Name: variant_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variant_types (id, name) FROM stdin;
1	SNP
2	DEL
3	INS
4	DNP
\.


--
-- Data for Name: versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY versions (id, name, sort_order, is_current, import_date) FROM stdin;
1	1	\N	f	\N
2	2	\N	t	\N
\.


--
-- Data for Name: variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variants (id, cdna_change, variant, strand, location_id, variant_type_id, amino_acid_id, gene_id, mutation_type_id, primary_variant_id, hgvs, tim_ley_annotation, transcript_id, version_id, meta) FROM stdin;
308	c.7514	G	-1	204	1	265	37	1	\N	ENST00000361445:c.7514G>C	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
309	c.7255	T	-1	205	1	266	37	1	\N	ENST00000361445:c.7255G>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
310	c.6667	T	-1	206	1	267	37	1	\N	ENST00000361445:c.6667C>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24622468"}]}
311	c.6644	T	-1	207	1	268	37	1	\N	ENST00000361445:c.6644C>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
318	c.1513	T	1	212	1	273	40	1	\N	ENST00000372470:c.1513A>T	\N	40	2	\N
330	c.182_181	CT	-1	218	4	27	42	1	\N	ENST00000369535:c.182_181CA>AG	\N	1	2	\N
331	c.181	A	-1	3	1	3	42	2	\N	ENST00000369535:c.181C>T	\N	1	2	\N
334	c.52	T	-1	219	1	278	42	1	\N	ENST00000369535:c.52G>A	\N	1	2	\N
335	c.38	A	-1	4	1	6	42	1	\N	ENST00000369535:c.38G>T	\N	1	2	\N
336	c.38	G	-1	4	1	7	42	1	\N	ENST00000369535:c.38G>C	\N	1	2	\N
337	c.38	T	-1	4	1	8	42	1	\N	ENST00000369535:c.38G>A	\N	1	2	\N
338	c.37	A	-1	5	1	9	42	1	\N	ENST00000369535:c.37G>T	\N	1	2	\N
339	c.37	G	-1	5	1	10	42	1	\N	ENST00000369535:c.37G>C	\N	1	2	\N
340	c.37	T	-1	5	1	33	42	1	\N	ENST00000369535:c.37G>A	\N	1	2	\N
341	c.35	A	-1	6	1	11	42	1	\N	ENST00000369535:c.35G>T	\N	1	2	\N
342	c.35	G	-1	6	1	12	42	1	\N	ENST00000369535:c.35G>C	\N	1	2	\N
343	c.35	T	-1	6	1	13	42	1	\N	ENST00000369535:c.35G>A	\N	1	2	\N
345	c.34	G	-1	7	1	15	42	1	\N	ENST00000369535:c.34G>C	\N	1	2	\N
370	c.3575	G	-1	230	1	289	45	1	\N	ENST00000389048:c.3575G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
1	c.183	A	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>T	\N	1	1	\N
2	c.182	A	-1	2	1	2	1	1	\N	ENST00000369535:c.182A>T	\N	1	1	\N
3	c.181	A	-1	3	1	3	1	2	\N	ENST00000369535:c.181C>T	\N	1	1	\N
4	c.181	C	-1	3	1	4	1	1	\N	ENST00000369535:c.181C>G	\N	1	1	\N
5	c.181	T	-1	3	1	5	1	1	\N	ENST00000369535:c.181C>A	\N	1	1	\N
6	c.38	A	-1	4	1	6	1	1	\N	ENST00000369535:c.38G>T	\N	1	1	\N
7	c.38	G	-1	4	1	7	1	1	\N	ENST00000369535:c.38G>C	\N	1	1	\N
8	c.38	T	-1	4	1	8	1	1	\N	ENST00000369535:c.38G>A	\N	1	1	\N
9	c.37	A	-1	5	1	9	1	1	\N	ENST00000369535:c.37G>T	\N	1	1	\N
10	c.37	G	-1	5	1	10	1	1	\N	ENST00000369535:c.37G>C	\N	1	1	\N
11	c.35	A	-1	6	1	11	1	1	\N	ENST00000369535:c.35G>T	\N	1	1	\N
12	c.35	G	-1	6	1	12	1	1	\N	ENST00000369535:c.35G>C	\N	1	1	\N
13	c.35	T	-1	6	1	13	1	1	\N	ENST00000369535:c.35G>A	\N	1	1	\N
14	c.34	A	-1	7	1	14	1	1	\N	ENST00000369535:c.34G>T	\N	1	1	\N
15	c.34	G	-1	7	1	15	1	1	\N	ENST00000369535:c.34G>C	\N	1	1	\N
16	c.34	T	-1	7	1	16	1	1	\N	ENST00000369535:c.34G>A	\N	1	1	\N
17	c.2304	A	1	8	1	17	2	1	\N	ENST00000367921:c.2304T>A	\N	2	1	\N
18	c.1853	A	-1	9	1	18	3	1	\N	ENST00000373103:c.1853C>T	\N	3	1	\N
19	c.2753	C	1	10	1	19	4	1	\N	ENST00000355710:c.2753T>C	\N	4	1	\N
20	c.388	G	1	11	1	20	5	1	\N	ENST00000371953:c.388C>G	\N	5	1	\N
21	c.388	T	1	11	1	21	5	2	\N	ENST00000371953:c.388C>T	\N	5	1	\N
22	c.389	A	1	12	1	22	5	1	\N	ENST00000371953:c.389G>A	\N	5	1	\N
23	c.477	T	1	13	1	23	5	1	\N	ENST00000371953:c.477G>T	\N	5	1	\N
24	c.697	T	1	14	1	24	5	2	\N	ENST00000371953:c.697C>T	\N	5	1	\N
25	c.800	-	1	15	2	25	5	3	\N	ENST00000371953:c.800delA	\N	5	1	\N
26	c.1143_1142	ACCGTACA	-1	16	3	26	6	4	\N	ENST00000332351:c.1143_1142insTGTACGGT	\N	6	1	\N
27	c.182	C	-1	17	1	27	7	1	\N	ENST00000311189:c.182A>G	\N	7	1	\N
28	c.37	A	-1	18	1	9	7	1	\N	ENST00000311189:c.37G>T	\N	7	1	\N
29	c.37	G	-1	18	1	10	7	1	\N	ENST00000311189:c.37G>C	\N	7	1	\N
30	c.35	A	-1	19	1	11	7	1	\N	ENST00000311189:c.35G>T	\N	7	1	\N
31	c.34	G	-1	20	1	15	7	1	\N	ENST00000311189:c.34G>C	\N	7	1	\N
32	c.437	A	-1	21	1	28	8	1	\N	ENST00000256078:c.437C>T	\N	8	1	\N
33	c.436	G	-1	22	1	29	8	1	\N	ENST00000256078:c.436G>C	\N	8	1	\N
34	c.436	T	-1	22	1	30	8	1	\N	ENST00000256078:c.436G>A	\N	8	1	\N
35	c.351	A	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>T	\N	8	1	\N
36	c.351	G	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>C	\N	8	1	\N
37	c.183	A	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>T	\N	8	1	\N
38	c.183	G	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>C	\N	8	1	\N
39	c.182	A	-1	25	1	2	8	1	\N	ENST00000256078:c.182A>T	\N	8	1	\N
40	c.182	C	-1	25	1	27	8	1	\N	ENST00000256078:c.182A>G	\N	8	1	\N
41	c.182	G	-1	25	1	32	8	1	\N	ENST00000256078:c.182A>C	\N	8	1	\N
42	c.181	T	-1	26	1	5	8	1	\N	ENST00000256078:c.181C>A	\N	8	1	\N
43	c.38	A	-1	27	1	6	8	1	\N	ENST00000256078:c.38G>T	\N	8	1	\N
44	c.38	G	-1	27	1	7	8	1	\N	ENST00000256078:c.38G>C	\N	8	1	\N
45	c.38	T	-1	27	1	8	8	1	\N	ENST00000256078:c.38G>A	\N	8	1	\N
46	c.37	A	-1	28	1	9	8	1	\N	ENST00000256078:c.37G>T	\N	8	1	\N
47	c.37	G	-1	28	1	10	8	1	\N	ENST00000256078:c.37G>C	\N	8	1	\N
48	c.37	T	-1	28	1	33	8	1	\N	ENST00000256078:c.37G>A	\N	8	1	\N
49	c.35	A	-1	29	1	11	8	1	\N	ENST00000256078:c.35G>T	\N	8	1	\N
50	c.35	G	-1	29	1	12	8	1	\N	ENST00000256078:c.35G>C	\N	8	1	\N
51	c.35	T	-1	29	1	13	8	1	\N	ENST00000256078:c.35G>A	\N	8	1	\N
52	c.34	A	-1	30	1	14	8	1	\N	ENST00000256078:c.34G>T	\N	8	1	\N
53	c.34	G	-1	30	1	15	8	1	\N	ENST00000256078:c.34G>C	\N	8	1	\N
54	c.34	T	-1	30	1	16	8	1	\N	ENST00000256078:c.34G>A	\N	8	1	\N
55	c.2516	C	-1	31	1	34	9	1	\N	ENST00000380982:c.2516A>G	\N	9	1	\N
56	c.2508	C	-1	32	1	35	9	1	\N	ENST00000380982:c.2508C>G	\N	9	1	\N
57	c.2506	G	-1	33	1	36	9	1	\N	ENST00000380982:c.2506A>C	\N	9	1	\N
58	c.2505	C	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>G	\N	9	1	\N
59	c.2505	T	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>A	\N	9	1	\N
60	c.2504	A	-1	35	1	38	9	1	\N	ENST00000380982:c.2504A>T	\N	9	1	\N
61	c.2504	G	-1	35	1	39	9	1	\N	ENST00000380982:c.2504A>C	\N	9	1	\N
62	c.2503	A	-1	36	1	40	9	1	\N	ENST00000380982:c.2503G>T	\N	9	1	\N
63	c.2503	G	-1	36	1	41	9	1	\N	ENST00000380982:c.2503G>C	\N	9	1	\N
64	c.2503	T	-1	36	1	42	9	1	\N	ENST00000380982:c.2503G>A	\N	9	1	\N
65	c.49	T	-1	37	1	43	10	1	\N	ENST00000349310:c.49G>A	\N	10	1	\N
66	c.2277	-	-1	38	2	44	11	5	\N	ENST00000261609:c.2277delAACGGTCCTGACCTG	\N	11	1	\N
67	c.2264	G	-1	39	1	45	11	1	\N	ENST00000261609:c.2264T>C	\N	11	1	\N
68	c.926	C	-1	40	1	46	11	1	\N	ENST00000261609:c.926C>G	\N	11	1	\N
69	c.157	C	1	41	1	47	12	1	\N	ENST00000307102:c.157T>C	\N	12	1	\N
70	c.167	C	1	42	1	48	12	1	\N	ENST00000307102:c.167A>C	\N	12	1	\N
71	c.171	T	1	43	1	49	12	1	\N	ENST00000307102:c.171G>T	\N	12	1	\N
72	c.199	A	1	44	1	50	12	1	\N	ENST00000307102:c.199G>A	\N	12	1	\N
73	c.332	G	1	45	1	51	12	1	\N	ENST00000307102:c.332T>G	\N	12	1	\N
74	c.362	C	1	46	1	52	12	1	\N	ENST00000307102:c.362G>C	\N	12	1	\N
75	c.370	T	1	47	1	53	12	1	\N	ENST00000307102:c.370C>T	\N	12	1	\N
76	c.371	T	1	48	1	54	12	1	\N	ENST00000307102:c.371C>T	\N	12	1	\N
77	c.607	A	1	49	1	55	12	1	\N	ENST00000307102:c.607G>A	\N	12	1	\N
78	c.790	T	1	50	1	56	12	1	\N	ENST00000307102:c.790C>T	\N	12	1	\N
79	c.1144	C	1	51	1	57	12	1	\N	ENST00000307102:c.1144A>C	\N	12	1	\N
80	c.516	G	-1	52	1	58	13	1	\N	ENST00000330062:c.516G>C	\N	13	1	\N
81	c.515	A	-1	53	1	59	13	1	\N	ENST00000330062:c.515G>T	\N	13	1	\N
82	c.515	T	-1	53	1	60	13	1	\N	ENST00000330062:c.515G>A	\N	13	1	\N
83	c.419	A	-1	54	1	61	13	1	\N	ENST00000330062:c.419G>T	\N	13	1	\N
84	c.419	T	-1	54	1	62	13	1	\N	ENST00000330062:c.419G>A	\N	13	1	\N
85	c.418	A	-1	55	1	63	13	1	\N	ENST00000330062:c.418C>T	\N	13	1	\N
86	c.926	C	1	56	1	64	14	1	\N	ENST00000269571:c.926G>C	\N	14	1	\N
87	c.2263	-	1	57	2	65	14	5	\N	ENST00000269571:c.2263delTTGAGGGAAAACACA	\N	14	1	\N
88	c.2264	C	1	58	1	45	14	1	\N	ENST00000269571:c.2264T>C	\N	14	1	\N
89	c.2305	C	1	59	1	66	14	1	\N	ENST00000269571:c.2305G>C	\N	14	1	\N
90	c.2305	T	1	59	1	67	14	1	\N	ENST00000269571:c.2305G>T	\N	14	1	\N
91	c.2329	T	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>T	\N	14	1	\N
92	c.2332_2333	GGCTCCCCA	1	61	3	69	14	6	\N	ENST00000269571:c.2332_2333insGGCTCCCCA	\N	14	1	\N
93	c.2524	A	1	62	1	70	14	1	\N	ENST00000269571:c.2524G>A	\N	14	1	\N
94	c.2686	T	1	63	1	71	14	1	\N	ENST00000269571:c.2686C>T	\N	14	1	\N
95	c.818	T	-1	64	1	72	15	1	\N	ENST00000269305:c.818G>A	\N	15	1	\N
96	c.817	A	-1	65	1	73	15	1	\N	ENST00000269305:c.817C>T	\N	15	1	\N
97	c.746	G	-1	66	1	74	15	1	\N	ENST00000269305:c.746G>C	\N	15	1	\N
98	c.745	A	-1	67	1	75	15	1	\N	ENST00000269305:c.745A>T	\N	15	1	\N
99	c.743	T	-1	68	1	76	15	1	\N	ENST00000269305:c.743G>A	\N	15	1	\N
100	c.659	C	-1	69	1	77	15	1	\N	ENST00000269305:c.659A>G	\N	15	1	\N
101	c.518	C	-1	70	1	78	15	1	\N	ENST00000269305:c.518T>G	\N	15	1	\N
102	c.518	G	-1	70	1	79	15	1	\N	ENST00000269305:c.518T>C	\N	15	1	\N
103	c.989	C	1	71	1	80	16	1	\N	ENST00000342988:c.989A>C	\N	16	1	\N
104	c.1051	A	1	72	1	81	16	1	\N	ENST00000342988:c.1051G>A	\N	16	1	\N
105	c.1051	C	1	72	1	82	16	1	\N	ENST00000342988:c.1051G>C	\N	16	1	\N
106	c.1065	A	1	73	1	83	16	1	\N	ENST00000342988:c.1065C>A	\N	16	1	\N
107	c.1081	A	1	74	1	84	16	1	\N	ENST00000342988:c.1081C>A	\N	16	1	\N
108	c.1081	T	1	74	1	85	16	1	\N	ENST00000342988:c.1081C>T	\N	16	1	\N
109	c.1082	A	1	75	1	86	16	1	\N	ENST00000342988:c.1082G>A	\N	16	1	\N
110	c.1609	T	1	76	1	87	16	1	\N	ENST00000342988:c.1609G>T	\N	16	1	\N
111	c.626	C	1	77	1	88	17	1	\N	ENST00000078429:c.626A>C	\N	17	1	\N
112	c.626	T	1	77	1	89	17	1	\N	ENST00000078429:c.626A>T	\N	17	1	\N
113	c.2100	A	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>T	\N	18	1	\N
114	c.2100	G	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>C	\N	18	1	\N
115	c.2099	A	-1	79	1	91	18	1	\N	ENST00000335508:c.2099A>T	\N	18	1	\N
116	c.2099	C	-1	79	1	92	18	1	\N	ENST00000335508:c.2099A>G	\N	18	1	\N
117	c.2099	G	-1	79	1	93	18	1	\N	ENST00000335508:c.2099A>C	\N	18	1	\N
118	c.2098	A	-1	80	1	94	18	2	\N	ENST00000335508:c.2098A>T	\N	18	1	\N
119	c.2098	C	-1	80	1	95	18	1	\N	ENST00000335508:c.2098A>G	\N	18	1	\N
120	c.2098	G	-1	80	1	96	18	1	\N	ENST00000335508:c.2098A>C	\N	18	1	\N
121	c.1998	A	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>T	\N	18	1	\N
122	c.1998	G	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>C	\N	18	1	\N
123	c.1997	C	-1	82	1	98	18	1	\N	ENST00000335508:c.1997A>G	\N	18	1	\N
124	c.1997	G	-1	82	1	99	18	1	\N	ENST00000335508:c.1997A>C	\N	18	1	\N
125	c.1996	C	-1	83	1	100	18	1	\N	ENST00000335508:c.1996A>G	\N	18	1	\N
126	c.395	A	-1	84	1	101	19	1	\N	ENST00000345146:c.395G>T	\N	19	1	\N
127	c.395	G	-1	84	1	102	19	1	\N	ENST00000345146:c.395G>C	\N	19	1	\N
128	c.395	T	-1	84	1	103	19	1	\N	ENST00000345146:c.395G>A	\N	19	1	\N
129	c.394	A	-1	85	1	104	19	1	\N	ENST00000345146:c.394C>T	\N	19	1	\N
130	c.394	C	-1	85	1	105	19	1	\N	ENST00000345146:c.394C>G	\N	19	1	\N
131	c.394	T	-1	85	1	106	19	1	\N	ENST00000345146:c.394C>A	\N	19	1	\N
132	c.2645	A	-1	86	1	107	20	1	\N	ENST00000264709:c.2645G>T	\N	20	1	\N
133	c.2645	G	-1	86	1	108	20	1	\N	ENST00000264709:c.2645G>C	\N	20	1	\N
134	c.2645	T	-1	86	1	109	20	1	\N	ENST00000264709:c.2645G>A	\N	20	1	\N
135	c.2644	A	-1	87	1	110	20	1	\N	ENST00000264709:c.2644C>T	\N	20	1	\N
136	c.2644	C	-1	87	1	111	20	1	\N	ENST00000264709:c.2644C>G	\N	20	1	\N
137	c.2644	T	-1	87	1	112	20	1	\N	ENST00000264709:c.2644C>A	\N	20	1	\N
138	c.3833	G	-1	88	1	113	21	1	\N	ENST00000389048:c.3833A>C	\N	21	1	\N
139	c.3824	T	-1	89	1	114	21	1	\N	ENST00000389048:c.3824G>A	\N	21	1	\N
140	c.3735	C	-1	90	1	115	21	1	\N	ENST00000389048:c.3735C>G	\N	21	1	\N
141	c.3734	C	-1	91	1	116	21	1	\N	ENST00000389048:c.3734T>G	\N	21	1	\N
142	c.3733	C	-1	92	1	117	21	1	\N	ENST00000389048:c.3733T>G	\N	21	1	\N
143	c.3673	T	-1	93	1	118	21	1	\N	ENST00000389048:c.3673G>A	\N	21	1	\N
144	c.3522	T	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>A	\N	21	1	\N
145	c.3521	C	-1	95	1	120	21	1	\N	ENST00000389048:c.3521T>G	\N	21	1	\N
146	c.3520	C	-1	96	1	121	21	1	\N	ENST00000389048:c.3520T>G	\N	21	1	\N
147	c.3520	T	-1	96	1	122	21	1	\N	ENST00000389048:c.3520T>A	\N	21	1	\N
148	c.3512	T	-1	97	1	123	21	1	\N	ENST00000389048:c.3512T>A	\N	21	1	\N
149	c.3452	A	-1	98	1	124	21	1	\N	ENST00000389048:c.3452C>T	\N	21	1	\N
150	c.3271	T	-1	99	1	125	21	1	\N	ENST00000389048:c.3271G>A	\N	21	1	\N
151	c.601	A	-1	100	1	126	22	2	\N	ENST00000300305:c.601C>T	\N	22	1	\N
152	c.486	A	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>T	\N	22	1	\N
153	c.486	G	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>C	\N	22	1	\N
154	c.485	T	-1	102	1	128	22	1	\N	ENST00000300305:c.485G>A	\N	22	1	\N
155	c.484	C	-1	103	1	129	22	1	\N	ENST00000300305:c.484A>G	\N	22	1	\N
156	c.470	C	-1	104	1	130	23	1	\N	ENST00000291552:c.470A>G	\N	23	1	\N
157	c.470	G	-1	104	1	131	23	1	\N	ENST00000291552:c.470A>C	\N	23	1	\N
158	c.101	A	-1	105	1	132	23	1	\N	ENST00000291552:c.101C>T	\N	23	1	\N
159	c.101	T	-1	105	1	133	23	1	\N	ENST00000291552:c.101C>A	\N	23	1	\N
160	c.1192	A	-1	106	1	134	24	1	\N	ENST00000341105:c.1192C>T	\N	24	1	\N
161	c.1061	A	-1	107	1	135	24	1	\N	ENST00000341105:c.1061C>T	\N	24	1	\N
162	c.1624	A	1	108	1	136	25	1	\N	ENST00000263967:c.1624G>A	\N	25	1	\N
163	c.1633	A	1	109	1	137	25	1	\N	ENST00000263967:c.1633G>A	\N	25	1	\N
164	c.1633	C	1	109	1	138	25	1	\N	ENST00000263967:c.1633G>C	\N	25	1	\N
165	c.1634	C	1	110	1	139	25	1	\N	ENST00000263967:c.1634A>C	\N	25	1	\N
166	c.1634	G	1	110	1	140	25	1	\N	ENST00000263967:c.1634A>G	\N	25	1	\N
167	c.1634	T	1	110	1	141	25	1	\N	ENST00000263967:c.1634A>T	\N	25	1	\N
168	c.1636	A	1	111	1	142	25	1	\N	ENST00000263967:c.1636C>A	\N	25	1	\N
169	c.1636	G	1	111	1	143	25	1	\N	ENST00000263967:c.1636C>G	\N	25	1	\N
170	c.1637	C	1	112	1	144	25	1	\N	ENST00000263967:c.1637A>C	\N	25	1	\N
171	c.1637	G	1	112	1	145	25	1	\N	ENST00000263967:c.1637A>G	\N	25	1	\N
172	c.1637	T	1	112	1	146	25	1	\N	ENST00000263967:c.1637A>T	\N	25	1	\N
173	c.1645	A	1	113	1	147	25	1	\N	ENST00000263967:c.1645G>A	\N	25	1	\N
174	c.3140	G	1	114	1	148	25	1	\N	ENST00000263967:c.3140A>G	\N	25	1	\N
175	c.3140	T	1	114	1	149	25	1	\N	ENST00000263967:c.3140A>T	\N	25	1	\N
176	c.110	A	1	115	1	150	26	1	\N	ENST00000349496:c.110C>A	\N	26	1	\N
177	c.110	T	1	115	1	151	26	1	\N	ENST00000349496:c.110C>T	\N	26	1	\N
178	c.133	C	1	116	1	152	26	1	\N	ENST00000349496:c.133T>C	\N	26	1	\N
179	c.134	A	1	117	1	153	26	1	\N	ENST00000349496:c.134C>A	\N	26	1	\N
180	c.134	T	1	117	1	154	26	1	\N	ENST00000349496:c.134C>T	\N	26	1	\N
181	c.1682	A	1	118	1	155	27	1	\N	ENST00000257290:c.1682T>A	\N	27	1	\N
182	c.1977	A	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>A	\N	27	1	\N
183	c.1977	G	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>G	\N	27	1	\N
184	c.2525	T	1	120	1	157	27	1	\N	ENST00000257290:c.2525A>T	\N	27	1	\N
185	c.1468	A	1	121	1	158	28	1	\N	ENST00000288135:c.1468G>A	\N	28	1	\N
186	c.1510	C	1	122	1	159	28	1	\N	ENST00000288135:c.1510T>C	\N	28	1	\N
187	c.1650	C	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>C	\N	28	1	\N
188	c.1650	T	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>T	\N	28	1	\N
189	c.1657	A	1	124	1	161	28	1	\N	ENST00000288135:c.1657T>A	\N	28	1	\N
190	c.1660	-	1	125	2	162	28	5	\N	ENST00000288135:c.1660delGAAGTACAGTGGAAG	\N	28	1	\N
191	c.1660	-	1	126	2	162	28	5	\N	ENST00000288135:c.1660delGAAGTACAGTGGAAGGTT	\N	28	1	\N
192	c.1666_1667	CTA	1	127	3	163	28	6	\N	ENST00000288135:c.1666_1667insCTA	\N	28	1	\N
193	c.1666_1667	CTC	1	127	3	164	28	6	\N	ENST00000288135:c.1666_1667insCTC	\N	28	1	\N
194	c.1666_1667	CTG	1	127	3	165	28	6	\N	ENST00000288135:c.1666_1667insCTG	\N	28	1	\N
195	c.1666_1667	CTT	1	127	3	166	28	6	\N	ENST00000288135:c.1666_1667insCTT	\N	28	1	\N
196	c.1666_1667	TTA	1	127	3	167	28	6	\N	ENST00000288135:c.1666_1667insTTA	\N	28	1	\N
197	c.1666_1667	TTG	1	127	3	168	28	6	\N	ENST00000288135:c.1666_1667insTTG	\N	28	1	\N
198	c.1669	A	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>A	\N	28	1	\N
199	c.1669	C	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>C	\N	28	1	\N
200	c.1674	C	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>C	\N	28	1	\N
201	c.1674	T	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>T	\N	28	1	\N
202	c.1675_1677	-	1	130	2	171	28	5	\N	ENST00000288135:c.1675_1677delGTT	\N	28	1	\N
203	c.1676	A	1	131	1	172	28	1	\N	ENST00000288135:c.1676T>A	\N	28	1	\N
204	c.1676	C	1	131	1	173	28	1	\N	ENST00000288135:c.1676T>C	\N	28	1	\N
205	c.1676	G	1	131	1	174	28	1	\N	ENST00000288135:c.1676T>G	\N	28	1	\N
206	c.1678	-	1	132	2	175	28	5	\N	ENST00000288135:c.1678delGTT	\N	28	1	\N
207	c.1679	A	1	133	1	176	28	1	\N	ENST00000288135:c.1679T>A	\N	28	1	\N
208	c.1679	C	1	133	1	177	28	1	\N	ENST00000288135:c.1679T>C	\N	28	1	\N
209	c.1679	G	1	133	1	178	28	1	\N	ENST00000288135:c.1679T>G	\N	28	1	\N
210	c.1694	T	1	134	1	179	28	1	\N	ENST00000288135:c.1694G>T	\N	28	1	\N
211	c.1696	G	1	135	1	180	28	1	\N	ENST00000288135:c.1696A>G	\N	28	1	\N
212	c.1696_1713	-	1	136	2	181	28	5	\N	ENST00000288135:c.1696_1713delAACAATTATGTTACAGAC	\N	28	1	\N
213	c.1696_1722	-	1	137	2	182	28	5	\N	ENST00000288135:c.1696_1722delAACAATTATGTTACAGACCCAACA	\N	28	1	\N
214	c.1706	G	1	138	1	183	28	1	\N	ENST00000288135:c.1706T>G	\N	28	1	\N
215	c.1723_1724	CCAGAA	1	139	3	184	28	6	\N	ENST00000288135:c.1723_1724insCCAGAA	\N	28	1	\N
216	c.1723_1724	CCAGAG	1	139	3	185	28	6	\N	ENST00000288135:c.1723_1724insCCAGAG	\N	28	1	\N
217	c.1723_1724	CCCGAA	1	139	3	184	28	6	\N	ENST00000288135:c.1723_1724insCCCGAA	\N	28	1	\N
218	c.1723_1724	CCCGAG	1	139	3	185	28	6	\N	ENST00000288135:c.1723_1724insCCCGAG	\N	28	1	\N
219	c.1723_1724	CCGGAA	1	139	3	186	28	6	\N	ENST00000288135:c.1723_1724insCCGGAA	\N	28	1	\N
220	c.1723_1724	CCGGAG	1	139	3	187	28	6	\N	ENST00000288135:c.1723_1724insCCGGAG	\N	28	1	\N
221	c.1723_1724	CCTGAA	1	139	3	188	28	6	\N	ENST00000288135:c.1723_1724insCCTGAA	\N	28	1	\N
222	c.1723_1724	CCTGAG	1	139	3	188	28	6	\N	ENST00000288135:c.1723_1724insCCTGAG	\N	28	1	\N
223	c.1727	C	1	140	1	189	28	1	\N	ENST00000288135:c.1727T>C	\N	28	1	\N
224	c.1730	-	1	141	2	190	28	5	\N	ENST00000288135:c.1730delCTTATGATC	\N	28	1	\N
225	c.1735_1737	-	1	142	2	191	28	5	\N	ENST00000288135:c.1735_1737delGAT	\N	28	1	\N
226	c.1900	T	1	143	1	192	28	1	\N	ENST00000288135:c.1900C>T	\N	28	1	\N
227	c.1924	G	1	144	1	193	28	1	\N	ENST00000288135:c.1924A>G	\N	28	1	\N
228	c.1961	A	1	145	1	194	28	1	\N	ENST00000288135:c.1961T>A	\N	28	1	\N
229	c.1961	C	1	145	1	195	28	1	\N	ENST00000288135:c.1961T>C	\N	28	1	\N
230	c.1964	G	1	146	1	196	28	1	\N	ENST00000288135:c.1964A>G	\N	28	1	\N
231	c.1965	A	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>A	\N	28	1	\N
232	c.1965	G	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>G	\N	28	1	\N
233	c.2089	T	1	148	1	198	28	1	\N	ENST00000288135:c.2089C>T	\N	28	1	\N
234	c.2446	C	1	149	1	199	28	1	\N	ENST00000288135:c.2446G>C	\N	28	1	\N
235	c.2446	T	1	149	1	200	28	1	\N	ENST00000288135:c.2446G>T	\N	28	1	\N
236	c.2446_2447	AT	1	150	4	201	28	1	\N	ENST00000288135:c.2446_2447GA>AT	\N	28	1	\N
237	c.2447	T	1	151	1	202	28	1	\N	ENST00000288135:c.2447A>T	\N	28	1	\N
238	c.2458	C	1	152	1	203	28	1	\N	ENST00000288135:c.2458G>C	\N	28	1	\N
239	c.2458	T	1	152	1	204	28	1	\N	ENST00000288135:c.2458G>T	\N	28	1	\N
240	c.2459	T	1	153	1	205	28	1	\N	ENST00000288135:c.2459A>T	\N	28	1	\N
241	c.2460	A	1	154	1	206	28	1	\N	ENST00000288135:c.2460T>A	\N	28	1	\N
242	c.2464	T	1	155	1	207	28	1	\N	ENST00000288135:c.2464A>T	\N	28	1	\N
243	c.2465	T	1	156	1	208	28	1	\N	ENST00000288135:c.2465A>T	\N	28	1	\N
244	c.2466	A	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>A	\N	28	1	\N
245	c.2466	G	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>G	\N	28	1	\N
246	c.2467	G	1	158	1	210	28	1	\N	ENST00000288135:c.2467T>G	\N	28	1	\N
247	c.2485	C	1	159	1	211	28	1	\N	ENST00000288135:c.2485G>C	\N	28	1	\N
248	c.2521	G	1	160	1	212	28	1	\N	ENST00000288135:c.2521A>G	\N	28	1	\N
249	c.2591	T	1	161	1	213	28	1	\N	ENST00000288135:c.2591C>T	\N	28	1	\N
250	c.862_863	CATG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCATG	\N	29	1	\N
251	c.862_863	CCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCCTG	\N	29	1	\N
252	c.862_863	TCAG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCAG	\N	29	1	\N
253	c.862_863	TCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCTG	\N	29	1	\N
254	c.1387	C	1	163	1	215	30	1	\N	ENST00000206249:c.1387T>C	\N	30	1	\N
255	c.1601	A	1	164	1	216	30	1	\N	ENST00000206249:c.1601T>A	\N	30	1	\N
256	c.1604	A	1	165	1	217	30	1	\N	ENST00000206249:c.1604C>A	\N	30	1	\N
257	c.1607	G	1	166	1	218	30	1	\N	ENST00000206249:c.1607T>G	\N	30	1	\N
258	c.1609	A	1	167	1	219	30	1	\N	ENST00000206249:c.1609T>A	\N	30	1	\N
259	c.1610	C	1	168	1	220	30	1	\N	ENST00000206249:c.1610A>C	\N	30	1	\N
260	c.1610	G	1	168	1	221	30	1	\N	ENST00000206249:c.1610A>G	\N	30	1	\N
261	c.1613	G	1	169	1	222	30	1	\N	ENST00000206249:c.1613A>G	\N	30	1	\N
262	c.203_204	TT	1	170	4	223	31	1	\N	ENST00000249373:c.203_204CC>TT	\N	31	1	\N
263	c.595	T	1	171	1	224	31	1	\N	ENST00000249373:c.595C>T	\N	31	1	\N
264	c.1046_1047	TT	1	172	4	225	31	1	\N	ENST00000249373:c.1046_1047CC>TT	\N	31	1	\N
265	c.1417	C	1	173	1	226	31	1	\N	ENST00000249373:c.1417G>C	\N	31	1	\N
266	c.1452_1453	TT	1	174	4	227	31	1	\N	ENST00000249373:c.1452_1453CC>TT	\N	31	1	\N
267	c.1542_1543	TT	1	175	4	228	31	1	\N	ENST00000249373:c.1542_1543CC>TT	\N	31	1	\N
268	c.1604	T	1	176	1	229	31	1	\N	ENST00000249373:c.1604G>T	\N	31	1	\N
269	c.1685	A	1	177	1	230	31	1	\N	ENST00000249373:c.1685G>A	\N	31	1	\N
270	c.1955	T	1	178	1	231	31	1	\N	ENST00000249373:c.1955C>T	\N	31	1	\N
271	c.2263_2264	TT	1	179	4	232	31	1	\N	ENST00000249373:c.2263_2264CC>TT	\N	31	1	\N
272	c.1801	C	-1	180	1	233	32	1	\N	ENST00000288602:c.1801A>G	\N	32	1	\N
273	c.1800_1799	AT	-1	181	4	234	32	1	\N	ENST00000288602:c.1800_1799TG>AT	\N	32	1	\N
274	c.1799	C	-1	182	1	235	32	1	\N	ENST00000288602:c.1799T>G	\N	32	1	\N
275	c.1799	T	-1	182	1	236	32	1	\N	ENST00000288602:c.1799T>A	\N	32	1	\N
276	c.1799_1798	CT	-1	183	4	237	32	1	\N	ENST00000288602:c.1799_1798GT>AG	\N	32	1	\N
277	c.1799_1798	TT	-1	183	4	238	32	1	\N	ENST00000288602:c.1799_1798GT>AA	\N	32	1	\N
278	c.1790	C	-1	184	1	239	32	1	\N	ENST00000288602:c.1790T>G	\N	32	1	\N
279	c.1782	T	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>A	\N	32	1	\N
280	c.1781	A	-1	186	1	241	32	1	\N	ENST00000288602:c.1781A>T	\N	32	1	\N
281	c.1781	C	-1	186	1	242	32	1	\N	ENST00000288602:c.1781A>G	\N	32	1	\N
282	c.1781	G	-1	186	1	243	32	1	\N	ENST00000288602:c.1781A>C	\N	32	1	\N
283	c.1780	A	-1	187	1	244	32	1	\N	ENST00000288602:c.1780G>T	\N	32	1	\N
284	c.1780	G	-1	187	1	245	32	1	\N	ENST00000288602:c.1780G>C	\N	32	1	\N
285	c.1780	T	-1	187	1	246	32	1	\N	ENST00000288602:c.1780G>A	\N	32	1	\N
286	c.1780_1779	TC	-1	188	4	246	32	1	\N	ENST00000288602:c.1780_1779TG>GA	\N	32	1	\N
287	c.1415	C	-1	189	1	247	32	1	\N	ENST00000288602:c.1415A>G	\N	32	1	\N
288	c.229	A	-1	190	1	248	32	2	\N	ENST00000496384:c.229G>T	\N	33	1	\N
289	c.1406	G	-1	190	1	249	32	1	\N	ENST00000288602:c.1406G>C	\N	32	1	\N
290	c.1406	T	-1	190	1	250	32	1	\N	ENST00000288602:c.1406G>A	\N	32	1	\N
291	c.229_228	AA	-1	191	4	251	32	2	\N	ENST00000496384:c.229_228GG>TT	\N	33	1	\N
292	c.1397	A	-1	192	1	252	32	1	\N	ENST00000288602:c.1397G>T	\N	32	1	\N
293	c.2155	A	1	193	1	253	33	1	\N	ENST00000275493:c.2155G>A	\N	34	1	\N
294	c.2155	T	1	193	1	254	33	1	\N	ENST00000275493:c.2155G>T	\N	34	1	\N
295	c.2156	C	1	194	1	255	33	1	\N	ENST00000275493:c.2156G>C	\N	34	1	\N
296	c.2369	T	1	195	1	256	33	1	\N	ENST00000275493:c.2369C>T	\N	34	1	\N
297	c.2573	G	1	196	1	257	33	1	\N	ENST00000275493:c.2573T>G	\N	34	1	\N
298	c.2582	A	1	197	1	258	33	1	\N	ENST00000275493:c.2582T>A	\N	34	1	\N
299	c.1849	T	1	198	1	259	34	1	\N	ENST00000381652:c.1849G>T	\N	35	1	\N
300	c.2047	G	1	199	1	260	34	1	\N	ENST00000381652:c.2047A>G	\N	35	1	\N
301	c.2048	C	1	200	1	261	34	1	\N	ENST00000381652:c.2048G>C	\N	35	1	\N
302	c.2049	C	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>C	\N	35	1	\N
303	c.2049	T	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>T	\N	35	1	\N
304	c.626	A	-1	202	1	89	35	1	\N	ENST00000286548:c.626A>T	\N	36	1	\N
305	c.626	C	-1	202	1	263	35	1	\N	ENST00000286548:c.626A>G	\N	36	1	\N
306	c.626	G	-1	202	1	88	35	1	\N	ENST00000286548:c.626A>C	\N	36	1	\N
307	c.695	C	-1	203	1	264	36	1	\N	ENST00000381567:c.695T>G	\N	37	1	\N
373	c.3521	C	-1	95	1	120	45	1	\N	ENST00000389048:c.3521T>G	\N	21	2	\N
374	c.3520	C	-1	96	1	121	45	1	\N	ENST00000389048:c.3520T>G	\N	21	2	\N
375	c.3520	T	-1	96	1	122	45	1	\N	ENST00000389048:c.3520T>A	\N	21	2	\N
376	c.3512	T	-1	97	1	123	45	1	\N	ENST00000389048:c.3512T>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
405	c.949	T	-1	238	1	296	48	1	\N	ENST00000342788:c.949G>A	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
483	c.1124	G	1	276	1	348	56	1	\N	ENST00000340107:c.1124A>G	\N	47	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"bortezomib","Status":"preclinical","Evidence":"emerging","PMID":"19331127, 21273588"},{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}]}
484	c.1663	A	1	277	1	349	56	1	\N	ENST00000340107:c.1663G>A	\N	47	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}]}
530	c.1961	C	1	145	1	195	58	1	\N	ENST00000288135:c.1961T>C	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
531	c.1964	G	1	146	1	196	58	1	\N	ENST00000288135:c.1964A>G	\N	28	2	\N
532	c.1965	A	1	147	1	197	58	1	\N	ENST00000288135:c.1965T>A	\N	28	2	\N
533	c.1965	G	1	147	1	197	58	1	\N	ENST00000288135:c.1965T>G	\N	28	2	\N
534	c.2009	T	1	295	1	365	58	1	\N	ENST00000288135:c.2009C>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"24687822"}]}
535	c.2089	T	1	148	1	198	58	1	\N	ENST00000288135:c.2089C>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"19861435"}]}
536	c.2446	C	1	149	1	199	58	1	\N	ENST00000288135:c.2446G>C	\N	28	2	\N
537	c.2446	T	1	149	1	200	58	1	\N	ENST00000288135:c.2446G>T	\N	28	2	\N
538	c.2446_2447	AT	1	150	4	201	58	1	\N	ENST00000288135:c.2446_2447GA>AT	\N	28	2	\N
539	c.2447	T	1	151	1	202	58	1	\N	ENST00000288135:c.2447A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"case report","Evidence":"emerging","PMID":"18986703"}]}
540	c.2458	C	1	152	1	203	58	1	\N	ENST00000288135:c.2458G>C	\N	28	2	\N
541	c.2458	T	1	152	1	204	58	1	\N	ENST00000288135:c.2458G>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"23775962"}]}
542	c.2459	T	1	153	1	205	58	1	\N	ENST00000288135:c.2459A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"early trials","Evidence":"emerging","PMID":"18559612"}]}
543	c.2460	A	1	154	1	206	58	1	\N	ENST00000288135:c.2460T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"19461405"}]}
548	c.2474	C	1	296	1	366	58	1	\N	ENST00000288135:c.2474T>C	\N	28	2	\N
551	c.553	T	1	298	1	368	59	1	\N	ENST00000303115:c.553A>T	\N	48	2	{"Description":"mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22897847, 22955920"},{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors  (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
552	c.1126	A	1	299	1	369	60	1	\N	ENST00000396611:c.1126G>A	\N	49	2	\N
553	c.1126	C	1	299	1	369	60	1	\N	ENST00000396611:c.1126G>C	\N	49	2	\N
554	c.1315	-	1	300	2	370	60	5	\N	ENST00000396611:c.1315delGAA	\N	49	2	\N
604	c.866	T	1	333	1	404	68	1	\N	ENST00000275493:c.866C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
605	c.1474	G	1	334	1	405	68	1	\N	ENST00000275493:c.1474A>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"22270724"},{"Association":"response","Therapeutic_context":"panitumumab","Status":"case report","Evidence":"emerging","PMID":"22270724"}]}
623	c.2257	T	1	348	1	420	68	1	\N	ENST00000275493:c.2257C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab plus sirolimus","Status":"case report","Evidence":"emerging","PMID":"24934779"}]}
624	c.2281	A	1	349	1	421	68	1	\N	ENST00000275493:c.2281G>A	\N	34	2	\N
625	c.2281	T	1	349	1	422	68	1	\N	ENST00000275493:c.2281G>T	\N	34	2	\N
627	c.2318	G	1	351	1	424	68	1	\N	ENST00000275493:c.2318A>G	\N	34	2	\N
641	c.3029	T	1	359	1	433	69	1	\N	ENST00000318493:c.3029C>T	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
642	c.3328	A	1	360	1	434	69	1	\N	ENST00000318493:c.3328G>A	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
643	c.3334	T	1	361	1	435	69	1	\N	ENST00000318493:c.3334C>T	\N	55	2	\N
644	c.3335	G	1	362	1	436	69	1	\N	ENST00000318493:c.3335A>G	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23213094"}]}
645	c.3742	C	1	363	1	437	69	1	\N	ENST00000318493:c.3742T>C	\N	55	2	\N
646	c.3743	G	1	364	1	438	69	1	\N	ENST00000318493:c.3743A>G	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
647	c.3757	G	1	365	1	439	69	1	\N	ENST00000318493:c.3757T>G	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
648	c.3803	C	1	366	1	440	69	1	\N	ENST00000318493:c.3803T>C	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"case report","Evidence":"emerging","PMID":"23610116"}]}
649	c.3804	A	1	367	1	441	69	1	\N	ENST00000318493:c.3804G>A	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
650	c.3804	C	1	367	1	441	69	1	\N	ENST00000318493:c.3804G>C	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
651	c.3804	T	1	367	1	441	69	1	\N	ENST00000318493:c.3804G>T	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
653	c.1814	T	-1	368	1	442	71	1	\N	ENST00000288602:c.1814G>A	\N	32	2	\N
654	c.1814_1813	AA	-1	369	4	443	71	1	\N	ENST00000288602:c.1814_1813AG>TT	\N	32	2	\N
693	c.1756	T	-1	385	1	462	71	1	\N	ENST00000288602:c.1756G>A	\N	32	2	\N
694	c.1742	C	-1	386	1	463	71	1	\N	ENST00000288602:c.1742A>G	\N	32	2	\N
735	c.416	A	-1	409	1	491	76	1	\N	ENST00000361570:c.416G>T	\N	60	2	\N
736	c.413	A	-1	410	1	492	76	1	\N	ENST00000361570:c.413C>T	\N	60	2	\N
737	c.238	A	-1	411	1	493	76	2	\N	ENST00000446177:c.238C>T	\N	59	2	\N
738	c.205	A	-1	412	1	494	76	2	\N	ENST00000446177:c.205G>T	\N	59	2	\N
695	c.1415	C	-1	189	1	247	71	1	\N	ENST00000288602:c.1415A>G	\N	32	2	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"case report","Evidence":"emerging","PMID":"22649091"}]}
696	c.1411	A	-1	387	1	464	71	1	\N	ENST00000288602:c.1411G>T	\N	32	2	\N
697	c.229	A	-1	190	1	248	71	2	\N	ENST00000496384:c.229G>T	\N	33	2	\N
688	c.1776	C	-1	381	1	458	71	1	\N	ENST00000288602:c.1776A>G	\N	32	2	\N
689	c.1774	C	-1	382	1	459	71	1	\N	ENST00000288602:c.1774A>G	\N	32	2	\N
664	c.1799	T	-1	182	1	236	71	1	\N	ENST00000288602:c.1799T>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"cetuximab, panitumumab","Status":"late trials","Evidence":"emerging","PMID":"20619739, 21163703, 23325582"},{"Association":"response","Therapeutic_context":"BRAF inhibitors +/- MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"22608338, J Clin Oncol 2010;28:(suppl; abstr 3534), J Clin Oncol 2012;30:(suppl; abstr 3528)"},{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors + EGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22281684"},{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors + PI3K pathway inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23251002, 23549875"},{"Association":"sensitivity","Therapeutic_context":"proteosome inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24107445.0"},{"Association":"mTOR inhibitors + BH3 mimetics","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"24163374"}]}
665	c.1799_1798	CT	-1	183	4	237	71	1	\N	ENST00000288602:c.1799_1798GT>AG	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23237741"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
666	c.1799_1798	TT	-1	183	4	238	71	1	\N	ENST00000288602:c.1799_1798GT>AA	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, dabrafenib + trametinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"vemurafenib","Status":"late trials","Evidence":"emerging","PMID":"22356324"}]}
667	c.1798	A	-1	373	1	448	71	1	\N	ENST00000288602:c.1798G>T	\N	32	2	\N
668	c.1798	G	-1	373	1	448	71	1	\N	ENST00000288602:c.1798G>C	\N	32	2	\N
698	c.1406	G	-1	190	1	249	71	1	\N	ENST00000288602:c.1406G>C	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"EGFR TKIs","Status":"case report","Evidence":"emerging","PMID":"22773810"},{"Association":"sensitivity","Therapeutic_context":"EGFR TKIs + MEK inhibitors in EGFR mutant","Status":"preclinical","Evidence":"emerging","PMID":"22773810"}]}
699	c.1406	T	-1	190	1	250	71	1	\N	ENST00000288602:c.1406G>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
700	c.229_228	AA	-1	191	4	251	71	2	\N	ENST00000496384:c.229_228GG>TT	\N	33	2	\N
701	c.1406_1405	GA	-1	191	4	465	71	1	\N	ENST00000288602:c.1406_1405GG>TC	\N	32	2	\N
702	c.1405	G	-1	388	1	466	71	1	\N	ENST00000288602:c.1405G>C	\N	32	2	\N
703	c.1405	T	-1	388	1	466	71	1	\N	ENST00000288602:c.1405G>A	\N	32	2	\N
704	c.1397	A	-1	192	1	252	71	1	\N	ENST00000288602:c.1397G>T	\N	32	2	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22649091"}]}
705	c.1397	G	-1	192	1	467	71	1	\N	ENST00000288602:c.1397G>C	\N	32	2	\N
739	c.181	A	-1	413	1	495	76	2	\N	ENST00000446177:c.181G>T	\N	59	2	\N
740	c.172	A	-1	414	1	496	76	2	\N	ENST00000446177:c.172C>T	\N	59	2	\N
741	c.626	A	-1	202	1	89	77	1	\N	ENST00000286548:c.626A>T	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
742	c.626	C	-1	202	1	263	77	1	\N	ENST00000286548:c.626A>G	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
743	c.626	G	-1	202	1	88	77	1	\N	ENST00000286548:c.626A>C	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
744	c.626_625	AA	-1	415	4	89	77	1	\N	ENST00000286548:c.626_625CA>TT	\N	36	2	\N
745	c.763	A	1	416	1	497	78	1	\N	ENST00000372348:c.763G>A	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
761	c.1006	G	1	430	1	512	78	1	\N	ENST00000372348:c.1006T>G	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
461	c.1634	T	1	110	1	141	55	1	\N	ENST00000263967:c.1634A>T	\N	25	2	\N
762	c.1007	G	1	431	1	513	78	1	\N	ENST00000372348:c.1007T>G	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
763	c.1008	A	1	432	1	514	78	1	\N	ENST00000372348:c.1008C>A	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
764	c.1008	G	1	432	1	514	78	1	\N	ENST00000372348:c.1008C>G	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
765	c.1109	C	1	433	1	515	78	1	\N	ENST00000372348:c.1109T>C	\N	61	2	\N
766	c.1121	G	1	434	1	516	78	1	\N	ENST00000372348:c.1121A>G	\N	61	2	\N
767	c.1132	A	1	435	1	517	78	1	\N	ENST00000372348:c.1132T>A	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
768	c.1132	C	1	435	1	518	78	1	\N	ENST00000372348:c.1132T>C	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
769	c.1132	G	1	435	1	519	78	1	\N	ENST00000372348:c.1132T>G	\N	61	2	\N
770	c.1133	G	1	436	1	520	78	1	\N	ENST00000372348:c.1133T>G	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
771	c.1244	G	1	437	1	521	78	1	\N	ENST00000372348:c.1244A>G	\N	61	2	\N
772	c.1834_1860	-	1	438	2	522	79	5	\N	ENST00000355710:c.1834_1860delTTCCCTGAGGAGGAGAAGTGCTTCTGC	\N	4	2	\N
773	c.1892	G	1	439	1	523	79	1	\N	ENST00000355710:c.1892A>G	\N	4	2	\N
410	c.481	T	1	243	1	301	49	2	\N	ENST00000256474:c.481C>T	\N	43	2	\N
411	c.499	T	1	244	1	302	49	1	\N	ENST00000256474:c.499C>T	\N	43	2	\N
412	c.1163	G	-1	245	1	303	50	1	\N	ENST00000442415:c.1163G>C	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
413	c.769	G	-1	246	1	304	50	1	\N	ENST00000442415:c.769T>C	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
414	c.1151	A	1	247	1	305	51	1	\N	ENST00000231790:c.1151T>A	\N	45	2	\N
415	c.818	C	1	248	1	306	52	1	\N	ENST00000417037:c.818T>C	\N	46	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21179087"}]}
416	c.37	A	1	249	1	307	53	1	\N	ENST00000349496:c.37G>A	\N	26	2	\N
417	c.61	A	1	250	1	308	53	1	\N	ENST00000349496:c.61G>A	\N	26	2	\N
418	c.64_114	-	1	251	2	309	53	5	\N	ENST00000349496:c.64_114delGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	\N	26	2	\N
419	c.65	C	1	252	1	310	53	1	\N	ENST00000349496:c.65T>C	\N	26	2	\N
420	c.73_96	-	1	253	2	311	53	5	\N	ENST00000349496:c.73_96delTGGCAGCAACAGTCTTACCTGGAC	\N	26	2	\N
806	c.1608	T	-1	460	1	544	81	1	\N	ENST00000457416:c.1608G>A	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
807	c.1144	G	-1	461	1	545	81	1	\N	ENST00000457416:c.1144T>C	\N	62	2	\N
808	c.1127	C	-1	462	1	546	81	1	\N	ENST00000457416:c.1127A>G	\N	62	2	\N
421	c.94	A	1	254	1	312	53	1	\N	ENST00000349496:c.94G>A	\N	26	2	\N
422	c.94	C	1	254	1	313	53	1	\N	ENST00000349496:c.94G>C	\N	26	2	\N
423	c.94	T	1	254	1	314	53	1	\N	ENST00000349496:c.94G>T	\N	26	2	\N
424	c.95	C	1	255	1	315	53	1	\N	ENST00000349496:c.95A>C	\N	26	2	\N
425	c.95	G	1	255	1	316	53	1	\N	ENST00000349496:c.95A>G	\N	26	2	\N
426	c.95	T	1	255	1	317	53	1	\N	ENST00000349496:c.95A>T	\N	26	2	\N
427	c.98	A	1	256	1	318	53	1	\N	ENST00000349496:c.98C>A	\N	26	2	\N
428	c.98	G	1	256	1	319	53	1	\N	ENST00000349496:c.98C>G	\N	26	2	\N
429	c.100	A	1	257	1	320	53	1	\N	ENST00000349496:c.100G>A	\N	26	2	\N
430	c.100	C	1	257	1	320	53	1	\N	ENST00000349496:c.100G>C	\N	26	2	\N
431	c.101	A	1	258	1	321	53	1	\N	ENST00000349496:c.101G>A	\N	26	2	\N
432	c.101	T	1	258	1	322	53	1	\N	ENST00000349496:c.101G>T	\N	26	2	\N
433	c.109	C	1	259	1	323	53	1	\N	ENST00000349496:c.109T>C	\N	26	2	\N
434	c.109	G	1	259	1	324	53	1	\N	ENST00000349496:c.109T>G	\N	26	2	\N
435	c.110	A	1	115	1	150	53	1	\N	ENST00000349496:c.110C>A	\N	26	2	\N
436	c.110	G	1	115	1	325	53	1	\N	ENST00000349496:c.110C>G	\N	26	2	\N
437	c.110	T	1	115	1	151	53	1	\N	ENST00000349496:c.110C>T	\N	26	2	\N
438	c.118	C	1	260	1	326	53	1	\N	ENST00000349496:c.118A>C	\N	26	2	\N
439	c.118	G	1	260	1	327	53	1	\N	ENST00000349496:c.118A>G	\N	26	2	\N
316	c.1853	A	-1	9	1	18	39	1	\N	ENST00000373103:c.1853C>T	\N	3	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"case report","Evidence":"emerging","PMID":"23656643"}]}
462	c.1635	C	1	266	1	337	55	1	\N	ENST00000263967:c.1635G>C	\N	25	2	\N
463	c.1635	T	1	266	1	337	55	1	\N	ENST00000263967:c.1635G>T	\N	25	2	\N
878	c.2503	A	-1	36	1	40	88	1	\N	ENST00000380982:c.2503G>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
879	c.2503	G	-1	36	1	41	88	1	\N	ENST00000380982:c.2503G>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
888	c.1855	A	-1	492	1	571	88	1	\N	ENST00000380982:c.1855G>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
889	c.1715	C	-1	493	1	572	88	1	\N	ENST00000380982:c.1715A>G	\N	9	2	\N
890	c.409	T	1	494	1	573	89	2	\N	ENST00000267163:c.409G>T	\N	66	2	\N
891	c.596	A	1	495	1	574	89	2	\N	ENST00000267163:c.596T>A	\N	66	2	\N
892	c.958	T	1	496	1	575	89	2	\N	ENST00000267163:c.958C>T	\N	66	2	\N
893	c.1072	T	1	497	1	576	89	2	\N	ENST00000267163:c.1072C>T	\N	66	2	\N
894	c.1363	T	1	498	1	577	89	2	\N	ENST00000267163:c.1363C>T	\N	66	2	\N
895	c.1654	T	1	499	1	578	89	2	\N	ENST00000267163:c.1654C>T	\N	66	2	\N
896	c.1666	T	1	500	1	579	89	2	\N	ENST00000267163:c.1666C>T	\N	66	2	\N
440	c.118	T	1	260	1	328	53	1	\N	ENST00000349496:c.118A>T	\N	26	2	\N
441	c.119	G	1	261	1	328	53	1	\N	ENST00000349496:c.119C>G	\N	26	2	\N
442	c.119	T	1	261	1	329	53	1	\N	ENST00000349496:c.119C>T	\N	26	2	\N
443	c.133	C	1	116	1	152	53	1	\N	ENST00000349496:c.133T>C	\N	26	2	\N
444	c.133	G	1	116	1	330	53	1	\N	ENST00000349496:c.133T>G	\N	26	2	\N
445	c.134	A	1	117	1	153	53	1	\N	ENST00000349496:c.134C>A	\N	26	2	\N
446	c.134	G	1	117	1	331	53	1	\N	ENST00000349496:c.134C>G	\N	26	2	\N
447	c.134	T	1	117	1	154	53	1	\N	ENST00000349496:c.134C>T	\N	26	2	\N
448	c.1192	A	-1	106	1	134	54	1	\N	ENST00000341105:c.1192C>T	\N	24	2	\N
449	c.1061	A	-1	107	1	135	54	1	\N	ENST00000341105:c.1061C>T	\N	24	2	\N
450	c.263	A	1	262	1	332	55	1	\N	ENST00000263967:c.263G>A	\N	25	2	\N
451	c.1035	A	1	263	1	333	55	1	\N	ENST00000263967:c.1035T>A	\N	25	2	\N
953	c.929	T	1	521	1	602	96	1	\N	ENST00000269571:c.929C>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
954	c.2263	-	1	57	2	65	96	5	\N	ENST00000269571:c.2263delTTGAGGGAAAACACA	\N	14	2	\N
955	c.2264	C	1	58	1	45	96	1	\N	ENST00000269571:c.2264T>C	\N	14	2	\N
956	c.2305	C	1	59	1	66	96	1	\N	ENST00000269571:c.2305G>C	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
958	c.2326	A	1	522	1	603	96	1	\N	ENST00000269571:c.2326G>A	\N	14	2	\N
312	c.6040	T	-1	208	1	269	37	1	\N	ENST00000361445:c.6040G>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
313	c.4379	G	-1	209	1	270	37	1	\N	ENST00000361445:c.4379T>C	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
314	c.1171	G	-1	210	1	271	38	1	\N	ENST00000358432:c.1171G>C	\N	39	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
452	c.1035	G	1	263	1	333	55	1	\N	ENST00000263967:c.1035T>G	\N	25	2	\N
453	c.1258	C	1	264	1	334	55	1	\N	ENST00000263967:c.1258T>C	\N	25	2	\N
454	c.1616	G	1	265	1	335	55	1	\N	ENST00000263967:c.1616C>G	\N	25	2	\N
990	c.136	A	-1	537	1	619	100	1	\N	ENST00000262948:c.136C>T	\N	69	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
992	c.2164	T	-1	539	1	621	101	1	\N	ENST00000458235:c.2164G>A	\N	70	2	\N
993	c.1970	T	-1	540	1	622	101	1	\N	ENST00000458235:c.1970G>A	\N	70	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
315	c.1171	T	-1	210	1	271	38	1	\N	ENST00000358432:c.1171G>A	\N	39	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
317	c.1843	C	-1	211	1	272	39	1	\N	ENST00000373103:c.1843A>G	\N	3	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"23656643"}]}
319	c.1514	A	1	213	1	274	40	1	\N	ENST00000372470:c.1514G>A	\N	40	2	\N
320	c.1544	T	1	214	1	275	40	1	\N	ENST00000372470:c.1544G>T	\N	40	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"16834459"}]}
321	c.1972	A	-1	215	1	276	41	1	\N	ENST00000342505:c.1972G>T	\N	41	2	\N
322	c.1937	A	-1	216	1	277	41	1	\N	ENST00000342505:c.1937C>T	\N	41	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
323	c.183	A	-1	1	1	1	42	1	\N	ENST00000369535:c.183A>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
324	c.183	G	-1	1	1	1	42	1	\N	ENST00000369535:c.183A>C	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
404	c.1177	A	-1	237	1	295	48	1	\N	ENST00000342788:c.1177C>T	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
529	c.1961	A	1	145	1	194	58	1	\N	ENST00000288135:c.1961T>A	\N	28	2	\N
325	c.183_182	CA	-1	217	4	2	42	1	\N	ENST00000369535:c.183_182AA>TG	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
326	c.183_182	CC	-1	217	4	27	42	1	\N	ENST00000369535:c.183_182AA>GG	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
327	c.182	A	-1	2	1	2	42	1	\N	ENST00000369535:c.182A>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
361	c.3824	T	-1	89	1	114	45	1	\N	ENST00000389048:c.3824G>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
455	c.1624	A	1	108	1	136	55	1	\N	ENST00000263967:c.1624G>A	\N	25	2	\N
362	c.3806	G	-1	226	1	285	45	1	\N	ENST00000389048:c.3806G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}]}
363	c.3735	C	-1	90	1	115	45	1	\N	ENST00000389048:c.3735C>G	\N	21	2	\N
464	c.1636	A	1	111	1	142	55	1	\N	ENST00000263967:c.1636C>A	\N	25	2	\N
465	c.1636	G	1	111	1	143	55	1	\N	ENST00000263967:c.1636C>G	\N	25	2	\N
328	c.182	C	-1	2	1	27	42	1	\N	ENST00000369535:c.182A>G	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
329	c.182	G	-1	2	1	32	42	1	\N	ENST00000369535:c.182A>C	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
332	c.181	C	-1	3	1	4	42	1	\N	ENST00000369535:c.181C>G	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
333	c.181	T	-1	3	1	5	42	1	\N	ENST00000369535:c.181C>A	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
344	c.34	A	-1	7	1	14	42	1	\N	ENST00000369535:c.34G>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
346	c.34	T	-1	7	1	16	42	1	\N	ENST00000369535:c.34G>A	\N	1	2	\N
347	c.187	G	1	220	1	279	43	1	\N	ENST00000367921:c.187C>G	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
348	c.716	G	1	221	1	280	43	1	\N	ENST00000367921:c.716T>G	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
349	c.757	T	1	222	1	281	43	1	\N	ENST00000367921:c.757G>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
350	c.1513	A	1	223	1	282	43	1	\N	ENST00000367921:c.1513G>A	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
351	c.1912	T	1	224	1	283	43	1	\N	ENST00000367921:c.1912A>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
352	c.2304	A	1	8	1	17	43	1	\N	ENST00000367921:c.2304T>A	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib + erlotinib","Status":"case report","Evidence":"emerging","PMID":"22328973"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
353	c.2321	T	1	225	1	284	43	1	\N	ENST00000367921:c.2321G>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
354	c.2645	A	-1	86	1	107	44	1	\N	ENST00000264709:c.2645G>T	\N	20	2	\N
355	c.2645	G	-1	86	1	108	44	1	\N	ENST00000264709:c.2645G>C	\N	20	2	\N
356	c.2645	T	-1	86	1	109	44	1	\N	ENST00000264709:c.2645G>A	\N	20	2	\N
357	c.2644	A	-1	87	1	110	44	1	\N	ENST00000264709:c.2644C>T	\N	20	2	\N
358	c.2644	C	-1	87	1	111	44	1	\N	ENST00000264709:c.2644C>G	\N	20	2	\N
359	c.2644	T	-1	87	1	112	44	1	\N	ENST00000264709:c.2644C>A	\N	20	2	\N
360	c.3833	G	-1	88	1	113	45	1	\N	ENST00000389048:c.3833A>C	\N	21	2	\N
408	c.266	A	1	241	1	299	49	1	\N	ENST00000256474:c.266T>A	\N	43	2	\N
409	c.473	A	1	242	1	300	49	1	\N	ENST00000256474:c.473T>A	\N	43	2	\N
364	c.3734	C	-1	91	1	116	45	1	\N	ENST00000389048:c.3734T>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
365	c.3733	C	-1	92	1	117	45	1	\N	ENST00000389048:c.3733T>G	\N	21	2	\N
366	c.3673	T	-1	93	1	118	45	1	\N	ENST00000389048:c.3673G>A	\N	21	2	\N
367	c.3617	T	-1	227	1	286	45	1	\N	ENST00000389048:c.3617C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}]}
368	c.3604	T	-1	228	1	287	45	1	\N	ENST00000389048:c.3604G>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}]}
369	c.3586	T	-1	229	1	288	45	1	\N	ENST00000389048:c.3586C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165, 24327273"}]}
371	c.3522	C	-1	94	1	119	45	1	\N	ENST00000389048:c.3522C>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}]}
372	c.3522	T	-1	94	1	119	45	1	\N	ENST00000389048:c.3522C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}]}
377	c.3455	C	-1	231	1	290	45	1	\N	ENST00000389048:c.3455T>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}]}
378	c.3452	A	-1	98	1	124	45	1	\N	ENST00000389048:c.3452C>T	\N	21	2	\N
379	c.3383	G	-1	232	1	291	45	1	\N	ENST00000389048:c.3383G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
380	c.3271	T	-1	99	1	125	45	1	\N	ENST00000389048:c.3271G>A	\N	21	2	\N
381	c.2100	A	-1	78	1	90	46	1	\N	ENST00000335508:c.2100A>T	\N	18	2	\N
382	c.2100	G	-1	78	1	90	46	1	\N	ENST00000335508:c.2100A>C	\N	18	2	\N
383	c.2099	A	-1	79	1	91	46	1	\N	ENST00000335508:c.2099A>T	\N	18	2	\N
384	c.2099	C	-1	79	1	92	46	1	\N	ENST00000335508:c.2099A>G	\N	18	2	\N
385	c.2099	G	-1	79	1	93	46	1	\N	ENST00000335508:c.2099A>C	\N	18	2	\N
386	c.2098	A	-1	80	1	94	46	2	\N	ENST00000335508:c.2098A>T	\N	18	2	\N
387	c.2098	C	-1	80	1	95	46	1	\N	ENST00000335508:c.2098A>G	\N	18	2	\N
388	c.2098	G	-1	80	1	96	46	1	\N	ENST00000335508:c.2098A>C	\N	18	2	\N
389	c.1998	A	-1	81	1	97	46	1	\N	ENST00000335508:c.1998G>T	\N	18	2	\N
390	c.1998	G	-1	81	1	97	46	1	\N	ENST00000335508:c.1998G>C	\N	18	2	\N
391	c.1997	C	-1	82	1	98	46	1	\N	ENST00000335508:c.1997A>G	\N	18	2	\N
392	c.1997	G	-1	82	1	99	46	1	\N	ENST00000335508:c.1997A>C	\N	18	2	\N
393	c.1996	C	-1	83	1	100	46	1	\N	ENST00000335508:c.1996A>G	\N	18	2	\N
394	c.395	A	-1	84	1	101	47	1	\N	ENST00000345146:c.395G>T	\N	19	2	\N
395	c.395	G	-1	84	1	102	47	1	\N	ENST00000345146:c.395G>C	\N	19	2	\N
396	c.395	T	-1	84	1	103	47	1	\N	ENST00000345146:c.395G>A	\N	19	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"IDH inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23558169"}]}
397	c.394	A	-1	85	1	104	47	1	\N	ENST00000345146:c.394C>T	\N	19	2	\N
398	c.394	C	-1	85	1	105	47	1	\N	ENST00000345146:c.394C>G	\N	19	2	\N
399	c.394	T	-1	85	1	106	47	1	\N	ENST00000345146:c.394C>A	\N	19	2	\N
400	c.2614	T	-1	233	1	292	48	1	\N	ENST00000342788:c.2614G>A	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
401	c.1630	A	-1	234	1	293	48	1	\N	ENST00000342788:c.1630C>T	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
402	c.1624	T	-1	235	1	136	48	1	\N	ENST00000342788:c.1624G>A	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
403	c.1354	T	-1	236	1	294	48	1	\N	ENST00000342788:c.1354G>A	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
406	c.241	T	1	239	1	297	49	1	\N	ENST00000256474:c.241C>T	\N	43	2	\N
407	c.254	C	1	240	1	298	49	1	\N	ENST00000256474:c.254T>C	\N	43	2	\N
456	c.1624	C	1	108	1	336	55	1	\N	ENST00000263967:c.1624G>C	\N	25	2	\N
457	c.1633	A	1	109	1	137	55	1	\N	ENST00000263967:c.1633G>A	\N	25	2	\N
458	c.1633	C	1	109	1	138	55	1	\N	ENST00000263967:c.1633G>C	\N	25	2	\N
459	c.1634	C	1	110	1	139	55	1	\N	ENST00000263967:c.1634A>C	\N	25	2	\N
460	c.1634	G	1	110	1	140	55	1	\N	ENST00000263967:c.1634A>G	\N	25	2	\N
466	c.1637	C	1	112	1	144	55	1	\N	ENST00000263967:c.1637A>C	\N	25	2	\N
467	c.1637	G	1	112	1	145	55	1	\N	ENST00000263967:c.1637A>G	\N	25	2	\N
468	c.1637	T	1	112	1	146	55	1	\N	ENST00000263967:c.1637A>T	\N	25	2	\N
469	c.1645	A	1	113	1	147	55	1	\N	ENST00000263967:c.1645G>A	\N	25	2	\N
470	c.2102	C	1	267	1	338	55	1	\N	ENST00000263967:c.2102A>C	\N	25	2	\N
471	c.3062	G	1	268	1	339	55	1	\N	ENST00000263967:c.3062A>G	\N	25	2	\N
472	c.3129	A	1	269	1	340	55	1	\N	ENST00000263967:c.3129G>A	\N	25	2	\N
473	c.3129	T	1	269	1	340	55	1	\N	ENST00000263967:c.3129G>T	\N	25	2	\N
474	c.3139	T	1	270	1	341	55	1	\N	ENST00000263967:c.3139C>T	\N	25	2	\N
475	c.3140	G	1	114	1	148	55	1	\N	ENST00000263967:c.3140A>G	\N	25	2	\N
476	c.3140	T	1	114	1	149	55	1	\N	ENST00000263967:c.3140A>T	\N	25	2	\N
477	c.3145	A	1	271	1	342	55	1	\N	ENST00000263967:c.3145G>A	\N	25	2	\N
478	c.3145	C	1	271	1	343	55	1	\N	ENST00000263967:c.3145G>C	\N	25	2	\N
479	c.742	T	1	272	1	344	56	1	\N	ENST00000340107:c.742C>T	\N	47	2	\N
480	c.746	G	1	273	1	345	56	1	\N	ENST00000340107:c.746C>G	\N	47	2	\N
481	c.1114	T	1	274	1	346	56	1	\N	ENST00000340107:c.1114G>T	\N	47	2	\N
482	c.1117	T	1	275	1	347	56	1	\N	ENST00000340107:c.1117A>T	\N	47	2	\N
526	c.1727	C	1	140	1	189	58	1	\N	ENST00000288135:c.1727T>C	\N	28	2	\N
527	c.1730	-	1	141	2	190	58	5	\N	ENST00000288135:c.1730delCTTATGATC	\N	28	2	\N
528	c.1924	G	1	144	1	193	58	1	\N	ENST00000288135:c.1924A>G	\N	28	2	\N
485	c.1954	C	1	278	1	350	56	1	\N	ENST00000340107:c.1954A>C	\N	47	2	\N
486	c.2095	T	1	279	1	351	56	1	\N	ENST00000340107:c.2095G>T	\N	47	2	\N
487	c.1682	A	1	118	1	155	57	1	\N	ENST00000257290:c.1682T>A	\N	27	2	\N
488	c.1729	T	1	280	1	352	57	1	\N	ENST00000257290:c.1729C>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
489	c.1973	C	1	281	1	353	57	1	\N	ENST00000257290:c.1973T>C	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"},{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
490	c.1977	A	1	119	1	156	57	1	\N	ENST00000257290:c.1977C>A	\N	27	2	\N
491	c.1977	G	1	119	1	156	57	1	\N	ENST00000257290:c.1977C>G	\N	27	2	\N
492	c.2521_2526	-	1	282	2	354	57	5	\N	ENST00000257290:c.2521_2526delAGAGAC	\N	27	2	\N
493	c.2522	A	1	283	1	355	57	1	\N	ENST00000257290:c.2522G>A	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
494	c.2524	T	1	284	1	356	57	1	\N	ENST00000257290:c.2524G>T	\N	27	2	\N
495	c.2524_2525	AT	1	285	4	357	57	1	\N	ENST00000257290:c.2524_2525GA>AT	\N	27	2	\N
496	c.2524_2532	-	1	286	2	358	57	5	\N	ENST00000257290:c.2524_2532delGACATCATG	\N	27	2	\N
497	c.2524_2535	-	1	287	2	359	57	5	\N	ENST00000257290:c.2524_2535delGACATCATGCAT	\N	27	2	\N
498	c.2525	T	1	120	1	157	57	1	\N	ENST00000257290:c.2525A>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib, sunitinib","Status":"late trials, preclinical","Evidence":"emerging","PMID":"22718859, 16638875"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18794084"},{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"22745105"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"18794084"}]}
499	c.2527_2538	-	1	288	2	359	57	5	\N	ENST00000257290:c.2527_2538delATCATGCATGAT	\N	27	2	\N
500	c.2533	T	1	289	1	360	57	1	\N	ENST00000257290:c.2533C>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
501	c.2536	T	1	290	1	361	57	1	\N	ENST00000257290:c.2536G>T	\N	27	2	\N
502	c.2558	A	1	291	1	362	57	1	\N	ENST00000257290:c.2558G>A	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
503	c.154	A	1	292	1	363	58	1	\N	ENST00000288135:c.154G>A	\N	28	2	\N
504	c.1468	A	1	121	1	158	58	1	\N	ENST00000288135:c.1468G>A	\N	28	2	\N
505	c.1510	C	1	122	1	159	58	1	\N	ENST00000288135:c.1510T>C	\N	28	2	\N
506	c.1650	C	1	123	1	160	58	1	\N	ENST00000288135:c.1650A>C	\N	28	2	\N
507	c.1650	T	1	123	1	160	58	1	\N	ENST00000288135:c.1650A>T	\N	28	2	\N
580	c.2905	G	-1	323	1	393	62	1	\N	ENST00000286301:c.2905T>C	\N	51	2	\N
686	c.1780	T	-1	187	1	246	71	1	\N	ENST00000288602:c.1780G>A	\N	32	2	\N
687	c.1780_1779	TC	-1	188	4	246	71	1	\N	ENST00000288602:c.1780_1779TG>GA	\N	32	2	\N
508	c.1657	A	1	124	1	161	58	1	\N	ENST00000288135:c.1657T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"21969494"},{"Association":"response","Therapeutic_context":"sunitinib","Status":"case report","Evidence":"emerging","PMID":"23375402"}]}
509	c.1669	A	1	293	1	169	58	1	\N	ENST00000288135:c.1669G>A	\N	28	2	\N
510	c.1669	C	1	293	1	169	58	1	\N	ENST00000288135:c.1669G>C	\N	28	2	\N
511	c.1669	A	1	128	1	169	58	1	\N	ENST00000288135:c.1669T>A	\N	28	2	\N
512	c.1669	C	1	128	1	169	58	1	\N	ENST00000288135:c.1669T>C	\N	28	2	\N
513	c.1674	C	1	129	1	170	58	1	\N	ENST00000288135:c.1674G>C	\N	28	2	\N
514	c.1674	T	1	129	1	170	58	1	\N	ENST00000288135:c.1674G>T	\N	28	2	\N
515	c.1675	A	1	294	1	364	58	1	\N	ENST00000288135:c.1675G>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
516	c.1675_1677	-	1	130	2	171	58	5	\N	ENST00000288135:c.1675_1677delGTT	\N	28	2	\N
517	c.1676	A	1	131	1	172	58	1	\N	ENST00000288135:c.1676T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
518	c.1676	C	1	131	1	173	58	1	\N	ENST00000288135:c.1676T>C	\N	28	2	\N
519	c.1676	G	1	131	1	174	58	1	\N	ENST00000288135:c.1676T>G	\N	28	2	\N
520	c.1678	-	1	132	2	175	58	5	\N	ENST00000288135:c.1678delGTT	\N	28	2	{"Description":"deletion mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"15201427"}]}
521	c.1679	A	1	133	1	176	58	1	\N	ENST00000288135:c.1679T>A	\N	28	2	\N
522	c.1679	C	1	133	1	177	58	1	\N	ENST00000288135:c.1679T>C	\N	28	2	\N
523	c.1679	G	1	133	1	178	58	1	\N	ENST00000288135:c.1679T>G	\N	28	2	\N
524	c.1696	G	1	135	1	180	58	1	\N	ENST00000288135:c.1696A>G	\N	28	2	\N
525	c.1706	G	1	138	1	183	58	1	\N	ENST00000288135:c.1706T>G	\N	28	2	\N
544	c.2465	T	1	156	1	208	58	1	\N	ENST00000288135:c.2465A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
545	c.2466	A	1	157	1	209	58	1	\N	ENST00000288135:c.2466T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
546	c.2466	G	1	157	1	209	58	1	\N	ENST00000288135:c.2466T>G	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
547	c.2467	G	1	158	1	210	58	1	\N	ENST00000288135:c.2467T>G	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
549	c.2485	C	1	159	1	211	58	1	\N	ENST00000288135:c.2485G>C	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
550	c.2515	A	1	297	1	367	58	1	\N	ENST00000288135:c.2515G>A	\N	28	2	\N
603	c.787	C	1	332	1	403	68	1	\N	ENST00000275493:c.787A>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
555	c.1381	T	1	301	1	371	60	2	\N	ENST00000396611:c.1381C>T	\N	49	2	\N
556	c.1678	T	1	302	1	372	60	1	\N	ENST00000396611:c.1678G>T	\N	49	2	\N
557	c.1678_1695	-	1	303	2	373	60	5	\N	ENST00000396611:c.1678_1695delGACAAACGTATGAACAGC	\N	49	2	\N
558	c.1690	G	1	304	1	374	60	1	\N	ENST00000396611:c.1690A>G	\N	49	2	\N
559	c.1692	A	1	305	1	375	60	1	\N	ENST00000396611:c.1692C>A	\N	49	2	\N
560	c.1692	G	1	305	1	375	60	1	\N	ENST00000396611:c.1692C>G	\N	49	2	\N
561	c.1726_1728	-	1	306	2	376	60	5	\N	ENST00000396611:c.1726_1728delACG	\N	49	2	\N
562	c.1747	-	1	307	2	377	60	5	\N	ENST00000396611:c.1747delTGG	\N	49	2	\N
563	c.2626	T	1	308	1	378	61	2	\N	ENST00000257430:c.2626C>T	\N	50	2	\N
564	c.3340	T	1	309	1	379	61	2	\N	ENST00000257430:c.3340C>T	\N	50	2	\N
565	c.3916	T	1	310	1	380	61	2	\N	ENST00000257430:c.3916G>T	\N	50	2	\N
566	c.3928_3938	-	1	311	2	381	61	3	\N	ENST00000257430:c.3928_3938delAAGATTGGAAC	\N	50	2	\N
567	c.3928_3947	-	1	312	2	381	61	3	\N	ENST00000257430:c.3928_3947delAAGATTGGAACTAGGTCAGC	\N	50	2	\N
568	c.4012	T	1	313	1	382	61	2	\N	ENST00000257430:c.4012C>T	\N	50	2	\N
569	c.4099	T	1	314	1	383	61	2	\N	ENST00000257430:c.4099C>T	\N	50	2	\N
570	c.4132	T	1	315	1	384	61	2	\N	ENST00000257430:c.4132C>T	\N	50	2	\N
571	c.4135	T	1	316	1	385	61	2	\N	ENST00000257430:c.4135G>T	\N	50	2	\N
572	c.4285	T	1	317	1	386	61	2	\N	ENST00000257430:c.4285C>T	\N	50	2	\N
573	c.4348	T	1	318	1	387	61	2	\N	ENST00000257430:c.4348C>T	\N	50	2	\N
574	c.4396_4400	-	1	319	2	388	61	3	\N	ENST00000257430:c.4396_4400delGGACC	\N	50	2	\N
575	c.4669_4676	-	1	320	2	389	61	3	\N	ENST00000257430:c.4669_4676delATTGATTC	\N	50	2	\N
576	c.2907	C	-1	321	1	390	62	2	\N	ENST00000286301:c.2907T>G	\N	51	2	\N
577	c.2907	T	-1	321	1	390	62	2	\N	ENST00000286301:c.2907T>A	\N	51	2	\N
578	c.2906	A	-1	322	1	391	62	1	\N	ENST00000286301:c.2906A>T	\N	51	2	\N
579	c.2906	C	-1	322	1	392	62	1	\N	ENST00000286301:c.2906A>G	\N	51	2	\N
581	c.1711	C	-1	324	1	394	62	1	\N	ENST00000286301:c.1711T>G	\N	51	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"18971950"}]}
582	c.902	G	-1	325	1	395	62	1	\N	ENST00000286301:c.902T>C	\N	51	2	\N
583	c.902	T	-1	325	1	396	62	2	\N	ENST00000286301:c.902T>A	\N	51	2	\N
584	c.862_863	CATG	1	162	3	214	63	4	\N	ENST00000296930:c.862_863insCATG	\N	29	2	\N
585	c.862_863	CCTG	1	162	3	214	63	4	\N	ENST00000296930:c.862_863insCCTG	\N	29	2	\N
586	c.862_863	TCAG	1	162	3	214	63	4	\N	ENST00000296930:c.862_863insTCAG	\N	29	2	\N
587	c.862_863	TCTG	1	162	3	214	63	4	\N	ENST00000296930:c.862_863insTCTG	\N	29	2	\N
857	c.35	G	-1	29	1	12	85	1	\N	ENST00000256078:c.35G>C	\N	8	2	\N
588	c.1605	A	1	326	1	397	64	1	\N	ENST00000292408:c.1605C>A	\N	52	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
589	c.1605	G	1	326	1	397	64	1	\N	ENST00000292408:c.1605C>G	\N	52	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
590	c.1649	A	1	327	1	398	64	1	\N	ENST00000292408:c.1649T>A	\N	52	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
591	c.6094	T	-1	328	1	399	65	1	\N	ENST00000368508:c.6094G>A	\N	53	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"23724914"}]}
592	c.1138	C	1	329	1	400	66	1	\N	ENST00000206249:c.1138G>C	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510, 24398047"}]}
593	c.1387	C	1	163	1	215	66	1	\N	ENST00000206249:c.1387T>C	\N	30	2	\N
594	c.1601	A	1	164	1	216	66	1	\N	ENST00000206249:c.1601T>A	\N	30	2	\N
595	c.1604	A	1	165	1	217	66	1	\N	ENST00000206249:c.1604C>A	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512"}]}
596	c.1607	G	1	166	1	218	66	1	\N	ENST00000206249:c.1607T>G	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510"}]}
597	c.1609	A	1	167	1	219	66	1	\N	ENST00000206249:c.1609T>A	\N	30	2	\N
598	c.1610	C	1	168	1	220	66	1	\N	ENST00000206249:c.1610A>C	\N	30	2	\N
599	c.1610	G	1	168	1	221	66	1	\N	ENST00000206249:c.1610A>G	\N	30	2	\N
600	c.1613	G	1	169	1	222	66	1	\N	ENST00000206249:c.1613A>G	\N	30	2	\N
601	c.85	T	1	330	1	401	67	1	\N	ENST00000356142:c.85C>T	\N	54	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"case report","Evidence":"emerging","PMID":"J Clin Oncol 31, 2013 (suppl; abstr 11009)"}]}
602	c.323	A	1	331	1	402	68	1	\N	ENST00000275493:c.323G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
606	c.1636	T	1	335	1	406	68	1	\N	ENST00000275493:c.1636C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"23578570"}]}
607	c.1793	T	1	336	1	407	68	1	\N	ENST00000275493:c.1793G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
608	c.2068	A	1	337	1	408	68	1	\N	ENST00000275493:c.2068G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"lapatinib","Status":"case report","Evidence":"emerging","PMID":"22885469"}]}
609	c.2155	A	1	193	1	253	68	1	\N	ENST00000275493:c.2155G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
610	c.2155	T	1	193	1	254	68	1	\N	ENST00000275493:c.2155G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
683	c.1781	C	-1	186	1	242	71	1	\N	ENST00000288602:c.1781A>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
611	c.2156	A	1	194	1	409	68	1	\N	ENST00000275493:c.2156G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
858	c.35	T	-1	29	1	13	85	1	\N	ENST00000256078:c.35G>A	\N	8	2	\N
612	c.2156	C	1	194	1	255	68	1	\N	ENST00000275493:c.2156G>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
613	c.2193	A	1	338	1	410	68	2	\N	ENST00000275493:c.2193G>A	\N	34	2	\N
614	c.2198	T	1	339	1	411	68	1	\N	ENST00000275493:c.2198C>T	\N	34	2	\N
615	c.2200	A	1	340	1	412	68	1	\N	ENST00000275493:c.2200G>A	\N	34	2	\N
616	c.2203	A	1	341	1	413	68	1	\N	ENST00000275493:c.2203G>A	\N	34	2	\N
617	c.2225	C	1	342	1	414	68	1	\N	ENST00000275493:c.2225T>C	\N	34	2	\N
618	c.2234	G	1	343	1	415	68	1	\N	ENST00000275493:c.2234A>G	\N	34	2	\N
619	c.2236	A	1	344	1	416	68	1	\N	ENST00000275493:c.2236G>A	\N	34	2	\N
620	c.2240	C	1	345	1	417	68	1	\N	ENST00000275493:c.2240T>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
621	c.2248	C	1	346	1	418	68	1	\N	ENST00000275493:c.2248G>C	\N	34	2	\N
622	c.2255	A	1	347	1	419	68	1	\N	ENST00000275493:c.2255C>A	\N	34	2	\N
690	c.1761	C	-1	383	1	460	71	1	\N	ENST00000288602:c.1761C>G	\N	32	2	\N
691	c.1761	T	-1	383	1	460	71	1	\N	ENST00000288602:c.1761C>A	\N	32	2	\N
626	c.2303	T	1	350	1	423	68	1	\N	ENST00000275493:c.2303G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
628	c.2369	T	1	195	1	256	68	1	\N	ENST00000275493:c.2369C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"erlotinib, afatinib","Status":"NCCN/ CAP guidelines","Evidence":"consensus","PMID":"NCCN"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"response","Therapeutic_context":"irreversible EGFR T790M inhibitors","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
629	c.2428	A	1	352	1	425	68	1	\N	ENST00000275493:c.2428G>A	\N	34	2	\N
630	c.2429	A	1	353	1	426	68	1	\N	ENST00000275493:c.2429G>A	\N	34	2	\N
631	c.2527	A	1	354	1	427	68	1	\N	ENST00000275493:c.2527G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"no response","Therapeutic_context":"gefitinib","Status":"case report","Evidence":"emerging","PMID":"21274259"}]}
632	c.2572	A	1	355	1	428	68	1	\N	ENST00000275493:c.2572C>A	\N	34	2	\N
633	c.2572_2573	AG	1	356	4	257	68	1	\N	ENST00000275493:c.2572_2573CT>AG	\N	34	2	\N
634	c.2573	A	1	196	1	429	68	1	\N	ENST00000275493:c.2573T>A	\N	34	2	\N
635	c.2573	G	1	196	1	257	68	1	\N	ENST00000275493:c.2573T>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
636	c.2573_2574	GT	1	357	4	257	68	1	\N	ENST00000275493:c.2573_2574TG>GT	\N	34	2	\N
684	c.1781	G	-1	186	1	243	71	1	\N	ENST00000288602:c.1781A>C	\N	32	2	\N
637	c.2582	A	1	197	1	258	68	1	\N	ENST00000275493:c.2582T>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
638	c.2582	C	1	197	1	430	68	1	\N	ENST00000275493:c.2582T>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
639	c.2582	G	1	197	1	431	68	1	\N	ENST00000275493:c.2582T>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
640	c.2962	T	1	358	1	432	69	1	\N	ENST00000318493:c.2962C>T	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
652	c.1417	C	1	173	1	226	70	1	\N	ENST00000249373:c.1417G>C	\N	31	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vismodegib","Status":"case report","Evidence":"emerging","PMID":"19726788"}]}
655	c.1803	A	-1	370	1	444	71	1	\N	ENST00000288602:c.1803A>T	\N	32	2	\N
656	c.1803	G	-1	370	1	444	71	1	\N	ENST00000288602:c.1803A>C	\N	32	2	\N
657	c.1803_1801	-	-1	371	2	445	71	5	\N	ENST00000288602:c.1803_1801delAAA	\N	32	2	\N
658	c.1802	C	-1	372	1	446	71	1	\N	ENST00000288602:c.1802A>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
659	c.1801	C	-1	180	1	233	71	1	\N	ENST00000288602:c.1801A>G	\N	32	2	\N
660	c.1800_1799	AT	-1	181	4	234	71	1	\N	ENST00000288602:c.1800_1799TG>AT	\N	32	2	\N
661	c.1800_1799	TT	-1	181	4	236	71	1	\N	ENST00000288602:c.1800_1799TG>AA	\N	32	2	\N
662	c.1799	C	-1	182	1	235	71	1	\N	ENST00000288602:c.1799T>G	\N	32	2	\N
663	c.1799	G	-1	182	1	447	71	1	\N	ENST00000288602:c.1799T>C	\N	32	2	\N
692	c.1760	G	-1	384	1	461	71	1	\N	ENST00000288602:c.1760A>C	\N	32	2	\N
669	c.1798	T	-1	373	1	449	71	1	\N	ENST00000288602:c.1798G>A	\N	32	2	\N
670	c.619	A	-1	374	1	450	71	2	\N	ENST00000496384:c.619C>T	\N	33	2	\N
671	c.1790	C	-1	184	1	239	71	1	\N	ENST00000288602:c.1790T>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
672	c.1790	T	-1	184	1	451	71	1	\N	ENST00000288602:c.1790T>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
673	c.1790_1789	GA	-1	375	4	452	71	1	\N	ENST00000288602:c.1790_1789CT>TC	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
674	c.1789	C	-1	376	1	453	71	1	\N	ENST00000288602:c.1789C>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
675	c.1786	G	-1	377	1	454	71	1	\N	ENST00000288602:c.1786G>C	\N	32	2	\N
676	c.1785	C	-1	378	1	455	71	1	\N	ENST00000288602:c.1785T>G	\N	32	2	\N
677	c.608	T	-1	378	1	456	71	2	\N	ENST00000496384:c.608T>A	\N	33	2	\N
678	c.1784	G	-1	379	1	457	71	1	\N	ENST00000288602:c.1784T>C	\N	32	2	\N
679	c.1783	G	-1	380	1	455	71	1	\N	ENST00000288602:c.1783T>C	\N	32	2	\N
680	c.1782	C	-1	185	1	240	71	1	\N	ENST00000288602:c.1782T>G	\N	32	2	\N
681	c.1782	T	-1	185	1	240	71	1	\N	ENST00000288602:c.1782T>A	\N	32	2	\N
682	c.1781	A	-1	186	1	241	71	1	\N	ENST00000288602:c.1781A>T	\N	32	2	\N
685	c.1780	G	-1	187	1	245	71	1	\N	ENST00000288602:c.1780G>C	\N	32	2	\N
706	c.1397	T	-1	192	1	468	71	1	\N	ENST00000288602:c.1397G>A	\N	32	2	\N
707	c.1396	T	-1	389	1	469	71	1	\N	ENST00000288602:c.1396G>A	\N	32	2	\N
708	c.1391	A	-1	390	1	470	71	1	\N	ENST00000288602:c.1391G>T	\N	32	2	\N
709	c.1391	T	-1	390	1	471	71	1	\N	ENST00000288602:c.1391G>A	\N	32	2	\N
710	c.1390	T	-1	391	1	472	71	1	\N	ENST00000288602:c.1390G>A	\N	32	2	\N
711	c.1330	A	-1	392	1	473	71	1	\N	ENST00000288602:c.1330C>T	\N	32	2	\N
712	c.2045	C	-1	393	1	474	72	1	\N	ENST00000320356:c.2045C>G	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
713	c.1937	A	-1	394	1	475	72	1	\N	ENST00000320356:c.1937A>T	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"24563539"}]}
714	c.1937	G	-1	394	1	476	72	1	\N	ENST00000320356:c.1937A>C	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
715	c.1936	G	-1	395	1	477	72	1	\N	ENST00000320356:c.1936T>C	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
716	c.1936	T	-1	395	1	478	72	1	\N	ENST00000320356:c.1936T>A	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
717	c.847	T	-1	396	1	479	73	1	\N	ENST00000425967:c.847C>A	\N	57	2	\N
718	c.473	A	-1	397	1	480	73	1	\N	ENST00000425967:c.473C>T	\N	57	2	\N
719	c.169	T	1	398	1	481	74	1	\N	ENST00000377970:c.169C>T	\N	58	2	\N
720	c.176	T	1	399	1	482	74	1	\N	ENST00000377970:c.176C>T	\N	58	2	\N
721	c.218	T	1	400	1	483	74	1	\N	ENST00000377970:c.218C>T	\N	58	2	\N
722	c.230	T	1	401	1	484	74	1	\N	ENST00000377970:c.230C>T	\N	58	2	\N
723	c.302	C	1	402	1	485	74	1	\N	ENST00000377970:c.302A>C	\N	58	2	\N
724	c.778	G	1	403	1	486	74	1	\N	ENST00000377970:c.778C>G	\N	58	2	\N
725	c.1849	T	1	198	1	259	75	1	\N	ENST00000381652:c.1849G>T	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"}]}
726	c.2047	G	1	199	1	260	75	1	\N	ENST00000381652:c.2047A>G	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
727	c.2048	C	1	200	1	261	75	1	\N	ENST00000381652:c.2048G>C	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
728	c.2049	C	1	201	1	262	75	1	\N	ENST00000381652:c.2049A>C	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
729	c.2049	T	1	201	1	262	75	1	\N	ENST00000381652:c.2049A>T	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
730	c.341	A	-1	404	1	487	76	1	\N	ENST00000446177:c.341C>T	\N	59	2	\N
731	c.330	T	-1	405	1	488	76	2	\N	ENST00000446177:c.330G>A	\N	59	2	\N
732	c.329	T	-1	406	1	488	76	2	\N	ENST00000446177:c.329G>A	\N	59	2	\N
733	c.488	A	-1	407	1	489	76	1	\N	ENST00000361570:c.488G>T	\N	60	2	\N
734	c.262	A	-1	408	1	490	76	2	\N	ENST00000446177:c.262G>T	\N	59	2	\N
746	c.764	T	1	417	1	498	78	1	\N	ENST00000372348:c.764A>T	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
747	c.787	G	1	418	1	499	78	1	\N	ENST00000372348:c.787A>G	\N	61	2	\N
748	c.799	G	1	419	1	500	78	1	\N	ENST00000372348:c.799C>G	\N	61	2	\N
749	c.806	A	1	420	1	501	78	1	\N	ENST00000372348:c.806G>A	\N	61	2	\N
750	c.813	C	1	421	1	502	78	1	\N	ENST00000372348:c.813G>C	\N	61	2	\N
751	c.813	T	1	421	1	502	78	1	\N	ENST00000372348:c.813G>T	\N	61	2	\N
752	c.814	C	1	422	1	503	78	1	\N	ENST00000372348:c.814T>C	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
753	c.815	T	1	423	1	504	78	1	\N	ENST00000372348:c.815A>T	\N	61	2	\N
754	c.820	A	1	424	1	505	78	1	\N	ENST00000372348:c.820G>A	\N	61	2	\N
755	c.821	T	1	425	1	506	78	1	\N	ENST00000372348:c.821A>T	\N	61	2	\N
756	c.904	G	1	426	1	507	78	1	\N	ENST00000372348:c.904A>G	\N	61	2	\N
757	c.952	C	1	427	1	508	78	1	\N	ENST00000372348:c.952G>C	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
758	c.1000	G	1	428	1	509	78	1	\N	ENST00000372348:c.1000A>G	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
759	c.1001	T	1	429	1	510	78	1	\N	ENST00000372348:c.1001C>T	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"},{"Association":"response","Therapeutic_context":"AURK inhibitors + BCR-ABL1 inhibitors","Status":"case report","Evidence":"emerging","PMID":"22772060"}]}
760	c.1006	A	1	430	1	511	78	1	\N	ENST00000372348:c.1006T>A	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"NCCN"}]}
774	c.1894_1899	-	1	440	2	524	79	5	\N	ENST00000355710:c.1894_1899delGAGCTG	\N	4	2	\N
775	c.1900	C	1	441	1	525	79	1	\N	ENST00000355710:c.1900T>C	\N	4	2	\N
776	c.1901	A	1	442	1	526	79	1	\N	ENST00000355710:c.1901G>A	\N	4	2	\N
859	c.34	A	-1	30	1	14	85	1	\N	ENST00000256078:c.34G>T	\N	8	2	\N
777	c.1902	G	1	443	1	527	79	1	\N	ENST00000355710:c.1902C>G	\N	4	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}]}
778	c.2304	C	1	444	1	528	79	1	\N	ENST00000355710:c.2304G>C	\N	4	2	\N
779	c.2647_2648	TT	1	445	4	529	79	1	\N	ENST00000355710:c.2647_2648GC>TT	\N	4	2	\N
780	c.2692_2703	-	1	446	2	530	79	5	\N	ENST00000355710:c.2692_2703delGATGTTTATGAA	\N	4	2	\N
781	c.2753	C	1	10	1	19	79	1	\N	ENST00000355710:c.2753T>C	\N	4	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}]}
782	c.388	G	1	11	1	20	80	1	\N	ENST00000371953:c.388C>G	\N	5	2	\N
783	c.388	T	1	11	1	21	80	2	\N	ENST00000371953:c.388C>T	\N	5	2	\N
784	c.389	A	1	12	1	22	80	1	\N	ENST00000371953:c.389G>A	\N	5	2	\N
785	c.477	T	1	13	1	23	80	1	\N	ENST00000371953:c.477G>T	\N	5	2	\N
786	c.517	T	1	447	1	531	80	1	\N	ENST00000371953:c.517C>T	\N	5	2	\N
787	c.518	A	1	448	1	532	80	1	\N	ENST00000371953:c.518G>A	\N	5	2	\N
788	c.697	T	1	14	1	24	80	2	\N	ENST00000371953:c.697C>T	\N	5	2	\N
789	c.700	T	1	449	1	533	80	1	\N	ENST00000371953:c.700C>T	\N	5	2	\N
790	c.800	-	1	15	2	25	80	3	\N	ENST00000371953:c.800delA	\N	5	2	\N
791	c.1003	T	1	450	1	534	80	2	\N	ENST00000371953:c.1003C>T	\N	5	2	\N
792	c.1978	C	-1	451	1	535	81	1	\N	ENST00000457416:c.1978A>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
793	c.1917	T	-1	452	1	536	81	1	\N	ENST00000457416:c.1917T>A	\N	62	2	\N
794	c.1852	T	-1	453	1	537	81	1	\N	ENST00000457416:c.1852T>A	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
795	c.1697	C	-1	454	1	538	81	1	\N	ENST00000457416:c.1697A>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
796	c.1693	T	-1	455	1	539	81	1	\N	ENST00000457416:c.1693G>A	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
797	c.1650	C	-1	456	1	540	81	1	\N	ENST00000457416:c.1650T>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
798	c.1650	T	-1	456	1	540	81	1	\N	ENST00000457416:c.1650T>A	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
799	c.1648	G	-1	457	1	541	81	1	\N	ENST00000457416:c.1648A>C	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
800	c.1642	C	-1	458	1	542	81	1	\N	ENST00000457416:c.1642A>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
801	c.1614	A	-1	459	1	543	81	1	\N	ENST00000457416:c.1614G>T	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
802	c.1614	G	-1	459	1	543	81	1	\N	ENST00000457416:c.1614G>C	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
803	c.1614	T	-1	459	1	543	81	1	\N	ENST00000457416:c.1614G>A	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
860	c.34	G	-1	30	1	15	85	1	\N	ENST00000256078:c.34G>C	\N	8	2	\N
861	c.34	T	-1	30	1	16	85	1	\N	ENST00000256078:c.34G>A	\N	8	2	\N
804	c.1608	A	-1	460	1	544	81	1	\N	ENST00000457416:c.1608G>T	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
805	c.1608	G	-1	460	1	544	81	1	\N	ENST00000457416:c.1608G>C	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
809	c.1118	C	-1	463	1	347	81	1	\N	ENST00000457416:c.1118C>G	\N	62	2	\N
810	c.959	C	-1	464	1	547	81	1	\N	ENST00000457416:c.959C>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
811	c.929	C	-1	465	1	548	81	1	\N	ENST00000457416:c.929A>G	\N	62	2	\N
812	c.870	G	-1	466	1	549	81	1	\N	ENST00000457416:c.870G>C	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
813	c.758	C	-1	467	1	550	81	1	\N	ENST00000457416:c.758C>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"pazopanib","Status":"case report","Evidence":"emerging","PMID":"23786770"}]}
814	c.755	C	-1	468	1	551	81	1	\N	ENST00000457416:c.755C>G	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"sensitivity","list":[{"Association":"FGFR inhibitors","Therapeutic_context":"preclinical","Status":"emerging","Evidence":"18552176, 22238366, 23002168","PMID":"nan"}]}
815	c.183	A	-1	469	1	1	82	1	\N	ENST00000311189:c.183G>T	\N	7	2	\N
816	c.183	G	-1	469	1	1	82	1	\N	ENST00000311189:c.183G>C	\N	7	2	\N
817	c.183_182	AC	-1	470	4	27	82	1	\N	ENST00000311189:c.183_182AG>GT	\N	7	2	\N
818	c.183_182	TC	-1	470	4	27	82	1	\N	ENST00000311189:c.183_182AG>GA	\N	7	2	\N
819	c.182	A	-1	17	1	2	82	1	\N	ENST00000311189:c.182A>T	\N	7	2	\N
820	c.182	C	-1	17	1	27	82	1	\N	ENST00000311189:c.182A>G	\N	7	2	\N
821	c.182	G	-1	17	1	32	82	1	\N	ENST00000311189:c.182A>C	\N	7	2	\N
822	c.181	T	-1	471	1	5	82	1	\N	ENST00000311189:c.181C>A	\N	7	2	\N
823	c.38	A	-1	472	1	6	82	1	\N	ENST00000311189:c.38G>T	\N	7	2	\N
824	c.37	A	-1	18	1	9	82	1	\N	ENST00000311189:c.37G>T	\N	7	2	\N
825	c.37	G	-1	18	1	10	82	1	\N	ENST00000311189:c.37G>C	\N	7	2	\N
826	c.37	T	-1	18	1	33	82	1	\N	ENST00000311189:c.37G>A	\N	7	2	\N
827	c.35	A	-1	19	1	11	82	1	\N	ENST00000311189:c.35G>T	\N	7	2	\N
828	c.35	T	-1	19	1	13	82	1	\N	ENST00000311189:c.35G>A	\N	7	2	\N
829	c.34	A	-1	20	1	14	82	1	\N	ENST00000311189:c.34G>T	\N	7	2	\N
830	c.34	G	-1	20	1	15	82	1	\N	ENST00000311189:c.34G>C	\N	7	2	\N
831	c.1143_1142	ACCGTACA	-1	16	3	26	83	4	\N	ENST00000332351:c.1143_1142insTGTACGGT	\N	6	2	\N
832	c.1111	C	1	473	1	552	84	1	\N	ENST00000264033:c.1111T>C	\N	63	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
833	c.1150	C	1	474	1	553	84	1	\N	ENST00000264033:c.1150T>C	\N	63	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
834	c.437	A	-1	21	1	28	85	1	\N	ENST00000256078:c.437C>T	\N	8	2	\N
835	c.436	G	-1	22	1	29	85	1	\N	ENST00000256078:c.436G>C	\N	8	2	\N
836	c.436	T	-1	22	1	30	85	1	\N	ENST00000256078:c.436G>A	\N	8	2	\N
837	c.351	A	-1	23	1	31	85	1	\N	ENST00000256078:c.351A>T	\N	8	2	\N
838	c.351	G	-1	23	1	31	85	1	\N	ENST00000256078:c.351A>C	\N	8	2	\N
839	c.183	A	-1	24	1	1	85	1	\N	ENST00000256078:c.183A>T	\N	8	2	\N
840	c.183	G	-1	24	1	1	85	1	\N	ENST00000256078:c.183A>C	\N	8	2	\N
841	c.182	A	-1	25	1	2	85	1	\N	ENST00000256078:c.182A>T	\N	8	2	\N
842	c.182	C	-1	25	1	27	85	1	\N	ENST00000256078:c.182A>G	\N	8	2	\N
843	c.182	G	-1	25	1	32	85	1	\N	ENST00000256078:c.182A>C	\N	8	2	\N
844	c.181	C	-1	26	1	4	85	1	\N	ENST00000256078:c.181C>G	\N	8	2	\N
845	c.181	T	-1	26	1	5	85	1	\N	ENST00000256078:c.181C>A	\N	8	2	\N
846	c.175	T	-1	475	1	554	85	1	\N	ENST00000256078:c.175G>A	\N	8	2	\N
847	c.64	T	-1	476	1	555	85	1	\N	ENST00000256078:c.64C>A	\N	8	2	\N
848	c.57	A	-1	477	1	556	85	1	\N	ENST00000256078:c.57G>T	\N	8	2	\N
849	c.57	G	-1	477	1	556	85	1	\N	ENST00000256078:c.57G>C	\N	8	2	\N
850	c.38	A	-1	27	1	6	85	1	\N	ENST00000256078:c.38G>T	\N	8	2	\N
851	c.38	G	-1	27	1	7	85	1	\N	ENST00000256078:c.38G>C	\N	8	2	\N
852	c.38	T	-1	27	1	8	85	1	\N	ENST00000256078:c.38G>A	\N	8	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"panitumumab","Status":"FDA-rejected","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"cetuximab","Status":"late trials","Evidence":"emerging","PMID":"22734028, 20978259"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors + PI3K pathway inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22392911"}]}
853	c.37	A	-1	28	1	9	85	1	\N	ENST00000256078:c.37G>T	\N	8	2	\N
854	c.37	G	-1	28	1	10	85	1	\N	ENST00000256078:c.37G>C	\N	8	2	\N
855	c.37	T	-1	28	1	33	85	1	\N	ENST00000256078:c.37G>A	\N	8	2	\N
856	c.35	A	-1	29	1	11	85	1	\N	ENST00000256078:c.35G>T	\N	8	2	\N
862	c.785	A	1	478	1	557	86	1	\N	ENST00000267101:c.785C>A	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
863	c.850	A	1	479	1	558	86	1	\N	ENST00000267101:c.850G>A	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
864	c.2426	G	1	480	1	559	86	1	\N	ENST00000267101:c.2426A>G	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
865	c.71	T	-1	481	1	560	87	1	\N	ENST00000257904:c.71G>A	\N	65	2	\N
866	c.2525	C	-1	482	1	561	88	1	\N	ENST00000380982:c.2525A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
867	c.2524	G	-1	483	1	562	88	1	\N	ENST00000380982:c.2524T>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
868	c.2516	C	-1	31	1	34	88	1	\N	ENST00000380982:c.2516A>G	\N	9	2	\N
869	c.2508	C	-1	32	1	35	88	1	\N	ENST00000380982:c.2508C>G	\N	9	2	\N
870	c.2508_2506	-	-1	484	2	563	88	5	\N	ENST00000380982:c.2508_2506delATC	\N	9	2	\N
871	c.2506	G	-1	33	1	36	88	1	\N	ENST00000380982:c.2506A>C	\N	9	2	\N
872	c.2505	C	-1	34	1	37	88	1	\N	ENST00000380982:c.2505T>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
873	c.2505	T	-1	34	1	37	88	1	\N	ENST00000380982:c.2505T>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
874	c.2505_2503	-	-1	485	2	564	88	5	\N	ENST00000380982:c.2505_2503delGAT	\N	9	2	\N
875	c.2504	A	-1	35	1	38	88	1	\N	ENST00000380982:c.2504A>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
876	c.2504	G	-1	35	1	39	88	1	\N	ENST00000380982:c.2504A>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
877	c.2504_2503	AA	-1	486	4	565	88	1	\N	ENST00000380982:c.2504_2503GA>TT	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
880	c.2503	T	-1	36	1	42	88	1	\N	ENST00000380982:c.2503G>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
881	c.2073	C	-1	487	1	566	88	1	\N	ENST00000380982:c.2073T>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
882	c.2073	T	-1	487	1	566	88	1	\N	ENST00000380982:c.2073T>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
883	c.2059	A	-1	488	1	567	88	1	\N	ENST00000380982:c.2059A>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
884	c.2028	C	-1	489	1	568	88	1	\N	ENST00000380982:c.2028C>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
885	c.2028	T	-1	489	1	568	88	1	\N	ENST00000380982:c.2028C>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
886	c.2026	C	-1	490	1	569	88	1	\N	ENST00000380982:c.2026A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
887	c.1952	C	-1	491	1	570	88	1	\N	ENST00000380982:c.1952A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
919	c.362	C	1	46	1	52	92	1	\N	ENST00000307102:c.362G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"21383288"},{"Association":"sensitivity","Therapeutic_context":"novel MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24448821"}]}
897	c.1735	T	1	501	1	580	89	2	\N	ENST00000267163:c.1735C>T	\N	66	2	\N
898	c.2117	T	1	502	1	581	89	1	\N	ENST00000267163:c.2117G>T	\N	66	2	\N
899	c.2242	T	1	503	1	582	89	2	\N	ENST00000267163:c.2242G>T	\N	66	2	\N
900	c.235	T	-1	504	1	583	90	1	\N	ENST00000349310:c.235C>A	\N	10	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265152"}]}
901	c.49	T	-1	37	1	43	90	1	\N	ENST00000349310:c.49G>A	\N	10	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"non-allosteric AKT inhibitors","Status":"case report","Evidence":"emerging","PMID":"AACR 2013; abstr LB-66"}]}
902	c.2277	-	-1	38	2	44	91	5	\N	ENST00000261609:c.2277delAACGGTCCTGACCTG	\N	11	2	\N
903	c.2264	G	-1	39	1	45	91	1	\N	ENST00000261609:c.2264T>C	\N	11	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
904	c.926	C	-1	40	1	46	91	1	\N	ENST00000261609:c.926C>G	\N	11	2	\N
905	c.157	C	1	41	1	47	92	1	\N	ENST00000307102:c.157T>C	\N	12	2	\N
906	c.167	C	1	42	1	48	92	1	\N	ENST00000307102:c.167A>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
907	c.169	G	1	505	1	584	92	1	\N	ENST00000307102:c.169A>G	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"}]}
908	c.171	C	1	43	1	49	92	1	\N	ENST00000307102:c.171G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
909	c.171	T	1	43	1	49	92	1	\N	ENST00000307102:c.171G>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
910	c.199	A	1	44	1	50	92	1	\N	ENST00000307102:c.199G>A	\N	12	2	\N
911	c.296	C	1	506	1	585	92	1	\N	ENST00000307102:c.296T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
912	c.308	A	1	507	1	586	92	1	\N	ENST00000307102:c.308T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
913	c.332	A	1	45	1	587	92	1	\N	ENST00000307102:c.332T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
914	c.332	G	1	45	1	51	92	1	\N	ENST00000307102:c.332T>G	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}]}
915	c.356	C	1	508	1	588	92	1	\N	ENST00000307102:c.356A>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
916	c.360	C	1	509	1	589	92	1	\N	ENST00000307102:c.360G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
917	c.360	T	1	509	1	589	92	1	\N	ENST00000307102:c.360G>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
918	c.361	A	1	510	1	52	92	1	\N	ENST00000307102:c.361T>A	\N	12	2	\N
920	c.370	T	1	47	1	53	92	1	\N	ENST00000307102:c.370C>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}]}
921	c.371	T	1	48	1	54	92	1	\N	ENST00000307102:c.371C>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"19915144"}]}
922	c.383	A	1	511	1	590	92	1	\N	ENST00000307102:c.383G>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
923	c.385	C	1	512	1	591	92	1	\N	ENST00000307102:c.385T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
924	c.607	A	1	49	1	55	92	1	\N	ENST00000307102:c.607G>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
925	c.632	A	1	513	1	592	92	1	\N	ENST00000307102:c.632T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
926	c.644	C	1	514	1	593	92	1	\N	ENST00000307102:c.644T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
927	c.790	T	1	50	1	56	92	1	\N	ENST00000307102:c.790C>T	\N	12	2	\N
928	c.1144	C	1	51	1	57	92	1	\N	ENST00000307102:c.1144A>C	\N	12	2	\N
929	c.516	G	-1	52	1	58	93	1	\N	ENST00000330062:c.516G>C	\N	13	2	\N
930	c.515	A	-1	53	1	59	93	1	\N	ENST00000330062:c.515G>T	\N	13	2	\N
931	c.515	T	-1	53	1	60	93	1	\N	ENST00000330062:c.515G>A	\N	13	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}]}
932	c.419	A	-1	54	1	61	93	1	\N	ENST00000330062:c.419G>T	\N	13	2	\N
933	c.419	T	-1	54	1	62	93	1	\N	ENST00000330062:c.419G>A	\N	13	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}]}
934	c.418	A	-1	55	1	63	93	1	\N	ENST00000330062:c.418C>T	\N	13	2	\N
935	c.1993	T	1	515	1	594	94	1	\N	ENST00000359376:c.1993C>T	\N	67	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
936	c.2535	C	1	516	1	595	94	1	\N	ENST00000359376:c.2535A>C	\N	67	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
937	c.2535	T	1	516	1	595	94	1	\N	ENST00000359376:c.2535A>T	\N	67	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
938	c.916	A	-1	517	1	596	95	2	\N	ENST00000269305:c.916C>T	\N	15	2	\N
939	c.818	T	-1	64	1	72	95	1	\N	ENST00000269305:c.818G>A	\N	15	2	\N
940	c.817	A	-1	65	1	73	95	1	\N	ENST00000269305:c.817C>T	\N	15	2	\N
941	c.746	G	-1	66	1	74	95	1	\N	ENST00000269305:c.746G>C	\N	15	2	\N
942	c.745	A	-1	67	1	75	95	1	\N	ENST00000269305:c.745A>T	\N	15	2	\N
943	c.743	T	-1	68	1	76	95	1	\N	ENST00000269305:c.743G>A	\N	15	2	\N
944	c.742	A	-1	518	1	597	95	1	\N	ENST00000269305:c.742C>T	\N	15	2	\N
945	c.733	T	-1	519	1	598	95	1	\N	ENST00000269305:c.733G>A	\N	15	2	\N
946	c.659	C	-1	69	1	77	95	1	\N	ENST00000269305:c.659A>G	\N	15	2	\N
947	c.524	T	-1	520	1	599	95	1	\N	ENST00000269305:c.524G>A	\N	15	2	\N
948	c.518	C	-1	70	1	78	95	1	\N	ENST00000269305:c.518T>G	\N	15	2	\N
949	c.518	G	-1	70	1	79	95	1	\N	ENST00000269305:c.518T>C	\N	15	2	\N
950	c.926	A	1	56	1	600	96	1	\N	ENST00000269571:c.926G>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
951	c.926	C	1	56	1	64	96	1	\N	ENST00000269571:c.926G>C	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
952	c.929	A	1	521	1	601	96	1	\N	ENST00000269571:c.929C>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
957	c.2305	T	1	59	1	67	96	1	\N	ENST00000269571:c.2305G>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
959	c.2326_2327	TGT	1	523	3	604	96	6	\N	ENST00000269571:c.2326_2327insTGT	\N	14	2	\N
960	c.2329	C	1	60	1	68	96	1	\N	ENST00000269571:c.2329G>C	\N	14	2	\N
961	c.2329	T	1	60	1	68	96	1	\N	ENST00000269571:c.2329G>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
962	c.2332_2333	GGCTCCCCA	1	61	3	69	96	6	\N	ENST00000269571:c.2332_2333insGGCTCCCCA	\N	14	2	\N
963	c.2354	C	1	524	1	605	96	1	\N	ENST00000269571:c.2354T>C	\N	14	2	\N
964	c.2524	A	1	62	1	70	96	1	\N	ENST00000269571:c.2524G>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
965	c.2686	T	1	63	1	71	96	1	\N	ENST00000269571:c.2686C>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
966	c.989	C	1	71	1	80	97	1	\N	ENST00000342988:c.989A>C	\N	16	2	\N
967	c.1051	A	1	72	1	81	97	1	\N	ENST00000342988:c.1051G>A	\N	16	2	\N
968	c.1051	C	1	72	1	82	97	1	\N	ENST00000342988:c.1051G>C	\N	16	2	\N
969	c.1065	A	1	73	1	83	97	1	\N	ENST00000342988:c.1065C>A	\N	16	2	\N
970	c.1081	A	1	74	1	84	97	1	\N	ENST00000342988:c.1081C>A	\N	16	2	\N
971	c.1081	T	1	74	1	85	97	1	\N	ENST00000342988:c.1081C>T	\N	16	2	\N
972	c.1082	A	1	75	1	86	97	1	\N	ENST00000342988:c.1082G>A	\N	16	2	\N
973	c.1609	T	1	76	1	87	97	1	\N	ENST00000342988:c.1609G>T	\N	16	2	\N
974	c.109	T	1	525	1	606	98	2	\N	ENST00000326873:c.109C>T	\N	68	2	\N
975	c.508	T	1	526	1	607	98	2	\N	ENST00000326873:c.508C>T	\N	68	2	\N
976	c.580	A	1	527	1	608	98	1	\N	ENST00000326873:c.580G>A	\N	68	2	\N
977	c.581	T	1	528	1	609	98	1	\N	ENST00000326873:c.581A>T	\N	68	2	\N
978	c.582	A	1	529	1	610	98	1	\N	ENST00000326873:c.582C>A	\N	68	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
979	c.582	G	1	529	1	610	98	1	\N	ENST00000326873:c.582C>G	\N	68	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
980	c.587	T	1	530	1	611	98	1	\N	ENST00000326873:c.587G>T	\N	68	2	\N
981	c.595	A	1	531	1	612	98	1	\N	ENST00000326873:c.595G>A	\N	68	2	\N
982	c.595	T	1	531	1	613	98	2	\N	ENST00000326873:c.595G>T	\N	68	2	\N
983	c.842	T	1	532	1	614	98	1	\N	ENST00000326873:c.842C>T	\N	68	2	\N
984	c.996	A	1	533	1	615	98	2	\N	ENST00000326873:c.996G>A	\N	68	2	\N
985	c.626	C	1	77	1	88	99	1	\N	ENST00000078429:c.626A>C	\N	17	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
986	c.626	T	1	77	1	89	99	1	\N	ENST00000078429:c.626A>T	\N	17	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
987	c.376	C	-1	534	1	616	100	1	\N	ENST00000262948:c.376A>G	\N	69	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
988	c.373	T	-1	535	1	617	100	1	\N	ENST00000262948:c.373T>A	\N	69	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
989	c.179	G	-1	536	1	618	100	1	\N	ENST00000262948:c.179A>C	\N	69	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF + MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"24265154"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265154"}]}
991	c.103	T	-1	538	1	620	100	1	\N	ENST00000262948:c.103G>A	\N	69	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
994	c.1715	A	-1	541	1	623	101	1	\N	ENST00000458235:c.1715C>T	\N	70	2	\N
995	c.1503	A	-1	542	1	624	101	1	\N	ENST00000458235:c.1503G>T	\N	70	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
996	c.1503	G	-1	542	1	624	101	1	\N	ENST00000458235:c.1503G>C	\N	70	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
997	c.394	T	-1	543	1	625	101	1	\N	ENST00000458235:c.394C>A	\N	70	2	\N
998	c.260	G	-1	544	1	626	101	1	\N	ENST00000458235:c.260T>C	\N	70	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
999	c.1681	G	1	545	1	627	102	1	\N	ENST00000222254:c.1681A>G	\N	71	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21984976"}]}
1000	c.1102	T	-1	546	1	628	103	1	\N	ENST00000392038:c.1102G>A	\N	72	2	\N
1001	c.904	C	-1	547	1	629	103	1	\N	ENST00000392038:c.904A>G	\N	72	2	\N
1002	c.1609	T	1	548	1	630	104	2	\N	ENST00000360723:c.1609C>T	\N	73	2	\N
1003	c.604	T	1	549	1	631	105	1	\N	ENST00000354359:c.604C>T	\N	74	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
1004	c.605	A	1	550	1	632	105	1	\N	ENST00000354359:c.605G>A	\N	74	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
1005	c.605	T	1	550	1	633	105	1	\N	ENST00000354359:c.605G>T	\N	74	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
1006	c.683	T	1	551	1	634	105	1	\N	ENST00000354359:c.683A>T	\N	74	2	\N
1007	c.601	A	-1	100	1	126	106	2	\N	ENST00000300305:c.601C>T	\N	22	2	\N
1008	c.486	A	-1	101	1	127	106	1	\N	ENST00000300305:c.486G>T	\N	22	2	\N
1009	c.486	G	-1	101	1	127	106	1	\N	ENST00000300305:c.486G>C	\N	22	2	\N
1010	c.485	T	-1	102	1	128	106	1	\N	ENST00000300305:c.485G>A	\N	22	2	\N
1011	c.484	C	-1	103	1	129	106	1	\N	ENST00000300305:c.484A>G	\N	22	2	\N
1012	c.470	C	-1	104	1	130	107	1	\N	ENST00000291552:c.470A>G	\N	23	2	\N
1013	c.470	G	-1	104	1	131	107	1	\N	ENST00000291552:c.470A>C	\N	23	2	\N
1014	c.101	A	-1	105	1	132	107	1	\N	ENST00000291552:c.101C>T	\N	23	2	\N
1015	c.101	T	-1	105	1	133	107	1	\N	ENST00000291552:c.101C>A	\N	23	2	\N
1016	c.695	C	-1	203	1	264	108	1	\N	ENST00000381567:c.695T>G	\N	37	2	\N
1017	c.641	G	1	552	1	635	109	1	\N	ENST00000377045:c.641C>G	\N	75	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"24569458"}]}
1018	c.1442	G	-1	553	1	636	110	1	\N	ENST00000308731:c.1442G>C	\N	76	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
1019	c.1441	T	-1	554	1	636	110	1	\N	ENST00000308731:c.1441T>A	\N	76	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
\.


--
-- Data for Name: disease_source_variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY disease_source_variants (id, disease_id, source_id, variant_id, my_cancer_genome_url) FROM stdin;
1	1	1	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81
2	1	2	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81
3	1	3	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81
4	2	4	1	\N
5	2	3	1	\N
6	1	5	2	http://www.mycancergenome.org/content/disease/melanoma/nras/76
7	3	6	3	\N
8	3	7	3	\N
9	3	8	3	\N
10	3	9	3	\N
11	1	10	4	http://www.mycancergenome.org/content/disease/melanoma/nras/97
12	1	11	4	http://www.mycancergenome.org/content/disease/melanoma/nras/97
13	4	11	5	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75
14	1	12	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75
15	1	12	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75
16	1	13	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75
17	1	14	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75
18	1	15	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75
19	3	13	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
20	3	16	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
21	3	17	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
22	3	11	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
23	2	13	5	\N
24	2	16	5	\N
25	2	17	5	\N
26	2	11	5	\N
27	5	13	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
28	5	16	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
29	5	17	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
30	5	11	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
31	1	13	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94
32	1	16	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94
33	1	17	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94
34	1	11	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94
35	2	18	6	\N
36	2	19	6	\N
37	2	20	6	\N
38	2	3	6	\N
39	1	21	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91
40	1	22	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91
41	1	23	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91
42	1	3	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91
43	1	18	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92
44	1	24	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92
45	1	25	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92
46	1	22	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92
47	1	3	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92
48	2	22	8	\N
49	2	23	8	\N
50	2	26	8	\N
51	2	3	8	\N
52	1	22	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
53	1	23	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
54	1	26	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
55	1	27	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
56	1	28	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
57	1	29	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
58	1	30	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
59	1	3	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297
60	1	23	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
61	1	26	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
62	1	31	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
63	1	29	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
64	1	30	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
65	1	27	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
66	1	3	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93
67	1	22	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90
68	1	18	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90
69	1	32	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90
70	1	33	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90
71	1	3	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90
72	2	22	11	\N
73	2	23	11	\N
74	2	26	11	\N
75	2	27	11	\N
76	2	3	11	\N
77	5	22	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
78	5	23	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
79	5	27	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
80	5	34	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
81	5	35	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
82	5	30	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
83	5	3	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
84	1	22	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
85	1	23	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
86	1	26	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
87	1	27	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
88	1	28	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
89	1	25	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
90	1	29	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
91	1	30	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
92	1	33	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
93	1	35	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
94	1	18	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
95	1	3	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85
96	3	20	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
97	3	36	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
98	3	37	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
99	5	38	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
100	5	39	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
101	5	40	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
102	5	41	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
103	5	42	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
104	5	43	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
105	5	44	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
106	5	45	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
107	5	46	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
108	5	47	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
109	5	48	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
110	5	49	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
111	5	50	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
112	5	51	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
113	5	52	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
114	5	53	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
115	5	54	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
116	5	55	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
117	1	38	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87
118	1	39	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87
119	1	40	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87
120	1	41	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87
121	1	56	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87
122	3	38	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
123	3	39	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
124	3	40	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
125	3	41	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
126	3	57	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
127	3	58	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
128	3	59	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
129	3	56	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
130	2	38	13	\N
131	2	39	13	\N
132	2	40	13	\N
133	2	41	13	\N
134	2	56	13	\N
135	2	49	13	\N
136	5	38	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
137	5	39	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
138	5	40	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
139	5	60	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
140	5	41	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
141	5	56	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
142	1	38	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
143	1	39	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
144	1	40	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
145	1	60	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
146	1	41	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
147	1	56	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86
148	3	38	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
149	3	39	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
150	3	40	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
151	3	60	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
152	3	41	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
153	3	56	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
154	2	38	14	\N
155	2	39	14	\N
156	2	40	14	\N
157	2	60	14	\N
158	2	41	14	\N
159	2	56	14	\N
160	5	61	14	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
161	1	62	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
162	1	63	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
163	1	64	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
164	1	65	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
165	1	66	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
166	1	67	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
167	1	68	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
322	2	68	26	\N
168	1	69	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88
169	3	62	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
170	3	63	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
171	3	64	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
172	3	65	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
173	3	66	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
174	3	67	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
175	3	68	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
176	3	69	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
177	1	62	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
178	1	63	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
179	1	64	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
180	1	65	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
181	1	66	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
182	1	67	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
183	1	68	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
184	1	69	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89
185	3	62	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
186	3	63	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
187	3	64	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
188	3	65	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
189	3	66	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
190	3	67	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
191	3	68	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
192	3	69	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
193	2	62	16	\N
194	2	63	16	\N
195	2	64	16	\N
196	2	65	16	\N
197	2	66	16	\N
198	2	67	16	\N
199	2	68	16	\N
200	2	69	16	\N
201	5	62	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
202	5	63	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
203	5	64	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
204	5	65	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
205	5	66	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
206	5	67	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
207	5	68	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
208	5	69	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
209	6	62	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
210	6	63	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
211	6	64	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
212	6	65	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
213	6	66	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
214	6	67	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
215	6	68	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
216	6	69	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
217	2	62	18	\N
218	2	63	18	\N
219	2	64	18	\N
220	2	65	18	\N
221	2	66	18	\N
222	2	67	18	\N
223	2	68	18	\N
224	2	69	18	\N
225	4	62	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
226	4	63	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
227	4	64	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
228	4	65	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
229	4	66	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
230	4	67	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
231	4	68	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
232	4	69	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
233	7	62	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
234	7	63	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
235	7	64	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
236	7	65	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
237	7	66	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
238	7	67	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
239	7	68	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
240	7	69	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
241	7	62	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
242	7	63	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
243	7	64	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
244	7	65	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
245	7	66	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
246	7	67	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
247	7	68	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
323	2	69	26	\N
911	2	162	96	\N
248	7	69	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
249	7	62	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
250	7	63	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
251	7	64	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
252	7	65	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
253	7	66	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
254	7	67	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
255	7	68	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
256	7	69	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
257	8	62	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
258	8	63	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
259	8	64	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
260	8	65	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
261	8	66	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
262	8	67	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
263	8	68	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
264	8	69	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
265	8	70	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
266	8	71	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
267	8	72	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
268	5	62	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
269	5	63	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
270	5	64	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
271	5	65	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
272	5	66	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
273	5	67	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
274	5	68	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
275	5	69	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
276	8	62	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
277	8	63	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
278	8	64	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
279	8	65	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
280	8	66	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
281	8	67	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
282	8	68	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
283	8	69	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
284	3	62	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
285	3	63	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
286	3	64	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
287	3	65	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
288	3	66	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
289	3	67	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
290	3	68	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
291	3	69	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
292	5	62	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
293	5	63	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
294	5	64	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
295	5	65	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
296	5	66	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
297	5	67	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
298	5	68	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
299	5	69	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
300	8	62	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
301	8	63	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
302	8	64	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
303	8	65	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
304	8	66	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
305	8	67	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
306	8	68	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
307	8	69	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
308	5	62	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
309	5	63	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
310	5	64	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
311	5	65	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
312	5	66	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
313	5	67	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
314	5	68	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
315	5	69	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
316	2	62	26	\N
317	2	63	26	\N
318	2	64	26	\N
319	2	65	26	\N
320	2	66	26	\N
321	2	67	26	\N
324	4	62	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
325	4	63	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
326	4	64	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
327	4	65	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
328	4	66	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
329	4	67	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
330	4	68	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
331	4	69	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
332	4	62	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
333	4	63	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
334	4	64	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
335	4	65	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
336	4	66	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
337	4	67	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
338	4	68	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
339	4	69	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
340	4	49	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
341	4	73	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
342	4	74	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
343	4	75	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
344	4	76	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
345	4	77	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
346	4	78	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
347	4	49	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
348	4	73	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
349	4	74	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
350	4	75	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
351	4	76	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
352	4	77	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
353	4	78	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
354	4	49	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
355	4	73	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
356	4	74	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
357	4	75	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
358	4	76	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
359	4	77	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
360	4	78	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
361	4	49	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
362	4	73	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
363	4	74	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
364	4	75	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
365	4	76	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
366	4	77	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
367	4	78	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
368	5	49	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
369	5	73	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
370	5	74	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
371	5	75	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
372	5	76	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
373	5	77	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
374	5	78	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
375	5	49	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
376	5	73	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
377	5	74	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
378	5	75	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
379	5	76	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
380	5	77	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
381	5	78	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
382	5	49	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
383	5	73	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
384	5	74	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
385	5	75	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
386	5	76	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
387	5	77	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
388	5	78	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
389	5	79	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
390	5	80	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
391	5	81	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
392	5	82	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
393	5	83	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
394	5	84	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
395	5	85	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
396	5	86	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
397	5	49	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
398	5	87	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
399	5	79	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
400	5	80	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
401	5	81	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
402	5	82	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
403	5	83	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
404	5	84	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
405	5	85	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
406	5	86	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
407	5	49	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
408	5	87	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
409	3	79	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
410	3	80	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
411	3	81	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
412	3	82	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
413	3	83	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
414	3	84	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
415	3	85	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
416	3	86	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
417	3	49	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
418	3	87	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
419	2	79	37	\N
420	2	80	37	\N
421	2	81	37	\N
422	2	82	37	\N
423	2	83	37	\N
424	2	84	37	\N
425	2	85	37	\N
426	2	86	37	\N
427	2	49	37	\N
428	2	87	37	\N
429	5	79	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
430	5	80	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
431	5	81	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
432	5	82	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
433	5	83	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
434	5	84	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
435	5	85	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
436	5	86	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
437	5	49	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
438	5	87	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
439	3	79	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
440	3	80	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
441	3	81	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
442	3	82	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
443	3	83	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
444	3	84	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
445	3	85	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
446	3	86	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
447	3	49	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
448	3	87	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
449	2	79	38	\N
450	2	80	38	\N
451	2	81	38	\N
452	2	82	38	\N
453	2	83	38	\N
454	2	84	38	\N
455	2	85	38	\N
456	2	86	38	\N
457	2	49	38	\N
458	2	87	38	\N
459	5	79	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
460	5	80	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
461	5	81	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
462	5	82	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
463	5	83	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
464	5	84	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
465	5	85	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
466	5	86	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
467	5	49	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
468	5	87	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
469	4	79	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
470	4	80	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
471	4	81	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
472	4	82	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
473	4	83	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
474	4	84	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
904	2	160	95	\N
905	2	161	95	\N
475	4	85	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
476	4	86	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
477	4	49	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
478	4	87	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
479	3	79	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
480	3	80	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
481	3	81	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
482	3	82	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
483	3	83	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
484	3	84	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
485	3	85	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
486	3	86	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
487	3	49	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
488	3	87	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
489	5	79	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
490	5	80	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
491	5	81	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
492	5	82	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
493	5	83	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
494	5	84	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
495	5	85	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
496	5	86	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
497	5	49	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
498	5	87	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
499	4	79	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
500	4	80	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
501	4	81	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
502	4	82	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
503	4	83	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
504	4	84	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
505	4	85	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
506	4	86	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
507	4	49	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
508	4	87	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
509	3	79	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
510	3	80	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
511	3	81	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
512	3	82	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
513	3	83	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
514	3	84	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
515	3	85	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
516	3	86	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
517	3	49	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
518	3	87	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
519	5	79	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
520	5	80	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
521	5	81	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
522	5	82	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
523	5	83	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
524	5	84	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
525	5	85	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
526	5	86	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
527	5	49	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
528	5	87	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
529	4	79	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
530	4	80	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
531	4	81	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
532	4	82	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
533	4	83	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
534	4	84	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
535	4	85	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
536	4	86	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
537	4	49	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
538	4	87	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
539	4	79	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
540	4	80	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
541	4	81	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
542	4	82	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
543	4	83	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
544	4	84	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
545	4	85	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
546	4	86	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
547	4	49	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
548	4	87	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
549	3	88	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
550	3	89	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
551	3	90	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
552	3	91	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
553	3	92	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
554	3	93	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
555	3	94	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
556	5	88	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
557	5	89	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
558	5	90	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
559	5	91	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
560	5	92	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
561	5	93	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
562	5	94	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
563	5	88	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
564	5	89	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
565	5	90	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
566	5	91	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
567	5	92	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
568	5	93	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
569	5	94	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
570	3	88	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
571	3	89	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
572	3	90	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
573	3	91	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
574	3	92	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
575	3	93	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
576	3	94	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
577	5	88	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
578	5	89	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
579	5	90	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
580	5	91	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
581	5	92	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
582	5	93	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
583	5	94	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
584	4	88	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
585	4	89	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
586	4	90	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
587	4	91	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
588	4	92	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
589	4	93	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
590	4	94	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
591	7	88	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
592	7	89	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
593	7	90	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
594	7	91	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
595	7	92	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
596	7	93	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
597	7	94	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
598	3	88	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
599	3	89	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
600	3	90	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
601	3	91	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
602	3	92	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
603	3	93	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
604	3	94	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
605	2	95	45	\N
606	2	41	45	\N
607	2	96	45	\N
608	2	97	45	\N
609	2	98	45	\N
610	2	51	45	\N
611	5	99	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
612	5	100	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
613	5	101	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
614	3	99	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38
615	3	100	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38
616	3	101	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38
617	5	99	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
906	2	162	95	\N
618	5	100	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
619	5	101	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
620	4	99	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
621	4	100	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
622	4	101	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
623	3	102	47	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40
624	5	103	47	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
625	4	99	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
626	4	100	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
627	4	101	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
628	3	104	48	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69
629	5	104	48	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
630	4	104	49	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37
631	7	99	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37
632	7	100	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37
633	7	101	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37
634	2	99	49	\N
635	2	100	49	\N
636	2	101	49	\N
637	5	99	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
638	5	100	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
639	5	101	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
640	7	99	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32
641	7	100	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32
642	7	101	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32
643	3	99	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32
644	3	100	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32
645	3	101	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32
646	5	105	50	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
647	5	106	50	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
648	4	105	51	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
649	4	106	51	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
650	7	105	51	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34
651	7	106	51	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34
652	3	105	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
653	3	106	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
654	3	107	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
655	3	108	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
656	3	109	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
657	3	110	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
658	2	111	51	\N
659	5	112	51	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
660	5	113	51	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
661	4	114	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
662	4	112	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
663	4	115	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
664	7	114	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
665	7	112	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
666	7	116	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
667	7	117	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
668	7	118	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
669	7	119	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
670	7	120	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
671	3	114	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
672	3	112	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
673	3	116	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
674	3	118	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
675	3	119	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
676	3	120	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
677	5	112	52	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
678	5	116	52	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
679	4	114	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
680	4	112	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
681	4	113	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
682	4	119	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
683	4	120	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
684	7	121	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35
685	7	122	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35
686	7	123	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35
687	3	121	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35
688	3	122	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35
689	3	123	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35
907	2	163	95	\N
908	2	164	95	\N
690	5	124	53	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
691	4	125	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
692	4	126	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
693	4	127	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
694	4	16	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
695	4	128	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
696	4	129	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
697	3	125	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
698	3	126	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
699	3	127	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
700	3	16	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
701	3	128	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
702	3	129	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
703	5	125	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
704	5	126	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
705	5	127	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
706	5	16	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
707	5	128	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
708	5	130	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
709	5	131	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
710	5	132	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
711	5	133	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
712	5	121	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
713	5	122	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
714	5	134	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
715	5	135	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
716	2	125	55	\N
717	2	126	55	\N
718	2	127	55	\N
719	2	16	55	\N
720	2	128	55	\N
721	2	130	55	\N
722	2	131	55	\N
723	2	132	55	\N
724	2	133	55	\N
725	2	121	55	\N
726	2	122	55	\N
727	2	134	55	\N
728	2	135	55	\N
729	2	125	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
730	2	126	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
731	2	127	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
732	2	16	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
733	2	128	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
734	2	130	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
735	2	131	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
736	2	132	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
737	2	133	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
738	2	121	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
739	2	122	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
740	2	134	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
741	2	135	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
742	2	121	57	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
743	2	125	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
744	2	126	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
745	2	127	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
746	2	16	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
747	2	128	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
748	2	130	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
749	2	121	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
750	2	122	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
751	2	134	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
752	2	135	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
753	2	121	59	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
754	2	125	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
755	2	126	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
756	2	127	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
757	2	16	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
758	2	128	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
759	2	130	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
760	2	131	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
761	2	132	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
762	2	133	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
763	2	121	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
764	2	122	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
909	2	160	96	\N
910	2	161	96	\N
765	2	134	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
766	2	135	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
767	2	121	61	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
768	2	125	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
769	2	126	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
770	2	127	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
771	2	16	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
772	2	128	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
773	2	121	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
774	2	131	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
775	2	132	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
776	2	122	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
777	2	134	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
778	2	135	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
779	2	125	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
780	2	126	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
781	2	127	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
782	2	16	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
783	2	128	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
784	2	136	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
785	2	131	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
786	2	132	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
787	2	121	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
788	2	122	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
789	2	134	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
790	2	135	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
791	2	121	64	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
792	8	121	65	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23
793	3	121	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
794	3	122	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
795	3	123	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
796	5	137	65	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23
797	5	123	65	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23
798	8	137	66	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242
799	8	123	66	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242
800	8	121	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246
801	8	122	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246
802	8	123	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246
803	8	121	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239
804	8	122	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239
805	8	123	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239
806	1	121	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210
807	1	122	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210
808	1	123	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210
809	3	138	70	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74
810	3	139	70	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74
811	3	138	71	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72
812	3	139	71	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72
813	3	112	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
814	3	116	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
815	3	140	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
816	3	141	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
817	1	112	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211
818	1	116	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211
819	1	140	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211
820	1	133	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
821	1	112	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
822	1	116	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
823	1	140	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
824	1	118	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
825	1	141	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
826	1	133	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
827	1	112	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
828	1	116	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
829	1	140	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
830	1	141	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
831	1	142	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
832	1	112	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
833	1	116	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
834	1	140	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
835	1	141	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
836	1	142	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
837	1	133	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
838	1	112	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
839	1	116	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
840	1	140	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
841	1	112	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
842	1	116	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
843	1	140	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
844	1	118	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
845	1	112	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217
846	1	116	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217
847	1	140	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217
848	2	112	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
849	2	140	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
850	2	118	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
851	2	143	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
852	2	141	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
853	2	142	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
854	2	112	81	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271
855	2	140	81	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271
856	2	112	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
857	2	118	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
858	2	143	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
859	2	144	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
860	2	141	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
861	2	142	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
862	2	112	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268
863	2	116	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268
864	2	140	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268
865	2	12	84	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
866	2	145	84	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
867	2	146	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
868	2	147	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
869	2	148	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
870	2	149	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
871	2	150	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
872	2	151	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
873	2	152	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
874	2	153	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
875	2	154	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
876	2	155	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
877	2	156	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
878	8	104	86	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/
879	8	128	86	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/
880	8	128	87	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/
881	8	104	87	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/
882	8	104	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/
883	8	128	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/
884	8	157	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/
885	8	158	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/
886	8	121	89	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240
887	8	159	90	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241
888	8	159	91	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247
889	8	160	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
890	8	161	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
891	8	162	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
892	8	163	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
893	8	164	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
894	8	160	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
895	8	161	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
896	8	162	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
897	8	163	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
898	8	164	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
899	8	160	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
900	8	161	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
901	8	162	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
902	8	163	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
903	8	164	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
912	2	163	96	\N
913	2	164	96	\N
914	2	133	97	\N
915	2	133	98	\N
916	2	133	99	\N
917	2	133	100	\N
918	2	133	101	\N
919	2	133	102	\N
920	5	160	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
921	5	161	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
922	5	162	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
923	5	163	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
924	5	164	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
925	5	133	104	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
926	5	133	105	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
927	5	133	106	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
928	5	133	107	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
929	5	133	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
930	5	160	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
931	5	161	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
932	5	162	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
933	5	163	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
934	5	164	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
935	5	133	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
936	5	160	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
937	5	161	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
938	5	162	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
939	5	163	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
940	5	164	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
941	5	133	110	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
942	1	165	111	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
943	1	166	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
944	1	167	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
945	1	168	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
946	2	166	113	\N
947	2	167	113	\N
948	2	168	113	\N
949	2	166	114	\N
950	2	169	114	\N
951	2	166	115	\N
952	2	169	115	\N
953	2	170	116	\N
954	2	170	117	\N
955	2	170	118	\N
956	2	170	119	\N
957	2	170	120	\N
958	2	170	121	\N
959	2	170	122	\N
960	2	170	123	\N
961	2	170	124	\N
962	2	170	125	\N
963	2	111	126	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264
964	2	111	127	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265
965	2	111	128	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
966	2	171	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
967	2	172	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
968	2	173	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
969	2	171	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
970	2	172	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
971	2	173	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
972	2	171	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
973	2	172	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
974	2	173	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
975	2	171	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296
976	2	172	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296
977	2	173	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296
978	2	171	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
979	2	172	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
980	2	173	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
981	2	171	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
982	2	172	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
983	2	173	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
984	2	171	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
985	2	172	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
986	2	173	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
987	2	171	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295
988	2	172	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295
989	2	173	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295
990	2	174	137	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
991	9	174	138	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184
992	9	174	139	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183
993	9	175	139	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183
1110	2	184	158	\N
994	9	174	140	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181
995	9	175	140	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181
996	9	166	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
997	9	176	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
998	9	177	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
999	9	178	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
1000	9	179	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
1001	9	180	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
1002	9	181	142	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182
1003	10	182	143	http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187
1004	9	182	144	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178
1005	9	182	145	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176
1006	9	182	146	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179
1007	9	183	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1008	9	184	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1009	9	185	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1010	9	186	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1011	9	187	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1012	9	188	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1013	9	189	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1014	9	190	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1015	9	3	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
1016	9	191	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1017	9	192	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1018	9	193	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1019	9	188	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1020	9	186	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1021	9	3	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
1022	9	194	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1023	9	195	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1024	9	188	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1025	9	186	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1026	9	184	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1027	9	196	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1028	9	183	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1029	9	3	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
1030	9	197	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1031	9	198	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1032	9	186	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1033	9	188	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1034	9	190	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1035	9	3	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
1036	2	188	151	\N
1037	2	197	151	\N
1038	2	3	151	\N
1039	2	186	152	\N
1040	2	188	152	\N
1041	2	190	152	\N
1042	2	3	152	\N
1043	2	183	153	\N
1044	2	184	153	\N
1045	2	194	153	\N
1046	2	186	153	\N
1047	2	199	153	\N
1048	2	200	153	\N
1049	2	201	153	\N
1050	2	197	153	\N
1051	2	202	153	\N
1052	2	203	153	\N
1053	2	190	153	\N
1054	2	195	153	\N
1055	2	204	153	\N
1056	2	205	153	\N
1057	2	3	153	\N
1058	2	206	154	\N
1059	2	207	154	\N
1060	2	208	154	\N
1061	2	209	154	\N
1062	2	210	154	\N
1063	2	211	154	\N
1064	2	202	154	\N
1065	2	188	154	\N
1066	2	195	154	\N
1067	2	190	154	\N
1068	2	4	154	\N
1069	2	2	154	\N
1070	2	183	154	\N
1071	2	212	154	\N
1072	2	213	154	\N
1073	2	214	154	\N
1074	2	3	154	\N
1075	2	183	155	\N
1076	2	202	155	\N
1077	2	188	155	\N
1078	2	190	155	\N
1079	2	2	155	\N
1080	2	215	155	\N
1081	2	207	155	\N
1082	2	216	155	\N
1083	2	217	155	\N
1084	2	3	155	\N
1085	2	184	156	\N
1086	2	202	156	\N
1087	2	204	156	\N
1088	2	218	156	\N
1089	2	3	156	\N
1090	2	219	157	\N
1091	2	220	157	\N
1092	2	196	157	\N
1093	2	221	157	\N
1094	2	222	157	\N
1095	2	184	157	\N
1096	2	223	157	\N
1097	2	224	157	\N
1098	2	186	157	\N
1099	2	183	157	\N
1100	2	202	157	\N
1101	2	188	157	\N
1102	2	190	157	\N
1103	2	2	157	\N
1104	2	207	157	\N
1105	2	195	157	\N
1106	2	225	157	\N
1107	2	211	157	\N
1108	2	226	157	\N
1109	2	3	157	\N
1111	2	227	158	\N
1112	2	228	158	\N
1113	2	229	158	\N
1114	2	188	158	\N
1115	2	186	158	\N
1116	2	3	158	\N
1117	2	183	159	\N
1118	2	230	159	\N
1119	2	227	159	\N
1120	2	186	159	\N
1121	2	188	159	\N
1122	2	195	159	\N
1123	2	3	159	\N
1124	2	183	160	\N
1125	2	220	160	\N
1126	2	202	160	\N
1127	2	188	160	\N
1128	2	195	160	\N
1129	2	190	160	\N
1130	2	225	160	\N
1131	2	231	160	\N
1132	2	232	160	\N
1133	2	233	160	\N
1134	2	234	160	\N
1135	2	235	160	\N
1136	2	201	160	\N
1137	2	236	160	\N
1138	2	3	160	\N
1139	2	183	161	\N
1140	2	188	161	\N
1141	2	190	161	\N
1142	2	204	161	\N
1143	2	237	161	\N
1144	2	238	161	\N
1145	2	235	161	\N
1146	2	3	161	\N
1147	8	183	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1148	8	188	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1149	8	184	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1150	8	186	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1151	8	202	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1152	8	210	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1153	8	239	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1154	8	231	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1155	8	240	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1156	8	3	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
1157	7	227	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1158	7	183	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1159	7	241	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1160	7	202	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1161	7	188	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1162	7	190	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1163	7	3	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
1164	3	210	162	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
1165	5	210	162	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
1166	8	210	163	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
1167	7	210	163	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8
1168	3	210	163	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
1169	5	210	163	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
1170	8	210	164	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
1171	3	210	164	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
1172	5	210	164	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
1173	8	210	165	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
1174	7	210	165	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12
1175	5	210	165	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
1176	8	210	166	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
1177	5	242	166	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
1178	8	242	167	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
1179	5	243	167	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
1180	5	244	167	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
1181	8	243	168	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
1182	8	244	168	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
1183	7	243	168	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16
1184	7	244	168	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16
1185	5	244	168	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
1186	5	243	168	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
1187	8	243	169	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
1188	8	244	169	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
1189	5	243	169	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
1190	5	244	169	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
1191	8	243	170	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
1192	8	244	170	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
1193	5	243	170	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
1194	5	244	170	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
1195	8	243	171	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
1196	8	244	171	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
1197	5	244	171	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
1198	5	243	171	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
1199	8	243	172	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
1200	8	244	172	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
1201	8	243	173	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2087	31	258	369	\N
1202	8	244	173	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
1203	5	245	173	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
1204	5	3	173	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
1205	8	246	174	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
1206	7	247	174	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11
1207	7	248	174	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11
1208	3	249	174	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
1209	5	250	174	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
1210	8	251	175	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
1211	7	252	175	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10
1212	3	251	175	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
1213	5	251	175	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
1214	1	253	176	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
1215	1	253	177	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
1216	1	254	178	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
1217	1	3	178	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
1218	1	255	179	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
1219	1	3	179	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
1220	1	256	180	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
1221	1	257	180	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
1222	11	256	181	http://www.mycancergenome.org/content/disease/gist/pdgfra/48
1223	11	257	181	http://www.mycancergenome.org/content/disease/gist/pdgfra/48
1224	11	256	182	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
1225	11	256	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
1226	11	257	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
1227	11	258	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
1228	11	256	184	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
1229	11	258	184	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
1230	12	256	185	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218
1231	12	258	185	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218
1232	1	256	186	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1233	1	259	187	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1234	1	260	188	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1235	1	261	189	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1236	12	262	189	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124
1237	1	20	190	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1238	1	3	190	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1239	1	263	191	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1240	1	3	191	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1241	1	264	192	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1242	1	3	192	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1243	1	265	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1244	1	266	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1245	1	267	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1246	1	20	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1247	1	268	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1248	1	269	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1249	1	270	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1250	1	271	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1251	1	272	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1252	1	273	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1253	1	274	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1254	1	275	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1255	1	276	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1256	1	277	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1257	1	268	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1258	1	269	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1259	1	270	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1260	1	271	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1261	1	272	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1262	1	273	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1263	1	274	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1264	1	275	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1265	1	276	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1266	1	277	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1267	1	268	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1268	1	269	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1269	1	270	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1270	1	271	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1271	1	272	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1272	1	273	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1273	1	274	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1274	1	275	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2088	31	257	369	\N
1275	1	276	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1276	1	277	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1277	1	268	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1278	1	269	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1279	1	270	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1280	1	278	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1281	1	279	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1282	1	280	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1283	1	281	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1284	1	282	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1285	1	283	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1286	1	284	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1287	1	285	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1288	1	286	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1289	1	287	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1290	1	288	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1291	1	289	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1292	1	277	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1293	1	268	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1294	1	269	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1295	1	270	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1296	1	271	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1297	1	290	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1298	1	291	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1299	1	292	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1300	1	293	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1301	1	294	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1302	1	295	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1303	1	296	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1304	1	297	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1305	1	298	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1306	1	299	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1307	1	300	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1308	1	301	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1309	1	276	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1310	1	275	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1311	1	277	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1312	1	268	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1313	1	269	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1314	1	270	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1315	1	271	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1316	1	276	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1317	1	277	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1318	12	302	199	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110
1319	12	303	199	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110
1320	1	302	200	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1321	1	303	200	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1322	1	302	201	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1323	1	303	201	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1324	1	302	202	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1325	1	303	202	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1326	1	302	203	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1327	1	303	203	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1328	1	302	204	\N
1329	1	303	204	\N
1330	12	302	204	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112
1331	12	303	204	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112
1332	1	302	205	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1333	1	303	205	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1334	12	302	206	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
1335	12	303	206	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
1336	1	302	207	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1337	1	303	207	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1338	1	302	208	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1339	1	303	208	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1340	1	302	209	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1341	1	303	209	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1342	1	302	210	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1343	1	303	210	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1344	1	302	211	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1345	1	303	211	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1346	1	302	212	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1347	1	303	212	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1348	1	304	213	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1349	1	305	213	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1350	1	304	214	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1351	1	306	215	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1352	1	304	215	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1353	1	302	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1354	1	255	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1355	1	307	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1356	1	302	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1357	1	255	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1358	1	307	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1359	1	302	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1360	1	255	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1361	1	307	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1362	1	308	219	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1363	1	307	219	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1364	1	307	220	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1365	1	302	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1366	1	255	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1367	1	307	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1368	1	302	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1369	1	255	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1370	1	307	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1371	1	302	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96
1372	1	255	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96
1373	1	307	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96
1374	12	302	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
1375	12	255	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
1376	12	307	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
1377	12	302	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122
1378	12	255	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122
1379	12	307	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122
1380	1	302	225	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1381	1	303	225	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1382	1	309	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1383	1	79	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1384	1	80	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1385	1	81	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1386	1	82	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1387	1	83	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1388	1	84	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1389	1	310	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1390	1	311	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1391	1	312	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1392	1	281	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1393	1	309	227	\N
1394	1	79	227	\N
1395	1	80	227	\N
1396	1	81	227	\N
1397	1	82	227	\N
1398	1	83	227	\N
1399	1	84	227	\N
1400	1	310	227	\N
1401	1	311	227	\N
1402	1	312	227	\N
1403	1	281	227	\N
1404	1	309	228	\N
1405	1	79	228	\N
1406	1	80	228	\N
1407	1	81	228	\N
1408	1	82	228	\N
1409	1	83	228	\N
1410	1	84	228	\N
1411	1	310	228	\N
1412	1	311	228	\N
1413	1	312	228	\N
1414	1	281	228	\N
1415	1	309	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1416	1	79	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1417	1	80	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1418	1	81	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1419	1	82	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1420	1	83	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1421	1	84	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1422	1	310	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1423	1	311	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1424	1	312	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1425	1	281	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1426	1	309	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1427	1	79	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1428	1	80	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1429	1	81	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1430	1	82	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1431	1	83	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1432	1	84	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1433	1	310	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1434	1	311	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1435	1	312	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1436	1	281	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1437	1	313	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1438	1	314	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1439	1	315	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1440	1	316	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1441	1	317	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1442	1	318	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1443	1	319	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1444	1	320	232	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1445	12	320	233	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121
1446	1	320	234	http://www.mycancergenome.org/content/disease/melanoma/kit/84
1447	2	320	234	\N
1448	1	320	235	\N
1449	2	320	235	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274
1450	11	276	235	\N
1451	11	277	235	\N
1452	2	276	236	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276
1453	2	277	236	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276
1454	1	276	237	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1455	1	277	237	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1456	2	276	237	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
1457	2	277	237	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
1458	11	276	237	\N
1459	11	277	237	\N
1460	1	321	238	http://www.mycancergenome.org/content/disease/melanoma/kit/84
1461	1	321	239	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1462	1	322	240	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1463	12	322	241	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120
1464	1	323	242	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1465	1	3	242	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1466	1	324	243	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1467	1	325	244	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1468	1	3	244	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1469	1	326	245	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1470	1	327	245	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1471	1	328	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1472	1	326	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1473	1	329	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1474	1	330	247	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1475	1	326	247	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1476	1	331	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1477	1	330	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1478	1	326	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1479	1	332	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1480	1	333	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1481	1	334	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1482	1	335	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132
1483	2	326	250	\N
1484	2	334	250	\N
1485	2	336	250	\N
1486	2	337	251	\N
1487	2	332	252	\N
1488	2	338	253	\N
1489	2	326	253	\N
1490	2	339	253	\N
1491	13	340	254	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1492	13	341	255	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1493	13	341	256	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1494	13	341	257	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1495	13	342	258	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1496	13	3	258	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1497	13	343	259	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1498	13	344	260	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1499	13	344	261	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
1500	14	344	262	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/164
1501	14	344	263	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/165
1502	14	345	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166
1503	14	346	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166
1504	14	347	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166
1505	14	344	265	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163
1506	15	345	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163
1507	15	346	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163
1508	15	347	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163
1509	14	344	266	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/167
1510	14	344	267	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/168
1511	14	344	268	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/169
1512	14	344	269	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/170
1513	14	344	270	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/171
1514	14	344	271	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/172
1515	1	344	272	\N
1516	1	344	273	http://www.mycancergenome.org/content/disease/melanoma/braf/114
1517	1	344	274	http://www.mycancergenome.org/content/disease/melanoma/braf/115
1518	16	344	275	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
2089	30	243	370	\N
2090	31	256	371	\N
1519	4	345	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
1520	4	346	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
1521	4	347	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
1522	7	348	275	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
1523	11	349	275	http://www.mycancergenome.org/content/disease/gist/braf/54
1524	5	349	275	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
1525	1	350	276	http://www.mycancergenome.org/content/disease/melanoma/braf/118
1526	1	351	277	http://www.mycancergenome.org/content/disease/melanoma/braf/116
1527	7	352	278	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
1528	7	353	278	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
1529	1	3	279	http://www.mycancergenome.org/content/disease/melanoma/braf/301
1530	5	354	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1531	5	355	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1532	5	41	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1533	5	96	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1534	5	97	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1535	5	51	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1536	5	356	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
1537	1	354	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1538	1	355	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1539	1	41	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1540	1	96	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1541	1	97	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1542	1	51	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148
1543	5	354	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
1544	5	355	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
1545	5	41	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
1546	5	357	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
1547	1	355	282	\N
1548	1	356	282	\N
1549	1	355	283	\N
1550	1	356	283	\N
1551	1	355	284	http://www.mycancergenome.org/content/disease/melanoma/braf/300
1552	1	356	284	http://www.mycancergenome.org/content/disease/melanoma/braf/300
1553	1	355	285	http://www.mycancergenome.org/content/disease/melanoma/braf/298
1554	1	356	285	http://www.mycancergenome.org/content/disease/melanoma/braf/298
1555	1	355	286	http://www.mycancergenome.org/content/disease/melanoma/braf/299
1556	1	356	286	http://www.mycancergenome.org/content/disease/melanoma/braf/299
1557	16	355	287	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
1558	16	356	287	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
1559	5	80	288	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
1560	5	358	288	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
1561	16	80	289	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
1562	16	358	289	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
1563	5	80	289	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
1564	5	358	289	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
1565	5	80	290	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
1566	5	358	290	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
1567	16	80	291	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
1568	16	358	291	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
1569	16	80	292	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
1570	16	358	292	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
1571	5	359	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
1572	5	317	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
1573	5	318	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
1574	3	359	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
1575	3	317	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
1576	3	318	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
1577	3	359	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
1578	3	317	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
1579	3	318	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
1580	3	248	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
1581	3	360	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
1582	3	361	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
1583	3	362	296	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
1584	3	247	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
1585	3	360	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
1586	3	248	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
1587	3	363	298	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
1588	2	364	299	\N
1589	17	365	300	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200
1590	17	366	301	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203
1591	17	367	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1592	17	41	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1593	17	357	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1594	17	96	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1595	17	97	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1596	17	368	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1597	17	369	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1598	17	370	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1599	17	371	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1600	17	372	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
1601	17	41	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1602	17	367	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1603	17	371	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1604	17	372	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1605	17	369	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1606	17	370	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1607	17	373	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1608	17	97	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1609	17	51	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1610	17	374	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1611	17	96	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1612	17	375	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1613	17	368	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1614	17	376	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
1615	1	41	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1616	1	367	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1617	1	97	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1618	1	51	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1619	1	374	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1620	1	96	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1621	1	375	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1622	1	368	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1623	1	369	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1624	1	370	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1625	1	371	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1626	1	372	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
1627	1	41	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1628	1	367	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1629	1	377	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1630	1	373	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1631	1	97	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1632	1	51	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1633	1	374	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1634	1	96	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1635	1	375	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1636	1	368	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1637	1	369	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1638	1	370	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1639	1	371	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1640	1	372	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1641	1	378	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1642	1	379	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1643	1	380	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1644	1	381	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1645	1	382	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1646	1	383	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
1647	1	41	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1648	1	367	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1649	1	384	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1650	1	376	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1651	1	97	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1652	1	51	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1653	1	374	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1654	1	96	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1655	1	375	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1656	1	368	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1657	1	369	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1658	1	370	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1659	1	371	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1660	1	372	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1661	1	366	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
1662	17	41	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1663	17	367	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1664	17	377	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1665	17	373	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1666	17	41	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1667	17	51	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1668	17	96	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1669	17	375	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1670	17	368	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1671	17	97	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1672	17	369	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1673	17	370	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1674	17	372	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1675	17	371	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1676	17	385	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1677	17	368	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
1678	18	251	308	\N
1679	19	253	309	\N
1680	18	252	310	\N
1681	18	251	311	\N
1682	19	253	312	\N
1683	18	251	313	\N
1684	20	321	314	\N
1685	20	321	315	\N
1686	2	111	316	\N
1687	21	242	316	\N
1688	21	242	317	\N
1689	22	362	318	\N
1690	22	360	319	\N
1691	23	360	319	\N
1692	24	248	319	\N
1693	22	248	319	\N
1694	23	248	319	\N
1695	23	363	319	\N
1696	24	247	319	\N
1697	23	247	319	\N
1698	22	361	319	\N
1699	25	351	320	\N
1700	26	181	321	\N
1701	27	15	321	\N
1702	27	13	321	\N
1703	27	14	321	\N
1704	2	145	321	\N
1705	27	12	321	\N
1706	2	12	321	\N
1707	27	11	322	\N
1708	1	386	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1709	1	391	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1710	1	392	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1711	1	388	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1712	2	133	323	\N
1713	1	393	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1714	1	394	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1715	1	395	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1716	1	396	323	\N
1717	1	387	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1718	1	389	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1719	1	390	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1720	1	383	323	http://www.mycancergenome.org/content/disease/melanoma/nras/81
1721	1	3	323	\N
1722	1	386	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1723	1	391	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1724	3	302	324	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80
1725	1	392	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1726	1	388	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1727	3	255	324	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80
1728	2	133	324	\N
1729	1	393	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1730	1	394	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1731	1	395	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1732	1	396	324	\N
1733	1	387	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1734	3	307	324	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80
1735	1	389	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1736	1	390	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1737	1	383	324	http://www.mycancergenome.org/content/disease/melanoma/nras/80
1738	1	3	324	\N
1739	1	386	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1740	1	391	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1741	1	392	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1742	1	388	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1743	1	393	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1744	1	397	325	\N
1745	1	394	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1746	1	398	325	\N
1747	1	395	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1748	1	387	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1749	1	389	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1750	1	390	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1751	1	383	325	http://www.mycancergenome.org/content/disease/melanoma/nras/83
1752	1	3	325	\N
1753	1	386	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1754	1	391	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1755	1	392	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
2091	31	258	371	\N
1756	1	388	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1757	1	393	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1758	1	394	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1759	1	395	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1760	1	387	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1761	1	389	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1762	1	390	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1763	1	383	326	http://www.mycancergenome.org/content/disease/melanoma/nras/82
1764	1	386	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1765	1	391	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1766	3	302	327	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76
1767	1	392	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1768	1	388	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1769	3	255	327	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76
1770	1	393	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1771	1	397	327	\N
1772	1	394	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1773	1	398	327	\N
1774	1	395	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1775	1	387	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1776	3	307	327	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76
1777	1	389	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1778	1	390	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1779	1	383	327	http://www.mycancergenome.org/content/disease/melanoma/nras/76
1780	1	3	327	\N
1781	2	163	328	\N
1782	1	386	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1783	2	164	328	\N
1784	1	391	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1785	3	302	328	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77
1786	5	78	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1787	1	392	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1788	2	162	328	\N
1789	4	399	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77
1790	5	77	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1791	1	388	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1792	3	255	328	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77
1793	2	161	328	\N
1794	4	400	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77
1795	4	401	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77
1796	1	393	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1797	1	394	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1798	5	49	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1799	5	73	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1800	1	402	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1801	5	75	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1802	5	76	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1803	5	74	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77
1804	2	160	328	\N
1805	1	395	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1806	4	403	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77
1807	1	387	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1808	3	307	328	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77
1809	1	389	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1810	1	390	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1811	1	383	328	http://www.mycancergenome.org/content/disease/melanoma/nras/77
1812	1	3	328	\N
1813	1	386	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1814	1	391	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1815	1	392	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1816	1	388	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1817	1	393	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1818	1	394	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1819	1	395	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1820	1	387	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1821	3	307	329	\N
1822	1	389	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1823	1	390	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1824	1	383	329	http://www.mycancergenome.org/content/disease/melanoma/nras/98
1825	3	308	329	\N
1826	1	3	329	\N
1827	1	3	330	\N
1828	1	396	331	\N
1829	3	307	331	\N
1830	1	3	331	\N
1831	1	386	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1832	1	391	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1833	1	392	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1834	1	388	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1835	1	393	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1836	1	394	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1837	1	395	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1838	1	387	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
2203	7	3	431	\N
2204	1	3	432	\N
1839	1	389	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1840	1	390	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1841	1	390	332	\N
1842	1	383	332	http://www.mycancergenome.org/content/disease/melanoma/nras/97
1843	1	3	332	\N
1844	1	386	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1845	1	391	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1846	3	302	333	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
1847	5	78	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1848	1	392	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1849	4	399	333	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75
1850	5	77	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1851	1	388	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1852	3	255	333	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
1853	4	400	333	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75
1854	2	133	333	\N
1855	4	401	333	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75
1856	1	393	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1857	1	394	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1858	5	49	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1859	5	73	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1860	1	402	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1861	5	75	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1862	5	76	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1863	5	74	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75
1864	1	395	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1865	4	403	333	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75
1866	1	387	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1867	3	307	333	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75
1868	1	389	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1869	1	390	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1870	1	383	333	http://www.mycancergenome.org/content/disease/melanoma/nras/75
1871	1	404	334	\N
1872	1	3	334	\N
1873	1	386	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1874	1	391	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1875	1	392	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1876	1	388	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1877	2	133	335	\N
1878	1	393	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1879	1	394	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1880	1	387	335	http://www.mycancergenome.org/content/disease/melanoma/nras/94
1881	28	3	335	\N
1882	1	386	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1883	1	391	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1884	1	392	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1885	1	388	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1886	1	393	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1887	1	394	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1888	1	387	336	http://www.mycancergenome.org/content/disease/melanoma/nras/91
1889	1	3	336	\N
1890	1	386	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1891	1	391	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1892	1	392	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1893	1	388	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1894	2	133	337	\N
1895	1	393	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1896	1	394	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1897	1	387	337	http://www.mycancergenome.org/content/disease/melanoma/nras/92
1898	1	405	337	\N
1899	1	3	337	\N
1900	1	386	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1901	1	391	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1902	1	392	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1903	1	388	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1904	1	393	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1905	1	394	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1906	1	387	338	http://www.mycancergenome.org/content/disease/melanoma/nras/297
1907	1	3	338	\N
1908	1	386	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1909	1	391	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1910	1	392	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1911	1	388	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1912	1	393	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1913	1	394	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1914	1	406	339	\N
1915	1	387	339	http://www.mycancergenome.org/content/disease/melanoma/nras/93
1916	1	3	339	\N
1917	29	3	340	\N
1918	1	386	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1919	1	391	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1920	5	78	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1921	1	392	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1922	5	77	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1923	1	388	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1924	2	133	341	\N
1925	1	393	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1926	1	394	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1927	5	49	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1928	5	73	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1929	5	75	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1930	5	76	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1931	5	74	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90
1932	1	387	341	http://www.mycancergenome.org/content/disease/melanoma/nras/90
1933	2	3	341	\N
1934	1	386	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1935	1	391	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1936	3	302	342	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
1937	5	78	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1938	1	392	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1939	5	77	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1940	1	388	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1941	3	255	342	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
1942	1	393	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1943	1	394	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1944	5	49	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1945	5	73	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1946	5	75	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1947	5	76	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1948	5	74	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85
1949	1	387	342	http://www.mycancergenome.org/content/disease/melanoma/nras/85
1950	3	307	342	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85
1951	5	3	342	\N
1952	2	163	343	\N
1953	1	386	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1954	2	164	343	\N
1955	1	391	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1956	3	302	343	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
1957	5	78	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1958	1	392	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1959	2	162	343	\N
1960	5	77	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1961	1	388	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1962	3	255	343	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
1963	2	161	343	\N
1964	2	133	343	\N
1965	1	393	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1966	1	394	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1967	5	49	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1968	5	73	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1969	5	75	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1970	5	76	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1971	5	74	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87
1972	2	407	343	\N
1973	2	160	343	\N
1974	1	387	343	http://www.mycancergenome.org/content/disease/melanoma/nras/87
1975	3	307	343	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87
1976	2	3	343	\N
1977	2	163	344	\N
1978	1	386	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1979	2	164	344	\N
1980	1	391	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1981	3	302	344	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
1982	5	78	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1983	1	392	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1984	2	162	344	\N
1985	5	77	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1986	1	388	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1987	3	255	344	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
1988	2	161	344	\N
1989	2	133	344	\N
1990	1	393	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1991	1	394	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1992	5	49	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1993	5	73	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1994	5	75	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1995	5	76	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1996	5	74	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86
1997	2	160	344	\N
1998	1	387	344	http://www.mycancergenome.org/content/disease/melanoma/nras/86
1999	3	307	344	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86
2000	1	383	344	\N
2001	5	408	344	\N
2002	5	3	344	\N
2003	1	386	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2004	1	391	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2005	3	302	345	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
2205	38	3	432	\N
2006	1	392	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2007	1	388	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2008	3	255	345	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
2009	1	393	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2010	1	394	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2011	21	409	345	\N
2012	1	387	345	http://www.mycancergenome.org/content/disease/melanoma/nras/88
2013	3	307	345	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88
2014	21	3	345	\N
2015	5	3	345	\N
2016	1	386	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2017	1	391	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2018	3	302	346	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
2019	5	78	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2020	1	392	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2021	5	77	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2022	1	388	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2023	3	303	346	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
2024	2	133	346	\N
2025	1	393	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2026	1	394	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2027	5	49	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2028	5	49	346	\N
2029	5	73	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2030	5	75	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2031	5	76	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2032	5	74	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89
2033	1	387	346	http://www.mycancergenome.org/content/disease/melanoma/nras/89
2034	5	3	346	\N
2035	20	320	347	\N
2036	20	320	348	\N
2037	20	320	349	\N
2038	20	320	350	\N
2039	20	320	351	\N
2040	6	410	352	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
2041	6	320	352	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
2042	6	411	352	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78
2043	20	320	353	\N
2044	2	112	354	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296
2045	2	113	354	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296
2046	2	114	355	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
2047	2	112	355	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
2048	2	115	355	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294
2049	2	114	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2050	2	120	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2051	2	112	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2052	2	119	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2053	2	116	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2054	2	118	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2055	2	117	356	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293
2056	2	114	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2057	2	120	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2058	2	112	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2059	2	119	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2060	2	116	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2061	2	118	357	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291
2062	2	112	358	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295
2063	2	116	358	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295
2064	2	114	359	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
2065	2	120	359	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
2066	2	112	359	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
2067	2	119	359	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
2068	2	113	359	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292
2069	9	244	360	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184
2070	9	243	360	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184
2071	9	244	361	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183
2072	9	243	361	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183
2073	30	243	361	\N
2074	31	256	362	\N
2075	31	257	362	\N
2076	9	244	363	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181
2077	9	243	363	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181
2078	9	244	364	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
2079	9	243	364	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180
2080	9	244	365	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182
2081	9	243	365	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182
2082	10	340	366	http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187
2083	31	256	367	\N
2084	31	257	367	\N
2085	31	256	368	\N
2086	31	256	369	\N
2092	9	244	372	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178
2093	9	243	372	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178
2094	31	256	372	\N
2095	31	258	372	\N
2096	9	244	373	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176
2097	9	243	373	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176
2098	9	244	374	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179
2099	9	243	374	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179
2100	9	244	375	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
2101	9	243	375	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177
2102	9	244	376	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
2103	9	243	376	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175
2104	31	256	377	\N
2105	9	244	378	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
2106	9	243	378	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174
2107	30	243	379	\N
2108	9	244	380	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
2109	9	243	380	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173
2110	2	170	381	\N
2111	2	170	382	\N
2112	2	170	383	\N
2113	2	170	384	\N
2114	2	170	385	\N
2115	2	170	386	\N
2116	2	170	387	\N
2117	2	170	388	\N
2118	2	170	389	\N
2119	2	170	390	\N
2120	2	111	391	\N
2121	2	111	392	\N
2122	2	111	393	\N
2123	2	112	394	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264
2124	2	141	394	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264
2125	2	140	394	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264
2126	2	116	394	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264
2127	2	112	395	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265
2128	2	140	395	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265
2129	2	116	395	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265
2130	2	133	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2131	32	412	396	\N
2132	32	413	396	\N
2133	2	112	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2134	2	141	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2135	2	140	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2136	2	116	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2137	30	414	396	\N
2138	2	118	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263
2139	32	3	396	\N
2140	2	133	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2141	2	142	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2142	2	112	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2143	2	141	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2144	2	140	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2145	2	116	397	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260
2146	32	3	397	\N
2147	2	142	398	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
2148	2	112	398	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
2149	2	141	398	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
2150	2	140	398	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
2151	2	116	398	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261
2152	2	133	399	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
2153	32	415	399	\N
2154	2	112	399	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
2155	2	140	399	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
2156	2	116	399	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262
2157	32	3	399	\N
2158	1	416	400	\N
2159	1	416	401	\N
2160	1	416	402	\N
2161	1	416	403	\N
2162	1	416	404	\N
2163	1	416	405	\N
2164	28	3	406	\N
2165	28	3	407	\N
2166	33	417	408	\N
2167	33	3	408	\N
2168	33	417	409	\N
2169	33	3	409	\N
2170	33	3	410	\N
2171	33	418	411	\N
2172	33	3	411	\N
2173	1	419	412	\N
2174	1	419	413	\N
2175	34	3	414	\N
2176	31	3	414	\N
2177	31	420	414	\N
2178	35	421	415	\N
2179	1	3	416	\N
2180	1	3	417	\N
2181	1	3	418	\N
2182	1	3	419	\N
2183	1	3	420	\N
2184	36	3	421	\N
2185	37	3	421	\N
2186	1	422	422	\N
2187	1	3	422	\N
2188	15	3	423	\N
2189	38	3	423	\N
2190	1	3	424	\N
2191	1	3	425	\N
2192	37	3	426	\N
2193	15	3	427	\N
2194	37	3	427	\N
2195	7	3	428	\N
2196	30	3	428	\N
2197	39	3	428	\N
2198	38	3	429	\N
2199	40	3	429	\N
2200	38	3	430	\N
2201	40	3	430	\N
2202	41	3	431	\N
2206	29	3	433	\N
2207	39	3	434	\N
2208	1	423	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2209	1	424	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2210	1	425	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2211	1	426	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2212	1	427	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2213	1	428	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2214	1	429	435	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105
2215	29	3	435	\N
2216	7	3	436	\N
2217	31	3	436	\N
2218	1	423	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2219	1	424	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2220	1	425	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2221	1	426	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2222	1	427	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2223	1	428	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2224	1	429	437	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104
2225	7	3	437	\N
2226	28	3	438	\N
2227	29	3	439	\N
2228	28	3	440	\N
2229	28	3	441	\N
2230	1	3	442	\N
2231	1	423	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2232	1	424	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2233	1	425	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2234	1	426	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2235	1	427	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2236	1	428	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2237	1	429	443	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107
2238	42	430	443	\N
2239	42	3	443	\N
2240	30	3	444	\N
2241	42	3	444	\N
2242	1	423	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2243	1	424	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2244	1	425	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2245	1	426	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2246	1	427	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2247	1	428	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2248	1	429	445	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108
2249	1	390	445	\N
2250	1	3	445	\N
2251	42	3	446	\N
2252	1	423	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2253	1	424	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2254	1	425	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2255	1	426	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2256	1	427	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2257	1	428	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2258	1	429	447	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106
2259	42	430	447	\N
2260	42	3	447	\N
2261	2	139	448	\N
2262	2	138	448	\N
2263	2	139	449	\N
2264	2	138	449	\N
2265	5	87	450	\N
2266	8	3	450	\N
2267	5	3	450	\N
2268	5	87	451	\N
2269	8	3	451	\N
2270	5	3	451	\N
2271	5	87	452	\N
2272	8	3	452	\N
2273	5	3	452	\N
2274	8	3	453	\N
2275	5	3	453	\N
2276	8	3	454	\N
2277	5	79	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2278	3	79	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2279	5	81	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2280	3	81	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2281	8	81	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2282	5	80	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2283	3	80	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2284	7	80	455	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
2285	8	80	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2286	8	431	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2287	3	312	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2288	3	309	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2289	8	432	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2290	5	83	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2291	3	83	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2292	8	83	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2293	3	311	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2294	5	87	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2295	3	310	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2296	5	86	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2297	5	82	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2298	3	82	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2299	8	82	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2300	5	49	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2301	3	281	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2302	5	85	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2303	8	85	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2304	5	84	455	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7
2305	3	84	455	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7
2306	8	84	455	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7
2307	7	358	455	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7
2308	8	433	455	\N
2309	8	3	455	\N
2310	3	3	456	\N
2311	5	79	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2312	3	79	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2313	5	81	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2314	3	81	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2315	8	81	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2316	5	80	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2317	3	80	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2318	7	80	457	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8
2319	8	80	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2320	8	431	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2321	3	312	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2322	3	309	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2323	8	432	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2324	5	83	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2325	3	83	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2326	8	83	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2327	3	311	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2328	5	87	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2329	3	310	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2330	5	86	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2331	5	82	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2332	3	82	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2333	8	82	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2334	5	49	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2335	3	281	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2336	5	85	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2337	8	85	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2338	5	84	457	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8
2339	3	84	457	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8
2340	8	84	457	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8
2341	7	358	457	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8
2342	8	433	457	\N
2343	8	3	457	\N
2344	5	79	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2345	3	79	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2346	5	81	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2347	3	81	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2348	8	81	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2349	5	80	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2350	3	80	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2351	8	80	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2352	8	431	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2353	3	312	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2354	3	309	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2355	8	432	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2356	5	83	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2357	3	83	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2358	8	83	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2359	3	311	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2360	5	87	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2361	3	310	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2362	5	86	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2363	5	82	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2364	3	82	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2365	8	82	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2366	5	49	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2367	3	281	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2368	5	85	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2369	8	85	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2370	5	84	458	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9
2371	3	84	458	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9
2372	8	84	458	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9
2373	43	434	458	\N
2374	43	3	458	\N
2375	5	79	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2376	5	81	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2377	8	81	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2378	5	80	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2379	7	80	459	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12
2380	8	80	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2381	8	431	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2382	8	432	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2383	5	83	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2384	8	83	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2385	5	87	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2386	5	86	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2387	5	82	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2388	8	82	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2389	5	49	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2390	5	85	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2391	8	85	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2392	5	84	459	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12
2393	8	84	459	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12
2394	7	358	459	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12
2395	8	3	459	\N
2396	5	79	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2397	5	81	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2398	8	81	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2399	5	80	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2400	8	80	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2401	8	431	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2402	8	432	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2403	5	83	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2404	8	83	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2405	5	87	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2406	5	86	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2407	5	82	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2408	8	82	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2409	5	49	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2410	5	85	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2411	8	85	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2412	5	84	460	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13
2413	8	84	460	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13
2414	1	435	460	\N
2415	5	3	460	\N
2416	1	3	460	\N
2417	5	79	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2418	5	81	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2419	8	81	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2420	5	80	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2421	8	80	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2422	8	431	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2423	8	432	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2424	5	83	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2425	8	83	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2426	5	87	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2427	5	86	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2428	5	82	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2429	8	82	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2430	5	49	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2431	5	85	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2432	8	85	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2433	5	84	461	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14
2434	8	84	461	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14
2435	8	3	462	\N
2436	8	3	463	\N
2437	5	79	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2438	5	81	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2439	8	81	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2440	5	80	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2441	7	80	464	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16
2442	8	80	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2443	8	431	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2444	8	432	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2445	5	83	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2446	8	83	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2447	5	87	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2448	5	86	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2449	5	82	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2450	8	82	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2451	5	49	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2452	5	85	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2453	8	85	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2454	5	84	464	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16
2455	8	84	464	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16
2456	7	358	464	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16
2457	16	3	464	\N
2458	5	79	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2459	5	81	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2460	8	81	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2461	5	80	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2462	8	80	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2463	8	431	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2464	8	432	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2465	5	83	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2466	8	83	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2467	5	87	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2468	5	86	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2469	5	82	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2470	8	82	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2471	5	49	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2472	5	85	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2473	8	85	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2474	5	84	465	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15
2475	8	84	465	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15
2476	5	79	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2477	5	81	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2478	8	81	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2479	5	80	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2480	8	80	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2481	8	431	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2482	8	432	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2483	5	83	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2484	8	83	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2485	5	87	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2486	5	86	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2487	5	82	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2488	8	82	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2489	5	49	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2490	5	85	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2491	8	85	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2492	5	84	466	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18
2493	8	84	466	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18
2494	5	79	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2495	5	81	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2496	8	81	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2497	5	80	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2498	8	80	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2499	8	431	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2500	8	432	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2501	5	83	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2502	8	83	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2503	5	87	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2504	5	86	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2505	5	82	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2506	8	82	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2507	5	49	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2508	5	85	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2509	8	85	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2510	5	84	467	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19
2511	8	84	467	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19
2512	8	81	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2513	8	80	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2514	8	431	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2515	8	432	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2516	8	83	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2517	8	82	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2518	8	85	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2519	8	84	468	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17
2520	5	79	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2521	5	81	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2522	8	81	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2523	5	80	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2524	8	80	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2525	8	431	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2526	8	432	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2527	5	83	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2528	8	83	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2529	5	87	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2530	5	86	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2531	5	82	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2532	8	82	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2533	5	49	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2534	5	85	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2535	8	85	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2536	5	84	469	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20
2537	8	84	469	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20
2538	8	431	470	\N
2539	8	3	470	\N
2540	8	3	471	\N
2541	5	436	472	\N
2542	5	3	472	\N
2543	5	436	473	\N
2544	5	3	473	\N
2545	44	437	474	\N
2546	44	3	474	\N
2547	5	79	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2548	3	79	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2549	5	81	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2550	3	81	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2551	8	81	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2552	5	80	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2553	3	80	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2554	7	80	475	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11
2555	8	80	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2556	8	431	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2557	3	312	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2558	3	309	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2559	8	432	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2560	5	83	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2561	3	83	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2562	8	83	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2563	3	311	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2564	5	87	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2565	3	310	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2566	5	86	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2567	5	82	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2568	3	82	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2569	8	82	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2570	5	49	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2571	3	281	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2572	5	85	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2573	8	85	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2574	5	84	475	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2575	3	84	475	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11
2576	8	84	475	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11
2577	7	358	475	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11
2578	28	3	475	\N
2579	5	79	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2580	3	79	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2581	5	81	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2582	3	81	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2583	8	81	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2584	5	80	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2585	3	80	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2586	7	80	476	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10
2587	8	80	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2588	8	431	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2589	3	312	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2590	3	309	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2591	8	432	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2592	5	83	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2593	3	83	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2594	8	83	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2595	3	311	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2596	5	87	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2597	3	310	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2598	5	86	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2599	5	82	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2600	3	82	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2601	8	82	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2602	5	49	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2603	5	49	476	\N
2604	3	281	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2605	5	85	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2606	8	85	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2607	5	84	476	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10
2608	3	84	476	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10
2609	8	84	476	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10
2610	7	358	476	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10
2611	5	3	476	\N
2612	5	49	477	\N
2613	5	3	477	\N
2614	44	437	478	\N
2615	44	3	478	\N
2616	31	322	479	\N
2617	31	3	479	\N
2618	45	438	480	\N
2619	45	3	480	\N
2620	45	438	481	\N
2621	45	3	481	\N
2622	45	3	482	\N
2623	46	439	483	\N
2624	45	438	483	\N
2625	46	441	483	\N
2626	46	440	483	\N
2627	45	3	483	\N
2628	46	440	484	\N
2629	45	3	485	\N
2630	45	3	486	\N
2631	11	105	487	http://www.mycancergenome.org/content/disease/gist/pdgfra/48
2632	11	106	487	http://www.mycancergenome.org/content/disease/gist/pdgfra/48
2633	11	442	487	\N
2634	11	443	487	\N
2635	11	3	487	\N
2636	1	444	488	\N
2637	1	444	489	\N
2638	11	105	490	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
2639	11	106	490	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
2640	11	105	491	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
2641	11	106	491	http://www.mycancergenome.org/content/disease/gist/pdgfra/51
2642	11	3	492	\N
2643	1	444	493	\N
2644	11	110	494	\N
2645	11	3	494	\N
2646	11	442	495	\N
2647	11	443	495	\N
2648	11	110	495	\N
2649	11	3	495	\N
2650	11	3	496	\N
2651	11	3	497	\N
2652	11	105	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2653	11	445	498	\N
2654	11	106	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2655	11	108	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2656	11	108	498	\N
2657	11	442	498	\N
2658	11	109	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2659	11	107	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2660	11	110	498	http://www.mycancergenome.org/content/disease/gist/pdgfra/45
2661	11	110	498	\N
2662	11	3	498	\N
2663	11	3	499	\N
2664	1	444	500	\N
2665	11	106	501	\N
2666	11	3	501	\N
2667	1	444	502	\N
2668	28	3	503	\N
2669	12	327	504	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218
2670	12	326	504	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218
2671	1	446	505	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2672	1	447	506	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2673	1	448	506	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2674	1	447	507	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2675	1	448	507	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2676	12	328	508	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124
2677	1	328	508	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2678	12	326	508	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124
2679	1	326	508	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2680	12	329	508	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124
2681	11	3	509	\N
2682	11	3	510	\N
2683	1	449	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2684	1	450	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2685	1	451	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2686	1	452	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2687	1	334	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2688	1	453	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2689	1	454	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2690	1	455	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2691	1	456	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2692	1	457	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2693	1	458	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2694	1	459	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2695	1	460	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2696	1	461	511	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2697	1	449	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2698	1	450	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2699	1	451	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2700	12	330	512	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110
2701	1	452	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2702	1	334	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2703	1	453	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2704	1	454	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2705	1	455	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2706	1	456	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2707	1	457	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2708	1	458	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2709	1	459	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2710	1	460	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2711	1	461	512	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2712	12	326	512	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110
2713	1	462	513	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2714	1	462	514	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2715	11	101	515	\N
2716	22	463	515	\N
2717	11	100	515	\N
2718	11	99	515	\N
2719	22	3	515	\N
2720	1	3	516	\N
2721	1	449	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2722	1	450	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2723	1	451	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2724	1	452	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2725	1	464	517	\N
2726	1	465	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2727	11	101	517	\N
2728	1	334	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2729	1	334	517	\N
2730	1	455	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2731	1	456	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2732	1	457	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2733	1	458	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2734	1	459	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2735	11	100	517	\N
2736	1	460	517	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2737	11	99	517	\N
2738	1	3	517	\N
2739	1	449	518	\N
2740	1	450	518	\N
2741	1	451	518	\N
2742	12	330	518	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112
2743	1	452	518	\N
2744	1	465	518	\N
2745	1	334	518	\N
2746	1	455	518	\N
2747	1	456	518	\N
2748	1	457	518	\N
2749	1	458	518	\N
2750	12	331	518	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112
2751	1	466	518	\N
2752	1	459	518	\N
2753	1	460	518	\N
2754	12	326	518	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112
2755	1	467	518	\N
2756	1	3	518	\N
2757	11	468	519	\N
2758	1	447	519	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2759	1	448	519	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2760	11	3	519	\N
2761	12	333	520	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
2762	12	335	520	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
2763	12	334	520	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
2764	12	332	520	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123
2765	1	455	521	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2766	11	104	521	\N
2767	1	457	521	\N
2768	1	3	521	\N
2769	11	3	521	\N
2770	1	455	522	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2771	11	469	523	\N
2772	1	455	523	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2773	11	470	523	\N
2774	11	3	523	\N
2775	1	447	524	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2776	1	448	524	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2777	1	447	525	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2778	1	448	525	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2779	1	449	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2780	1	450	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2781	1	451	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2782	1	452	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2783	1	465	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2784	12	334	526	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
2785	1	334	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2786	1	334	526	\N
2787	12	336	526	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
2788	1	456	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2789	1	457	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2790	1	457	526	\N
2791	1	471	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2792	1	459	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2793	1	460	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2794	1	461	526	http://www.mycancergenome.org/content/disease/melanoma/kit/96
2795	12	326	526	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96
2796	1	3	526	\N
2797	12	337	527	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122
2798	1	449	528	\N
2799	1	450	528	\N
2800	1	451	528	\N
2801	11	472	528	\N
2802	1	452	528	\N
2803	1	465	528	\N
2804	1	334	528	\N
2805	11	473	528	\N
2806	1	454	528	\N
2807	1	456	528	\N
2808	1	474	528	\N
2809	1	459	528	\N
2810	11	3	528	\N
2811	1	475	529	\N
2812	11	445	530	\N
2813	11	108	530	\N
2814	11	102	530	\N
2815	11	101	530	\N
2816	11	476	530	\N
2817	11	100	530	\N
2818	1	477	530	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2819	1	475	530	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2820	11	99	530	\N
2821	11	3	530	\N
2822	1	447	531	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2823	1	448	531	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2824	1	447	532	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2825	1	448	532	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2826	1	478	533	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2827	11	479	534	\N
2828	11	445	534	\N
2829	11	108	534	\N
2830	11	101	534	\N
2831	11	100	534	\N
2832	11	99	534	\N
2833	11	103	534	\N
2834	11	3	534	\N
2835	12	332	535	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121
2836	1	449	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2837	1	450	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2838	1	451	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2839	1	452	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2840	1	480	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2841	11	104	536	\N
2842	11	481	536	\N
2843	1	459	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2844	1	460	536	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2845	11	3	536	\N
2846	11	452	537	\N
2847	11	469	537	\N
2848	1	482	537	\N
2849	11	104	537	\N
2850	2	104	537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274
2851	2	128	537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274
2852	11	3	537	\N
2853	2	104	538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276
2854	2	128	538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276
2855	47	483	539	\N
2856	47	484	539	\N
2857	11	101	539	\N
2858	47	485	539	\N
2859	2	158	539	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
2860	11	104	539	\N
2861	2	104	539	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
2862	11	100	539	\N
2863	2	121	539	\N
2864	11	99	539	\N
2865	2	128	539	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
2866	2	157	539	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275
2867	47	3	539	\N
2868	1	449	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2869	1	450	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2870	1	451	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2871	1	452	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2872	1	480	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2873	1	459	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2874	1	460	540	http://www.mycancergenome.org/content/disease/melanoma/kit/84
2875	1	486	541	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2876	1	459	541	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2877	1	487	541	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2878	48	324	542	\N
2879	12	339	543	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120
2880	12	338	543	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120
2881	12	326	543	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120
2882	11	101	544	\N
2883	1	466	544	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2884	11	100	544	\N
2885	11	99	544	\N
2886	11	445	545	\N
2887	11	339	545	\N
2888	1	459	545	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2889	1	475	545	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2890	2	159	545	\N
2891	11	3	545	\N
2892	11	445	546	\N
2893	11	339	546	\N
2894	1	459	546	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2895	1	475	546	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2896	2	159	546	\N
2897	11	3	546	\N
2898	11	101	547	\N
2899	11	100	547	\N
2900	11	99	547	\N
2901	1	457	548	\N
2902	1	390	548	\N
2903	1	3	548	\N
2904	11	101	549	\N
2905	11	100	549	\N
2906	11	99	549	\N
2907	1	99	549	http://www.mycancergenome.org/content/disease/melanoma/kit/132
2908	11	452	550	\N
2909	11	3	550	\N
2910	27	10	551	\N
2911	27	11	551	\N
2912	28	488	552	\N
2913	28	3	552	\N
2914	28	488	553	\N
2915	28	3	553	\N
2916	28	3	554	\N
2917	28	3	555	\N
2918	28	3	556	\N
2919	28	3	557	\N
2920	28	3	558	\N
2921	28	489	559	\N
2922	28	3	559	\N
2923	28	489	560	\N
2924	28	3	560	\N
2925	28	3	561	\N
2926	28	3	562	\N
2927	5	23	563	\N
2928	5	22	563	\N
2929	5	21	563	\N
2930	5	3	563	\N
2931	5	24	564	\N
2932	5	22	564	\N
2933	31	255	564	\N
2934	5	25	564	\N
2935	5	18	564	\N
2936	5	3	564	\N
2937	31	3	564	\N
2938	5	23	565	\N
2939	5	22	565	\N
2940	5	26	565	\N
2941	5	3	565	\N
2942	28	3	566	\N
2943	28	3	567	\N
2944	5	29	568	\N
2945	5	23	568	\N
2946	5	22	568	\N
2947	5	30	568	\N
2948	5	27	568	\N
2949	5	28	568	\N
2950	5	26	568	\N
2951	5	3	568	\N
2952	5	29	569	\N
2953	5	23	569	\N
2954	5	30	569	\N
2955	5	27	569	\N
2956	5	31	569	\N
2957	5	26	569	\N
2958	5	3	569	\N
2959	5	22	570	\N
2960	5	32	570	\N
2961	5	33	570	\N
2962	5	18	570	\N
2963	5	3	570	\N
2964	5	23	571	\N
2965	5	22	571	\N
2966	5	27	571	\N
2967	5	26	571	\N
2968	5	3	571	\N
2969	5	23	572	\N
2970	5	22	572	\N
2971	5	30	572	\N
2972	5	35	572	\N
2973	5	27	572	\N
2974	5	34	572	\N
2975	5	3	572	\N
2976	5	29	573	\N
2977	5	23	573	\N
2978	5	22	573	\N
2979	5	30	573	\N
2980	5	35	573	\N
2981	5	33	573	\N
2982	5	25	573	\N
2983	5	27	573	\N
2984	5	28	573	\N
2985	5	18	573	\N
2986	5	26	573	\N
2987	5	3	573	\N
2988	28	3	574	\N
2989	28	3	575	\N
2990	28	3	576	\N
2991	28	3	577	\N
2992	28	3	578	\N
2993	28	3	579	\N
2994	28	3	580	\N
2995	25	350	581	\N
2996	28	3	582	\N
2997	28	3	583	\N
2998	2	133	584	\N
2999	2	133	585	\N
3000	2	133	586	\N
3001	2	133	587	\N
3002	10	341	588	\N
3003	10	341	589	\N
3004	10	341	590	\N
3005	31	262	591	\N
3006	8	490	592	\N
3007	8	491	592	\N
3008	8	492	592	\N
3009	13	491	593	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3010	13	491	594	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3011	13	491	595	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3012	13	490	596	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3013	13	491	596	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3014	13	491	597	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3015	13	492	597	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3016	13	490	598	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3017	13	491	598	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3018	13	492	598	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3019	13	491	599	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3020	13	492	599	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3021	13	490	600	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3022	13	491	600	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3023	13	493	600	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3024	13	492	600	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/
3025	1	494	601	\N
3026	30	495	602	\N
3027	30	495	603	\N
3028	30	495	604	\N
3029	5	61	605	\N
3030	43	496	606	\N
3031	30	495	607	\N
3032	49	343	608	\N
3033	3	268	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3034	3	269	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3035	3	270	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3036	3	272	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3037	3	273	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3038	3	274	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3039	3	497	609	\N
3040	3	498	609	\N
3041	3	271	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3042	3	275	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3043	3	276	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3044	3	277	609	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3
3045	3	3	609	\N
3046	3	268	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3047	3	269	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3048	3	270	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3049	3	272	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3050	3	273	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3051	3	274	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3052	3	499	610	\N
3053	3	500	610	\N
3054	3	271	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3055	3	275	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3056	3	276	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3057	3	277	610	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2
3058	3	3	610	\N
3059	20	276	611	\N
3060	20	277	611	\N
3061	3	501	611	\N
3062	3	3	611	\N
3063	3	502	612	\N
3064	3	268	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3065	3	269	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3066	3	270	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3067	3	272	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3068	3	273	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3069	3	274	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3070	3	503	612	\N
3071	3	271	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3072	3	275	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3073	3	276	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3074	3	277	612	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1
3075	3	504	612	\N
3076	3	3	612	\N
3077	3	3	613	\N
3078	3	505	614	\N
3079	36	3	614	\N
3080	3	3	614	\N
3081	3	506	615	\N
3082	3	3	615	\N
3083	3	505	616	\N
3084	50	3	616	\N
3085	3	3	616	\N
3086	3	507	617	\N
3087	3	3	617	\N
3088	51	508	618	\N
3089	51	509	618	\N
3090	51	3	618	\N
3091	3	3	619	\N
3092	20	276	620	\N
3093	20	277	620	\N
3094	31	280	621	\N
3095	3	510	621	\N
3096	31	3	621	\N
3097	3	3	621	\N
3098	3	3	622	\N
3099	3	511	623	\N
3100	43	512	623	\N
3101	3	3	623	\N
3102	3	507	624	\N
3103	3	513	624	\N
3104	3	3	624	\N
3105	3	514	625	\N
3106	3	515	625	\N
3107	3	3	625	\N
3108	52	516	626	\N
3109	3	517	626	\N
3110	3	507	626	\N
3111	20	276	626	\N
3112	20	277	626	\N
3113	52	3	626	\N
3114	3	3	626	\N
3115	3	518	627	\N
3116	3	3	627	\N
3117	3	268	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3118	3	269	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3119	3	270	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3120	3	279	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3121	3	280	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3122	3	285	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3123	3	285	628	\N
3124	3	278	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3125	3	519	628	\N
3126	3	284	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3127	3	282	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3128	3	520	628	\N
3129	3	281	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3130	3	283	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3131	3	521	628	\N
3132	3	287	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3133	3	286	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3134	3	277	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3135	3	288	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3136	3	289	628	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4
3137	3	3	628	\N
3138	53	3	629	\N
3139	53	3	630	\N
3140	43	522	631	\N
3141	3	506	632	\N
3142	3	523	632	\N
3143	3	3	632	\N
3144	3	3	633	\N
3145	3	3	634	\N
3146	3	268	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3147	3	269	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3148	3	270	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3149	3	498	635	\N
3254	1	3	663	\N
3150	3	300	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3151	3	299	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3152	3	506	635	\N
3153	3	293	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3154	3	294	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3155	3	271	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3156	3	292	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3157	3	275	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3158	3	291	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3159	3	290	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3160	3	298	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3161	3	295	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3162	3	297	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3163	3	276	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3164	3	277	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3165	3	296	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3166	3	301	635	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5
3167	3	3	635	\N
3168	3	3	636	\N
3169	3	268	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3170	3	269	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3171	3	270	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3172	3	271	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3173	3	276	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3174	3	277	637	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6
3175	20	276	638	\N
3176	20	277	638	\N
3177	20	276	639	\N
3178	20	277	639	\N
3179	28	524	640	\N
3180	28	524	641	\N
3181	28	524	642	\N
3182	18	525	643	\N
3183	18	3	643	\N
3184	18	249	644	\N
3185	18	3	644	\N
3186	18	526	645	\N
3187	18	527	645	\N
3188	18	3	645	\N
3189	18	526	646	\N
3190	28	524	646	\N
3191	18	3	646	\N
3192	28	524	647	\N
3193	18	250	648	\N
3194	18	3	648	\N
3195	28	524	649	\N
3196	28	524	650	\N
3197	28	524	651	\N
3198	14	352	652	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163
3199	15	352	652	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163
3200	14	353	652	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163
3201	15	353	652	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163
3202	1	3	653	\N
3203	1	3	654	\N
3204	1	3	655	\N
3205	1	3	656	\N
3206	1	3	657	\N
3207	1	366	658	\N
3208	1	41	659	\N
3209	1	367	659	\N
3210	1	96	659	\N
3211	1	97	659	\N
3212	1	371	659	\N
3213	1	368	659	\N
3214	1	369	659	\N
3215	1	357	659	\N
3216	1	370	659	\N
3217	1	372	659	\N
3218	1	3	659	\N
3219	1	41	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3220	1	367	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3221	1	376	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3222	1	373	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3223	1	96	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3224	1	97	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3225	1	371	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3226	1	368	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3227	1	51	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3228	1	369	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3229	1	375	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3230	1	370	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3231	1	372	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3232	1	374	660	http://www.mycancergenome.org/content/disease/melanoma/braf/114
3233	1	528	660	\N
3234	1	3	660	\N
3235	1	97	661	\N
3236	54	46	661	\N
3237	1	529	661	\N
3238	1	530	661	\N
3239	1	531	661	\N
3240	1	3	661	\N
3241	54	3	661	\N
3242	1	41	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3243	1	367	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3244	1	96	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3245	1	97	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3246	1	371	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3247	1	368	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3248	1	51	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3249	1	369	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3250	1	375	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3251	1	370	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3252	1	372	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3253	1	374	662	http://www.mycancergenome.org/content/disease/melanoma/braf/115
3255	5	41	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3256	11	41	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3257	7	41	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3259	1	41	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3260	4	41	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3261	16	41	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3262	16	302	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3263	16	536	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3264	1	367	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3265	4	537	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3266	16	535	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3267	7	356	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3268	16	538	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3269	4	400	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3270	1	378	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3271	5	38	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3272	11	95	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3273	4	401	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3274	5	40	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3275	4	539	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3276	5	44	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3277	5	49	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3278	1	373	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3279	11	96	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3280	7	96	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3282	1	96	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3283	4	96	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3284	5	43	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3285	5	39	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3286	1	380	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3287	5	42	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3288	5	45	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3289	16	540	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3290	11	97	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3291	7	97	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3293	1	97	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3294	1	97	664	\N
3295	7	354	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3297	7	355	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3299	30	541	664	\N
3300	1	371	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3301	5	48	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3302	4	532	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3303	5	46	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3304	54	46	664	\N
3305	1	381	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3306	1	368	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3307	1	379	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3308	5	47	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3309	1	377	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3310	30	542	664	\N
3311	5	51	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3312	11	51	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3313	7	51	664	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54
3315	1	51	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3316	4	51	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3317	16	51	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3318	16	543	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3319	1	369	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3320	1	375	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3321	16	534	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3322	16	260	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3323	1	370	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3324	1	372	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3325	1	382	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3326	1	374	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3327	1	529	664	\N
3328	5	52	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3329	5	50	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3330	4	403	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3331	11	98	664	http://www.mycancergenome.org/content/disease/gist/braf/54
3332	4	544	664	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54
3333	16	533	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3334	5	53	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3335	46	545	664	\N
3336	1	383	664	http://www.mycancergenome.org/content/disease/melanoma/braf/54
3337	16	546	664	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54
3338	1	530	664	\N
3339	5	54	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3340	5	55	664	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54
3341	1	531	664	\N
3342	1	3	664	\N
3343	54	3	664	\N
3344	1	41	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3345	1	367	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3346	1	376	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3347	1	96	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3348	1	97	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3349	1	371	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3350	1	368	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3351	1	51	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3352	1	369	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3353	1	375	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3354	1	370	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3355	1	372	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3356	1	374	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3357	1	384	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3358	1	366	665	http://www.mycancergenome.org/content/disease/melanoma/braf/118
3359	1	528	665	\N
3360	1	3	665	\N
3361	1	41	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3362	1	367	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3363	1	373	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3364	1	373	666	\N
3365	1	96	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3366	1	97	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3367	1	371	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3368	1	368	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3369	1	377	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3370	1	51	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3371	1	369	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3372	1	375	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3373	1	370	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3374	1	372	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3375	1	530	666	\N
3376	1	531	666	\N
3377	1	3	666	\N
3378	1	494	666	http://www.mycancergenome.org/content/disease/melanoma/braf/116
3379	1	378	667	\N
3380	1	547	667	\N
3381	1	390	667	\N
3382	1	3	667	\N
3383	1	390	668	\N
3384	1	3	668	\N
3385	1	41	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3386	1	302	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3387	1	536	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3388	1	535	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3389	1	538	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3390	1	540	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3391	1	543	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3392	1	534	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3393	1	529	669	\N
3394	1	533	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3395	1	546	669	http://www.mycancergenome.org/content/disease/melanoma/braf/117
3396	1	3	669	\N
3397	1	3	670	\N
3398	7	41	671	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
3399	1	41	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3400	1	302	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3401	1	536	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3402	1	535	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3403	1	538	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3404	1	540	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3405	7	354	671	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
3406	7	355	671	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
3407	1	543	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3408	7	357	671	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138
3409	1	357	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3410	1	357	671	\N
3411	1	370	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3412	1	548	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3413	1	548	671	\N
3414	1	546	671	http://www.mycancergenome.org/content/disease/melanoma/braf/138
3415	1	3	671	\N
3416	1	549	672	\N
3417	1	41	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3418	1	302	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3419	1	536	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3420	1	535	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3421	1	538	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3422	1	540	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3423	1	543	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3424	1	357	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3425	1	357	672	\N
3426	1	370	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3427	1	548	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3428	1	546	672	http://www.mycancergenome.org/content/disease/melanoma/braf/188
3429	1	3	672	\N
3430	1	41	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3431	1	302	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3432	1	536	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3433	1	535	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3434	1	538	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3435	1	540	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3436	1	543	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3437	1	357	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3438	1	357	673	\N
3439	1	370	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3440	1	548	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3441	1	546	673	http://www.mycancergenome.org/content/disease/melanoma/braf/189
3442	1	3	673	\N
3443	1	41	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3444	16	41	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3445	1	302	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3446	16	302	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3447	1	536	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3448	16	536	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3449	1	535	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3450	16	535	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3451	1	538	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3452	16	538	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3453	1	540	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3454	16	540	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3455	1	543	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3456	16	543	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3457	1	357	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3458	16	357	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3459	1	370	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3460	1	548	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3461	1	546	674	http://www.mycancergenome.org/content/disease/melanoma/braf/73
3462	16	546	674	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73
3463	1	3	674	\N
3464	5	41	675	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150
3465	5	38	675	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150
3466	5	40	675	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150
3467	5	39	675	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150
3468	5	48	675	\N
3469	5	56	675	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150
3470	1	3	675	\N
3471	5	3	675	\N
3472	1	390	676	\N
3473	1	3	676	\N
3474	1	3	677	\N
3475	1	3	678	\N
3476	1	390	679	\N
3477	1	3	679	\N
3478	1	41	680	http://www.mycancergenome.org/content/disease/melanoma/braf/302
3479	1	367	680	http://www.mycancergenome.org/content/disease/melanoma/braf/302
3480	1	41	681	http://www.mycancergenome.org/content/disease/melanoma/braf/301
3481	1	367	681	http://www.mycancergenome.org/content/disease/melanoma/braf/301
3482	1	550	681	\N
3483	1	3	681	\N
3484	5	41	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3485	1	41	682	http://www.mycancergenome.org/content/disease/melanoma/braf/149
3486	5	59	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3487	5	57	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3488	1	367	682	http://www.mycancergenome.org/content/disease/melanoma/braf/149
3489	5	58	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3490	5	38	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3491	5	40	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3492	5	39	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3493	5	56	682	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149
3494	1	3	682	\N
3495	5	41	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3496	1	41	683	http://www.mycancergenome.org/content/disease/melanoma/braf/148
3497	1	367	683	http://www.mycancergenome.org/content/disease/melanoma/braf/148
3498	1	551	683	http://www.mycancergenome.org/content/disease/melanoma/braf/148
3499	1	551	683	\N
3500	5	38	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3501	5	40	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3502	5	49	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3503	5	49	683	\N
3504	5	39	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3505	5	56	683	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148
3506	1	3	683	\N
3507	5	3	683	\N
3508	1	552	684	\N
3509	1	41	685	http://www.mycancergenome.org/content/disease/melanoma/braf/300
3510	1	367	685	http://www.mycancergenome.org/content/disease/melanoma/braf/300
3511	1	41	686	http://www.mycancergenome.org/content/disease/melanoma/braf/298
3512	1	367	686	http://www.mycancergenome.org/content/disease/melanoma/braf/298
3513	1	41	687	http://www.mycancergenome.org/content/disease/melanoma/braf/299
3514	1	367	687	http://www.mycancergenome.org/content/disease/melanoma/braf/299
3515	1	553	687	http://www.mycancergenome.org/content/disease/melanoma/braf/299
3516	28	3	688	\N
3517	1	554	689	\N
3518	1	3	689	\N
3519	28	3	690	\N
3520	28	3	691	\N
3521	28	3	692	\N
3522	1	393	693	\N
3523	1	555	693	\N
3524	1	3	693	\N
3525	21	556	694	\N
3526	21	3	694	\N
3527	1	3	694	\N
3528	16	41	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3529	16	302	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3530	16	536	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3531	16	535	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3532	16	538	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3533	16	540	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3534	16	543	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3535	16	546	695	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209
3536	1	3	696	\N
3537	5	41	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3538	5	60	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3539	5	38	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3540	5	40	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3541	5	39	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3542	5	56	697	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147
3543	28	3	697	\N
3544	5	41	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3545	16	41	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3546	16	302	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3547	16	536	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3548	5	60	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3549	16	535	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3550	16	538	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3551	5	38	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3552	5	40	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3553	5	39	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3554	16	540	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3555	5	56	698	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71
3556	16	543	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3557	31	260	698	\N
3558	31	260	698	\N
3559	16	546	698	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71
3560	31	3	698	\N
3561	5	41	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3562	5	60	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3563	1	551	699	\N
3564	1	551	699	\N
3565	5	38	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3566	5	40	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3567	5	39	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3568	5	56	699	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146
3569	1	3	699	\N
3570	16	41	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3571	16	302	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3572	16	536	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3573	16	535	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3574	16	538	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3575	16	540	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3576	16	543	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3577	16	546	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3578	16	557	700	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310
3579	1	558	701	\N
3580	1	3	701	\N
3581	1	3	702	\N
3582	1	3	703	\N
3583	5	41	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3584	16	41	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3585	16	302	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3586	16	536	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3587	5	60	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3588	16	535	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3589	16	538	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3590	5	38	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3591	5	40	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3592	5	39	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3593	16	540	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3594	5	56	704	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70
3595	16	543	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3596	3	543	704	\N
3597	16	546	704	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70
3598	3	3	704	\N
3599	1	3	705	\N
3600	1	559	706	\N
3601	1	3	706	\N
3602	7	3	707	\N
3603	8	41	708	\N
3604	8	560	708	\N
3605	8	3	708	\N
3606	55	306	709	\N
3607	55	3	709	\N
3608	1	404	710	\N
3609	1	3	710	\N
3610	1	306	711	\N
3611	1	3	711	\N
3612	35	561	712	\N
3613	35	561	713	\N
3614	35	562	713	\N
3615	35	561	714	\N
3616	35	561	715	\N
3617	35	561	716	\N
3618	28	3	717	\N
3619	28	3	718	\N
3620	28	3	719	\N
3621	28	3	720	\N
3622	28	3	721	\N
3623	28	3	722	\N
3624	28	3	723	\N
3625	28	3	724	\N
3626	24	563	725	\N
3627	2	154	725	\N
3628	2	155	725	\N
3629	2	153	725	\N
3630	2	152	725	\N
3631	2	151	725	\N
3632	2	156	725	\N
3633	2	150	725	\N
3634	2	149	725	\N
3635	2	148	725	\N
3636	2	147	725	\N
3637	2	146	725	\N
3638	24	246	725	\N
3639	24	3	725	\N
3640	27	17	726	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200
3641	27	13	726	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200
3642	27	16	726	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200
3643	27	11	726	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200
3644	27	17	727	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203
3645	27	13	727	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203
3646	27	16	727	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203
3647	27	11	727	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203
3648	27	17	728	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
3649	27	13	728	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
3650	27	16	728	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
3651	27	11	728	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202
3652	27	17	729	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
3653	27	13	729	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
3654	27	16	729	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
3655	27	11	729	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201
3656	1	3	730	\N
3657	28	3	731	\N
3658	28	3	732	\N
3659	28	3	733	\N
3660	28	3	734	\N
3661	28	3	735	\N
3662	28	3	736	\N
3663	1	564	737	\N
3664	1	3	737	\N
3665	28	3	738	\N
3666	28	3	739	\N
3667	28	3	740	\N
3668	1	565	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3669	1	568	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3670	1	569	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3671	1	570	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3672	1	571	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3673	1	572	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3674	1	567	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3675	1	566	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3676	56	566	741	\N
3677	1	573	741	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100
3678	56	3	741	\N
3679	1	565	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3680	1	568	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3681	1	569	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3682	1	570	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3683	1	571	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3684	1	572	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3685	1	567	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3686	1	566	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3687	1	573	742	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103
3688	1	565	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3689	1	568	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3690	1	569	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3691	1	570	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3692	1	571	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3693	1	572	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3694	1	567	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3695	1	566	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3696	56	566	743	\N
3697	1	573	743	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102
3698	56	3	743	\N
3699	56	3	744	\N
3700	21	210	745	\N
3701	27	494	745	\N
3702	27	494	746	\N
3703	21	190	747	\N
3704	21	189	747	\N
3705	21	188	747	\N
3706	21	187	747	\N
3707	21	186	747	\N
3708	21	185	747	\N
3709	21	184	747	\N
3710	21	183	747	\N
3711	21	3	747	\N
3712	21	188	748	\N
3713	21	191	748	\N
3714	21	193	748	\N
3715	21	186	748	\N
3716	21	192	748	\N
3717	21	3	748	\N
3718	21	195	749	\N
3719	21	188	749	\N
3720	21	186	749	\N
3721	21	194	749	\N
3722	21	184	749	\N
3723	21	196	749	\N
3724	21	183	749	\N
3725	21	3	749	\N
3726	21	190	750	\N
3727	21	188	750	\N
3728	21	197	750	\N
3729	21	186	750	\N
3730	21	198	750	\N
3731	21	3	750	\N
3732	21	188	751	\N
3733	21	197	751	\N
3734	21	3	751	\N
3735	27	2	752	\N
3736	21	195	752	\N
3737	21	190	752	\N
3738	21	203	752	\N
3739	21	202	752	\N
3740	21	197	752	\N
3741	21	201	752	\N
3742	27	1	752	\N
3743	21	200	752	\N
3744	21	199	752	\N
3745	21	186	752	\N
3746	21	205	752	\N
3747	21	194	752	\N
3748	21	210	752	\N
3749	21	184	752	\N
3750	21	183	752	\N
3751	21	204	752	\N
3752	27	3	752	\N
3753	21	3	752	\N
3754	27	494	752	\N
3755	21	190	753	\N
3756	21	188	753	\N
3757	21	186	753	\N
3758	21	3	753	\N
3759	21	211	754	\N
3760	21	212	754	\N
3761	21	2	754	\N
3762	21	4	754	\N
3763	21	195	754	\N
3764	21	190	754	\N
3765	21	188	754	\N
3766	21	202	754	\N
3767	21	209	754	\N
3768	21	214	754	\N
3769	21	213	754	\N
3770	21	210	754	\N
3771	21	206	754	\N
3772	21	208	754	\N
3773	21	183	754	\N
3774	21	207	754	\N
3775	21	3	754	\N
3776	21	215	755	\N
3777	21	2	755	\N
3778	21	190	755	\N
3779	21	188	755	\N
3780	21	202	755	\N
3781	21	217	755	\N
3782	21	216	755	\N
3783	21	183	755	\N
3784	21	207	755	\N
3785	21	3	755	\N
3786	21	202	756	\N
3787	21	218	756	\N
3788	21	184	756	\N
3789	21	204	756	\N
3790	21	3	756	\N
3791	21	210	757	\N
3792	27	494	757	\N
3793	21	210	758	\N
3794	27	494	758	\N
3795	21	211	759	\N
3796	21	2	759	\N
3797	27	4	759	\N
3798	21	195	759	\N
3799	21	225	759	\N
3800	21	190	759	\N
3801	21	188	759	\N
3802	21	202	759	\N
3803	21	186	759	\N
3804	21	223	759	\N
3805	21	224	759	\N
3806	21	210	759	\N
3807	21	222	759	\N
3808	21	226	759	\N
3809	21	184	759	\N
3810	21	221	759	\N
3811	27	5	759	\N
3812	21	196	759	\N
3813	21	220	759	\N
3814	21	219	759	\N
3815	21	183	759	\N
3816	21	207	759	\N
3817	27	3	759	\N
3818	21	3	759	\N
3819	21	210	760	\N
3820	27	494	760	\N
3821	21	210	761	\N
3822	27	494	761	\N
3823	21	210	762	\N
3824	27	494	762	\N
3825	21	188	763	\N
3826	21	228	763	\N
3827	21	229	763	\N
3828	21	186	763	\N
3829	21	227	763	\N
3830	21	210	763	\N
3831	21	184	763	\N
3832	21	3	763	\N
3833	27	494	763	\N
3834	21	195	764	\N
3835	21	188	764	\N
3836	21	186	764	\N
3837	21	227	764	\N
3838	21	210	764	\N
3839	21	230	764	\N
3840	21	183	764	\N
3841	21	3	764	\N
3842	27	494	764	\N
3843	21	195	765	\N
3844	21	225	765	\N
3845	21	190	765	\N
3846	21	188	765	\N
3847	21	235	765	\N
3848	21	202	765	\N
3849	21	201	765	\N
3850	21	236	765	\N
3851	21	232	765	\N
3852	21	231	765	\N
3853	21	234	765	\N
3854	21	233	765	\N
3855	21	220	765	\N
3856	21	183	765	\N
3857	21	3	765	\N
3858	21	190	766	\N
3859	21	188	766	\N
3860	21	235	766	\N
3861	21	238	766	\N
3862	21	237	766	\N
3863	21	183	766	\N
3864	21	204	766	\N
3865	21	3	766	\N
3866	21	210	767	\N
3867	27	494	767	\N
3868	21	210	768	\N
3869	27	494	768	\N
3870	21	188	769	\N
3871	21	202	769	\N
3872	21	231	769	\N
3873	21	186	769	\N
3874	21	210	769	\N
3875	21	184	769	\N
3876	21	240	769	\N
3877	21	183	769	\N
3878	21	239	769	\N
3879	21	3	769	\N
3880	21	210	770	\N
3881	27	494	770	\N
3882	21	190	771	\N
3883	21	188	771	\N
3884	21	202	771	\N
3885	21	241	771	\N
3886	21	227	771	\N
3887	21	183	771	\N
3888	21	3	771	\N
3889	57	3	772	\N
3890	57	3	773	\N
3891	57	3	774	\N
3892	57	574	775	\N
3893	57	3	775	\N
3894	28	3	776	\N
3895	4	575	777	\N
3896	57	578	777	\N
3897	4	576	777	\N
3898	4	579	777	\N
3899	4	577	777	\N
3900	57	3	777	\N
3901	28	3	778	\N
3902	57	574	779	\N
3903	57	3	779	\N
3904	57	3	780	\N
3905	4	580	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3906	57	581	781	\N
3907	4	537	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3908	4	400	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3909	4	575	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3910	4	539	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3911	4	582	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3912	4	583	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3913	4	576	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3914	4	579	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3915	4	577	781	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128
3916	57	3	781	\N
3917	7	318	782	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
3918	7	359	782	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
3919	7	317	782	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145
3920	44	437	782	\N
3921	44	3	782	\N
3922	30	584	783	\N
3923	7	318	783	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
3924	7	359	783	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
3925	7	317	783	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137
3926	30	3	783	\N
3927	7	318	784	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
3928	7	359	784	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
3929	7	317	784	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144
3930	28	3	784	\N
3931	8	316	785	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
3932	8	318	785	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
3933	5	79	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3934	5	81	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3935	5	80	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3936	5	83	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3937	5	87	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3938	5	86	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3939	8	317	785	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
3940	5	82	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3941	8	82	785	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24
3942	5	49	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3943	5	85	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3944	5	84	785	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24
3945	30	3	786	\N
3946	30	585	787	\N
3947	30	3	787	\N
3948	3	314	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3949	3	316	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3950	8	316	788	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
3951	3	318	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3952	8	318	788	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
3953	5	79	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3954	5	81	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3955	5	80	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3956	5	83	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3957	3	319	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3958	5	87	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3959	5	86	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3960	3	313	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3961	3	317	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3962	8	317	788	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
3963	5	82	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3964	8	82	788	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25
3965	5	49	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3966	3	315	788	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25
3967	5	85	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3968	5	84	788	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25
3969	28	3	789	\N
4580	60	3	894	\N
4581	60	3	895	\N
3970	8	316	790	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
3971	8	318	790	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
3972	5	79	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3973	5	81	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3974	5	80	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3975	5	83	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3976	5	87	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3977	5	86	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3978	8	317	790	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
3979	5	82	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3980	8	82	790	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26
3981	5	49	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3982	5	85	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3983	5	84	790	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26
3984	30	3	791	\N
3985	49	344	792	\N
3986	37	3	793	\N
3987	49	344	794	\N
3988	49	344	795	\N
3989	49	344	796	\N
3990	49	345	797	\N
3991	49	346	797	\N
3992	49	347	797	\N
3993	49	344	797	\N
3994	49	345	798	\N
3995	49	346	798	\N
3996	49	347	798	\N
3997	49	344	798	\N
3998	49	344	799	\N
3999	49	344	800	\N
4000	49	344	801	\N
4001	49	344	802	\N
4002	49	344	803	\N
4003	49	344	804	\N
4004	49	344	805	\N
4005	49	344	806	\N
4006	37	3	807	\N
4007	37	586	808	\N
4008	37	3	808	\N
4009	37	586	809	\N
4010	37	3	809	\N
4011	20	322	810	\N
4012	37	345	811	\N
4013	37	3	811	\N
4014	20	322	812	\N
4015	43	322	813	\N
4016	49	345	814	\N
4017	37	345	814	\N
4018	37	586	814	\N
4019	49	346	814	\N
4020	49	347	814	\N
4021	37	3	814	\N
4022	28	3	815	\N
4023	28	3	816	\N
4024	28	3	817	\N
4025	28	3	818	\N
4026	58	587	819	\N
4027	58	588	819	\N
4028	58	3	819	\N
4029	4	399	820	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
4030	4	400	820	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
4031	4	401	820	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
4032	4	403	820	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307
4033	28	3	820	\N
4034	28	3	821	\N
4035	8	3	822	\N
4036	12	589	823	\N
4037	12	3	823	\N
4038	4	399	824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
4039	4	400	824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
4040	4	401	824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
4041	4	403	824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305
4042	28	3	824	\N
4043	4	399	825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
4044	4	400	825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
4045	4	401	825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
4046	4	403	825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306
4047	4	3	825	\N
4048	28	3	826	\N
4049	4	399	827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
4050	4	400	827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
4051	4	401	827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
4052	4	403	827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304
4053	1	3	827	\N
4054	8	3	828	\N
4055	45	3	829	\N
4056	5	590	830	\N
4057	4	399	830	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
4058	4	400	830	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
4059	4	401	830	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
4060	4	403	830	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303
4061	5	3	830	\N
4062	2	180	831	\N
4063	2	179	831	\N
4064	2	178	831	\N
4065	2	166	831	\N
4066	2	177	831	\N
4067	2	176	831	\N
4068	25	349	832	\N
4069	25	349	833	\N
4070	5	64	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4071	5	68	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4072	5	62	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4073	5	65	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4074	4	400	834	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
4075	5	63	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4076	4	401	834	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
4077	5	69	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4078	5	67	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4079	5	66	834	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29
4080	4	403	834	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29
4081	5	64	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4082	5	68	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4083	5	62	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4084	5	65	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4085	5	63	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4086	5	69	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4087	5	67	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4088	5	66	835	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27
4089	5	64	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4090	5	68	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4091	5	62	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4092	5	65	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4093	5	63	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4094	5	69	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4095	5	67	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4096	5	66	836	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28
4097	5	591	836	\N
4098	5	3	836	\N
4099	5	64	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4100	5	68	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4101	5	62	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4102	5	65	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4103	5	63	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4104	5	69	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4105	5	67	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4106	5	66	837	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161
4107	5	64	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4108	5	68	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4109	5	62	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4110	5	65	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4111	5	63	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4112	5	69	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4113	5	67	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4114	5	66	838	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160
4115	2	163	839	\N
4116	2	164	839	\N
4117	3	302	839	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
4118	5	64	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4119	2	162	839	\N
4120	5	68	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4121	5	62	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4122	3	303	839	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31
4123	2	161	839	\N
4124	5	65	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4125	5	63	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4126	5	69	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4127	5	67	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4128	5	66	839	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31
4129	2	160	839	\N
4130	5	592	839	\N
4131	5	50	839	\N
4132	5	3	839	\N
4133	2	163	840	\N
4134	2	164	840	\N
4135	3	302	840	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
4136	5	64	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4137	2	162	840	\N
4138	5	68	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4139	5	62	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4140	3	303	840	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30
4141	2	161	840	\N
4142	5	65	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4143	5	63	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4144	5	69	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4145	5	67	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4146	5	66	840	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30
4147	2	160	840	\N
4148	5	592	840	\N
4149	5	50	840	\N
4150	5	3	840	\N
4151	3	302	841	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
4152	5	64	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4153	5	68	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4154	4	399	841	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
4155	5	62	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4156	3	303	841	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42
4157	5	65	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4158	4	400	841	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
4159	5	63	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4160	4	401	841	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
4161	5	49	841	\N
4162	5	69	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4163	5	67	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4164	5	66	841	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42
4165	4	403	841	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42
4166	5	3	841	\N
4167	3	302	842	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
4168	5	64	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4169	5	68	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4170	4	399	842	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
4171	5	62	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4172	3	303	842	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43
4173	5	65	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4174	4	400	842	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
4175	5	63	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4176	4	401	842	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
4177	5	69	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4178	5	67	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4179	5	66	842	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43
4180	4	403	842	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43
4181	5	3	842	\N
4182	4	399	843	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
4183	4	400	843	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
4184	4	401	843	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
4185	4	403	843	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308
4186	5	3	843	\N
4187	5	3	844	\N
4188	3	302	845	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
4189	5	64	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4190	5	68	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4191	4	399	845	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
4192	5	62	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4193	3	303	845	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41
4194	5	65	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4195	4	400	845	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
4196	5	63	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4197	4	401	845	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
4198	5	69	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4199	5	67	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4200	5	66	845	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41
4201	4	403	845	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41
4202	5	3	845	\N
4203	5	591	846	\N
4204	5	3	846	\N
4205	5	3	847	\N
4206	59	593	848	\N
4207	59	3	848	\N
4208	59	593	849	\N
4209	59	3	849	\N
4210	5	64	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4211	5	68	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4212	5	62	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4213	5	65	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4214	5	63	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4215	5	69	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4216	5	67	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4217	5	66	850	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159
4218	4	594	850	\N
4219	5	3	850	\N
4220	4	3	850	\N
4221	3	302	851	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
4222	5	64	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4223	5	68	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4224	5	62	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4225	3	303	851	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68
4226	5	65	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4227	5	63	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4228	5	69	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4229	5	67	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4230	5	66	851	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68
4231	5	3	851	\N
4232	2	163	852	\N
4233	2	164	852	\N
4234	3	302	852	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
4235	5	64	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4236	2	162	852	\N
4237	5	68	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4238	4	399	852	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
4239	5	62	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4240	3	303	852	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39
4241	7	356	852	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
4242	2	161	852	\N
4243	5	65	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4244	4	400	852	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
4245	5	63	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4246	4	401	852	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
4247	5	69	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4248	5	67	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4249	5	71	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4250	5	66	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4251	5	591	852	\N
4252	7	355	852	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39
4253	5	72	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4254	2	160	852	\N
4255	5	70	852	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39
4256	5	70	852	\N
4257	5	595	852	\N
4258	4	403	852	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39
4259	5	596	852	\N
4260	5	3	852	\N
4261	3	302	853	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38
4262	5	64	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4263	5	68	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4264	5	62	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4265	3	303	853	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38
4266	5	65	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4267	5	63	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4268	5	69	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4269	5	67	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4270	5	66	853	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38
4271	5	3	853	\N
4272	3	302	854	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40
4273	5	64	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4274	5	68	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4275	4	399	854	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
4276	5	62	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4277	3	303	854	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40
4278	5	65	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4279	4	400	854	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
4280	5	63	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4281	4	401	854	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
4282	5	69	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4283	5	67	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4284	5	66	854	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40
4285	4	403	854	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40
4286	5	3	854	\N
4287	3	302	855	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69
4288	5	64	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4289	5	68	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4290	4	399	855	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
4291	5	62	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4292	3	303	855	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69
4293	5	65	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4294	4	400	855	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
4295	5	63	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4296	4	401	855	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
4297	5	69	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4298	5	67	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4299	5	66	855	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69
4300	4	403	855	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69
4301	5	3	855	\N
4302	2	163	856	\N
4303	2	164	856	\N
4304	5	64	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4305	2	162	856	\N
4306	5	68	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4307	4	399	856	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37
4308	5	62	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4309	7	356	856	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37
4310	2	161	856	\N
4311	5	65	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4312	4	400	856	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37
4313	5	63	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4314	4	401	856	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37
4315	5	597	856	\N
4316	5	69	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4317	5	67	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4318	5	66	856	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37
4319	3	591	856	\N
4320	5	591	856	\N
4321	7	355	856	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37
4322	3	598	856	\N
4323	2	160	856	\N
4324	5	70	856	\N
4325	3	599	856	\N
4582	60	609	895	\N
4583	28	3	896	\N
4326	4	403	856	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37
4327	3	3	856	\N
4328	5	3	856	\N
4329	3	302	857	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32
4330	5	64	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4331	5	68	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4332	5	62	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4333	3	303	857	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32
4334	7	356	857	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32
4335	5	65	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4336	5	63	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4337	5	69	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4338	5	67	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4339	5	66	857	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32
4340	7	355	857	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32
4341	11	600	857	\N
4342	5	595	857	\N
4343	11	3	857	\N
4344	5	3	857	\N
4345	2	163	858	\N
4346	2	164	858	\N
4347	3	302	858	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
4348	5	64	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4349	2	162	858	\N
4350	5	68	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4351	4	399	858	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
4352	5	62	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4353	3	303	858	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34
4354	7	356	858	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34
4355	16	311	858	\N
4356	2	161	858	\N
4357	5	65	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4358	4	400	858	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
4359	5	63	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4360	4	401	858	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
4361	5	69	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4362	5	67	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4363	5	66	858	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34
4364	7	355	858	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34
4365	2	160	858	\N
4366	4	403	858	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34
4367	16	601	858	\N
4368	16	3	858	\N
4369	3	302	859	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
4370	5	64	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4371	5	68	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4372	4	399	859	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
4373	5	62	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4374	3	303	859	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33
4375	7	356	859	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
4376	5	65	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4377	4	400	859	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
4378	5	63	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4379	4	401	859	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
4380	5	69	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4381	5	67	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4382	5	66	859	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33
4383	7	355	859	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33
4384	5	595	859	\N
4385	4	403	859	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33
4386	31	601	859	\N
4387	5	3	859	\N
4388	31	3	859	\N
4389	3	302	860	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35
4390	5	64	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4391	5	68	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4392	4	399	860	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
4393	5	62	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4394	3	303	860	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35
4395	7	356	860	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35
4396	5	65	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4397	4	400	860	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
4398	5	63	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4399	4	401	860	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
4400	5	69	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4401	5	67	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4402	5	66	860	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35
4403	7	355	860	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35
4404	5	592	860	\N
4405	5	595	860	\N
4406	4	403	860	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35
4407	5	3	860	\N
4408	3	302	861	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
4409	5	64	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4410	5	68	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4411	4	399	861	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
4412	5	62	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4413	3	602	861	\N
4414	3	303	861	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36
4415	5	65	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4416	4	400	861	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
4417	5	63	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4418	4	401	861	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
4419	5	69	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4420	5	67	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4421	5	66	861	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36
4422	4	403	861	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36
4423	3	3	861	\N
4424	28	364	862	\N
4425	54	364	863	\N
4426	29	364	863	\N
4427	28	364	864	\N
4428	1	3	865	\N
4429	2	121	866	\N
4430	2	122	866	\N
4431	2	123	866	\N
4432	2	121	867	\N
4433	2	122	867	\N
4434	2	123	867	\N
4435	2	124	868	\N
4436	2	16	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4437	2	129	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4438	2	125	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4439	2	127	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4440	2	128	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4441	2	126	869	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290
4442	2	3	869	\N
4443	2	3	870	\N
4444	2	16	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4445	2	129	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4446	2	125	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4447	2	127	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4448	2	128	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4449	2	126	871	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284
4450	2	132	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4451	2	131	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4452	2	131	872	\N
4453	2	603	872	\N
4454	2	135	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4455	2	133	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4456	2	134	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4457	2	16	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4458	2	130	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4459	2	121	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4460	2	125	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4461	2	127	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4462	2	122	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4463	2	128	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4464	2	126	872	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283
4465	2	3	872	\N
4466	2	132	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4467	2	131	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4468	2	131	873	\N
4469	2	603	873	\N
4470	2	135	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4471	2	133	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4472	2	134	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4473	2	16	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4474	2	130	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4475	2	121	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4476	2	125	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4477	2	127	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4478	2	122	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4479	2	128	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4480	2	126	873	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288
4481	2	3	873	\N
4482	2	3	874	\N
4483	2	132	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4484	2	604	875	\N
4485	2	131	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4486	2	135	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4487	2	605	875	\N
4488	2	133	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4489	2	134	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4490	2	16	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4584	60	3	897	\N
4585	61	3	898	\N
4491	2	130	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4492	2	121	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4493	2	121	875	\N
4494	2	125	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4495	2	127	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4496	2	122	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4497	2	128	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4498	2	126	875	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282
4499	2	606	875	\N
4500	2	3	875	\N
4501	2	135	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4502	2	134	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4503	2	16	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4504	2	130	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4505	2	121	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4506	2	125	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4507	2	127	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4508	2	122	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4509	2	128	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4510	2	126	876	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281
4511	2	121	877	\N
4512	2	132	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4513	2	131	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4514	2	135	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4515	2	607	878	\N
4516	2	133	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4517	2	134	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4518	2	16	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4519	2	130	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4520	2	121	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4521	2	121	878	\N
4522	2	125	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4523	2	127	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4524	2	122	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4525	2	128	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4526	2	126	878	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280
4527	2	3	878	\N
4528	2	132	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4529	2	604	879	\N
4530	2	131	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4531	2	135	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4532	2	608	879	\N
4533	2	134	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4534	2	16	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4535	2	121	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4536	2	125	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4537	2	127	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4538	2	122	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4539	2	128	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4540	2	126	879	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278
4541	2	606	879	\N
4542	2	3	879	\N
4543	2	132	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4544	2	131	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4545	2	135	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4546	2	134	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4547	2	16	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4548	2	121	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4549	2	136	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4550	2	125	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4551	2	127	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4552	2	122	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4553	2	128	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4554	2	126	880	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279
4555	2	121	881	\N
4556	2	121	882	\N
4557	2	121	883	\N
4558	2	122	883	\N
4559	2	123	883	\N
4560	2	137	884	\N
4561	2	123	884	\N
4562	2	137	885	\N
4563	2	123	885	\N
4564	2	121	886	\N
4565	2	122	886	\N
4566	2	123	886	\N
4567	2	121	887	\N
4568	2	122	887	\N
4569	2	123	887	\N
4570	2	121	888	\N
4571	2	122	888	\N
4572	2	123	888	\N
4573	2	3	889	\N
4574	28	3	890	\N
4575	60	3	891	\N
4576	60	3	892	\N
4577	60	609	892	\N
4578	60	3	893	\N
4579	60	609	893	\N
4586	28	3	899	\N
4587	1	365	900	\N
4588	5	20	901	\N
4589	5	20	901	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23
4590	3	20	901	\N
4591	3	20	901	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
4592	8	20	901	\N
4593	8	20	901	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23
4594	3	267	901	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
4595	5	37	901	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23
4596	3	265	901	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
4597	3	266	901	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23
4598	8	611	901	\N
4599	8	612	901	\N
4600	49	342	901	\N
4601	5	36	901	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23
4602	8	82	901	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23
4603	8	610	901	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23
4604	8	613	901	\N
4605	8	560	901	\N
4606	50	614	901	\N
4607	8	615	901	\N
4608	50	616	901	\N
4609	31	254	901	\N
4610	8	617	901	\N
4611	62	323	901	\N
4612	5	18	901	\N
4613	3	263	901	\N
4614	5	19	901	\N
4615	63	325	901	\N
4616	61	245	901	\N
4617	5	3	901	\N
4618	61	3	901	\N
4619	31	3	901	\N
4620	3	3	901	\N
4621	62	3	901	\N
4622	63	3	901	\N
4623	49	3	901	\N
4624	8	3	901	\N
4625	50	3	901	\N
4626	7	494	901	\N
4627	8	618	902	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242
4628	8	619	902	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242
4629	8	619	903	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246
4630	8	619	904	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239
4631	1	620	905	http://www.mycancergenome.org/content/disease/melanoma/mek1/210
4632	3	305	906	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74
4633	3	304	906	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74
4634	1	621	906	\N
4635	1	390	906	\N
4636	3	3	906	\N
4637	1	390	907	\N
4638	1	622	908	\N
4639	31	3	908	\N
4640	3	304	909	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72
4641	1	622	909	\N
4642	31	3	909	\N
4643	3	306	910	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
4644	3	304	910	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60
4645	1	390	910	\N
4646	1	3	910	\N
4647	28	621	911	\N
4648	28	621	912	\N
4649	28	383	912	\N
4650	28	621	913	\N
4651	1	620	914	http://www.mycancergenome.org/content/disease/melanoma/mek1/211
4652	1	623	914	http://www.mycancergenome.org/content/disease/melanoma/mek1/211
4653	28	621	915	\N
4654	28	621	916	\N
4655	28	621	917	\N
4656	31	3	918	\N
4657	1	624	919	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
4658	1	620	919	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
4659	1	623	919	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
4660	1	625	919	http://www.mycancergenome.org/content/disease/melanoma/mek1/212
4661	31	3	919	\N
4662	1	620	920	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
4663	1	623	920	http://www.mycancergenome.org/content/disease/melanoma/mek1/214
4664	1	621	921	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
4665	1	626	921	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
4666	1	620	921	http://www.mycancergenome.org/content/disease/melanoma/mek1/213
4667	1	3	921	\N
4668	1	621	922	\N
4669	1	621	923	\N
4670	1	383	923	\N
4671	1	621	924	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
4672	1	620	924	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
4673	1	390	924	http://www.mycancergenome.org/content/disease/melanoma/mek1/215
4674	28	621	925	\N
4675	28	621	926	\N
4676	28	383	926	\N
4677	1	620	927	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
4678	1	627	927	http://www.mycancergenome.org/content/disease/melanoma/mek1/216
4679	1	620	928	http://www.mycancergenome.org/content/disease/melanoma/mek1/217
4680	2	112	929	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
4681	2	140	929	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
4682	2	116	929	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
4683	2	118	929	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272
4684	2	112	930	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271
4685	2	140	930	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271
4686	2	116	930	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271
4687	2	142	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4688	2	628	931	\N
4689	2	112	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4690	2	141	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4691	2	140	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4899	2	167	1008	\N
4900	2	166	1008	\N
4692	2	143	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4693	2	118	931	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270
4694	2	3	931	\N
4695	2	112	932	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268
4696	2	140	932	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268
4697	2	142	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4698	2	112	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4699	2	141	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4700	2	629	933	\N
4701	2	144	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4702	2	143	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4703	2	118	933	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266
4704	2	3	933	\N
4705	2	112	934	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
4706	2	140	934	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
4707	2	116	934	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267
4708	55	630	935	\N
4709	55	630	936	\N
4710	55	630	937	\N
4711	5	3	938	\N
4712	43	3	938	\N
4713	2	173	939	\N
4714	2	172	939	\N
4715	2	171	939	\N
4716	28	3	939	\N
4717	41	631	940	\N
4718	2	173	940	\N
4719	2	172	940	\N
4720	2	171	940	\N
4721	41	3	940	\N
4722	28	3	940	\N
4723	2	173	941	\N
4724	2	172	941	\N
4725	2	171	941	\N
4726	2	173	942	\N
4727	2	172	942	\N
4728	2	171	942	\N
4729	41	631	943	\N
4730	2	173	943	\N
4731	2	172	943	\N
4732	2	171	943	\N
4733	28	632	943	\N
4734	28	3	943	\N
4735	41	3	943	\N
4736	2	633	944	\N
4737	2	3	944	\N
4738	28	3	944	\N
4739	28	634	945	\N
4740	28	3	945	\N
4741	2	173	946	\N
4742	2	172	946	\N
4743	2	171	946	\N
4744	28	635	947	\N
4745	28	636	947	\N
4746	28	3	947	\N
4747	2	173	948	\N
4748	2	172	948	\N
4749	2	171	948	\N
4750	2	173	949	\N
4751	2	172	949	\N
4752	2	171	949	\N
4753	31	261	950	\N
4754	8	619	951	\N
4755	28	261	952	\N
4756	28	261	953	\N
4757	8	619	954	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/
4758	8	637	955	\N
4759	8	638	955	\N
4760	8	3	955	\N
4761	8	618	956	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240
4762	8	619	956	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240
4763	8	619	956	\N
4764	8	3	956	\N
4765	8	618	957	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241
4766	8	619	957	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241
4767	8	619	957	\N
4768	28	3	958	\N
4769	8	3	959	\N
4770	8	638	960	\N
4771	8	639	960	\N
4772	8	3	960	\N
4773	8	618	961	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247
4774	8	638	961	\N
4775	8	619	961	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247
4776	8	639	961	\N
4777	8	3	961	\N
4778	8	619	962	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/
4779	8	3	963	\N
4780	8	618	964	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
4781	8	618	964	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
4782	8	619	964	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
4783	8	619	964	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244
4784	8	618	965	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
4785	8	619	965	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245
4786	5	91	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4787	5	92	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4788	5	89	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4789	5	94	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4790	5	90	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4791	5	88	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4792	5	93	966	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151
4793	5	91	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4794	5	92	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4795	5	89	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4796	5	94	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4797	5	90	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4798	5	88	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4799	5	93	967	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154
4800	5	91	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4801	5	92	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4802	5	89	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4803	5	94	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4804	5	90	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4805	5	88	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4806	5	93	968	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152
4807	5	91	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4808	5	92	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4809	5	89	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4810	5	94	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4811	5	90	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4812	5	88	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4813	5	93	969	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155
4814	5	91	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4815	5	92	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4816	5	89	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4817	5	94	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4818	5	90	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4819	5	88	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4820	5	93	970	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156
4821	5	91	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4822	5	92	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4823	5	89	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4824	5	94	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4825	5	90	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4826	5	88	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4827	5	93	971	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157
4828	5	91	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4829	5	92	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4830	5	89	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4831	5	94	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4832	5	90	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4833	5	88	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4834	5	93	972	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158
4835	5	91	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4836	5	92	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4837	5	89	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4838	5	94	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4839	5	90	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4840	5	88	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4841	5	93	973	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153
4842	28	3	974	\N
4843	28	3	975	\N
4844	28	3	976	\N
4845	28	3	977	\N
4846	64	640	978	\N
4847	64	640	979	\N
4848	3	3	980	\N
4849	28	3	981	\N
4850	28	3	982	\N
4851	28	3	983	\N
4852	28	3	984	\N
4853	1	565	985	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
4854	1	568	985	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
4855	1	571	985	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
4856	1	566	985	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
4857	56	566	985	\N
4858	1	573	985	http://www.mycancergenome.org/content/disease/melanoma/gna11/101
4859	56	3	985	\N
4860	1	565	986	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
4861	1	568	986	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
4862	1	571	986	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
4863	56	641	986	\N
4864	1	566	986	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
4865	56	566	986	\N
4866	1	573	986	http://www.mycancergenome.org/content/disease/melanoma/gna11/99
4867	56	642	986	\N
4868	56	3	986	\N
4869	1	643	987	\N
4870	1	643	988	\N
4871	1	644	989	\N
4872	1	643	990	\N
4873	1	643	991	\N
4874	27	3	992	\N
4875	65	182	993	\N
4876	22	645	994	\N
4877	22	646	994	\N
4878	22	647	994	\N
4879	22	3	994	\N
4880	65	182	995	\N
4881	65	182	996	\N
4882	27	645	997	\N
4883	27	3	997	\N
4884	65	182	998	\N
4885	49	348	999	\N
4886	3	264	1000	\N
4887	3	3	1000	\N
4888	5	648	1001	\N
4889	5	3	1001	\N
4890	28	3	1002	\N
4891	28	649	1003	\N
4892	28	3	1003	\N
4893	28	649	1004	\N
4894	28	3	1004	\N
4895	28	649	1005	\N
4896	28	3	1006	\N
4897	2	165	1007	\N
4898	2	168	1008	\N
4901	2	168	1009	\N
4902	2	167	1009	\N
4903	2	166	1009	\N
4904	2	169	1010	\N
4905	2	166	1010	\N
4906	2	169	1011	\N
4907	2	166	1011	\N
4908	2	174	1012	\N
4909	2	174	1013	\N
4910	2	174	1014	\N
4911	2	175	1014	\N
4912	2	174	1015	\N
4913	2	175	1015	\N
4914	27	6	1016	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
4915	27	7	1016	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
4916	27	8	1016	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
4917	27	9	1016	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199
4918	31	259	1017	\N
4919	8	630	1018	\N
4920	8	630	1019	\N
\.


--
-- Name: disease_source_variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('disease_source_variants_id_seq', 4920, true);


--
-- Name: diseases_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('diseases_id_seq', 65, true);


--
-- Data for Name: drug_interactions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY drug_interactions (id, effect, pathway, therapeutic_context, status, evidence, variant_id, source_id, clinical_association) FROM stdin;
1	gain-of-function	activation	rapamycin	preclinical	emerging	308	251	sensitivity
2	gain-of-function	activation	everolimus	case report	emerging	309	253	sensitivity
3	gain-of-function	activation	everolimus	case report	emerging	310	252	response
4	gain-of-function	activation	rapamycin	preclinical	emerging	311	251	sensitivity
5	gain-of-function	activation	everolimus	case report	emerging	312	253	sensitivity
6	gain-of-function	activation	rapamycin	preclinical	emerging	313	251	sensitivity
7	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	314	321	sensitivity
8	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	315	321	sensitivity
9	gain-of-function	activation	ruxolitinib	case report	emerging	316	242	response
10	gain-of-function	activation	ruxolitinib	preclinical	emerging	317	242	sensitivity
11	gain-of-function	activation	JAK inhibitors	preclinical	emerging	320	351	sensitivity
12	gain-of-function	activation	ruxolitinib	preclinical	emerging	322	11	sensitivity
13	gain-of-function	activation	MEK inhibitors	late trials	emerging	323	387	response
14	gain-of-function	activation	MEK inhibitors	early trials	emerging	323	388	response
15	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	323	389	sensitivity
16	gain-of-function	activation	BRAF inhibitors	case report	emerging	323	390	resistance
17	gain-of-function	activation	preclinical	preclinical	emerging	323	383	ERK inhibitors
18	gain-of-function	activation	MEK inhibitors	late trials	emerging	324	387	response
19	gain-of-function	activation	MEK inhibitors	early trials	emerging	324	388	response
20	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	324	389	sensitivity
21	gain-of-function	activation	BRAF inhibitors	case report	emerging	324	390	resistance
22	gain-of-function	activation	preclinical	preclinical	emerging	324	383	ERK inhibitors
23	gain-of-function	activation	MEK inhibitors	late trials	emerging	325	387	response
24	gain-of-function	activation	MEK inhibitors	early trials	emerging	325	388	response
25	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	325	389	sensitivity
26	gain-of-function	activation	BRAF inhibitors	case report	emerging	325	390	resistance
27	gain-of-function	activation	preclinical	preclinical	emerging	325	383	ERK inhibitors
28	gain-of-function	activation	MEK inhibitors	late trials	emerging	326	387	response
29	gain-of-function	activation	MEK inhibitors	early trials	emerging	326	388	response
30	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	326	389	sensitivity
31	gain-of-function	activation	BRAF inhibitors	case report	emerging	326	390	resistance
32	gain-of-function	activation	preclinical	preclinical	emerging	326	383	ERK inhibitors
33	gain-of-function	activation	MEK inhibitors	late trials	emerging	327	387	response
34	gain-of-function	activation	MEK inhibitors	early trials	emerging	327	388	response
35	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	327	389	sensitivity
36	gain-of-function	activation	BRAF inhibitors	case report	emerging	327	390	resistance
37	gain-of-function	activation	preclinical	preclinical	emerging	327	383	ERK inhibitors
38	gain-of-function	activation	MEK inhibitors	late trials	emerging	328	387	response
39	gain-of-function	activation	MEK inhibitors	early trials	emerging	328	388	response
40	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	328	389	sensitivity
41	gain-of-function	activation	BRAF inhibitors	case report	emerging	328	390	resistance
42	gain-of-function	activation	preclinical	preclinical	emerging	328	383	ERK inhibitors
43	gain-of-function	activation	MEK inhibitors	late trials	emerging	329	387	response
44	gain-of-function	activation	MEK inhibitors	early trials	emerging	329	388	response
45	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	329	389	sensitivity
46	gain-of-function	activation	BRAF inhibitors	case report	emerging	329	390	resistance
47	gain-of-function	activation	preclinical	preclinical	emerging	329	383	ERK inhibitors
48	gain-of-function	activation	MEK inhibitors	late trials	emerging	332	387	response
49	gain-of-function	activation	MEK inhibitors	early trials	emerging	332	388	response
50	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	332	389	sensitivity
51	gain-of-function	activation	BRAF inhibitors	case report	emerging	332	390	resistance
52	gain-of-function	activation	preclinical	preclinical	emerging	332	383	ERK inhibitors
53	gain-of-function	activation	MEK inhibitors	late trials	emerging	333	387	response
54	gain-of-function	activation	MEK inhibitors	early trials	emerging	333	388	response
55	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	333	389	sensitivity
56	gain-of-function	activation	BRAF inhibitors	case report	emerging	333	390	resistance
57	gain-of-function	activation	preclinical	preclinical	emerging	333	383	ERK inhibitors
58	gain-of-function	activation	ERK inhibitors	preclinical	emerging	344	383	sensitivity
59	gain-of-function	activation	dasatinib	preclinical	emerging	347	320	sensitivity
60	gain-of-function	activation	dasatinib	preclinical	emerging	348	320	sensitivity
61	gain-of-function	activation	dasatinib	preclinical	emerging	349	320	sensitivity
62	gain-of-function	activation	dasatinib	preclinical	emerging	350	320	sensitivity
63	gain-of-function	activation	dasatinib	preclinical	emerging	351	320	sensitivity
64	gain-of-function	activation	dasatinib + erlotinib	case report	emerging	352	320	response
65	gain-of-function	activation	dasatinib	preclinical	emerging	352	320	sensitivity
66	gain-of-function	activation	dasatinib	preclinical	emerging	353	320	sensitivity
67	gain-of-function	activation	crizotinib	preclinical	emerging	361	243	sensitivity
68	gain-of-function	activation	crizotinib	case report	emerging	362	256	resistance
69	gain-of-function	activation	ceritinib	FDA-approved	consensus	362	257	response
70	gain-of-function	activation	crizotinib	preclinical	emerging	364	243	sensitivity
71	gain-of-function	activation	crizotinib	case report	emerging	367	256	resistance
72	gain-of-function	activation	ceritinib	FDA-approved	consensus	367	257	response
73	gain-of-function	activation	crizotinib	case report	emerging	368	256	resistance
74	gain-of-function	activation	crizotinib	case report	emerging	369	256	resistance
75	gain-of-function	activation	ceritinib	FDA-approved	consensus	369	257	response
76	gain-of-function	activation	crizotinib	preclinical	emerging	370	243	sensitivity
77	gain-of-function	activation	crizotinib	case report	emerging	371	256	resistance
78	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	371	258	response
79	gain-of-function	activation	crizotinib	preclinical	emerging	372	243	reduced sensitivity
80	gain-of-function	activation	crizotinib	case report	emerging	372	256	resistance
81	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	372	258	response
82	gain-of-function	activation	crizotinib	preclinical	emerging	376	243	sensitivity
83	gain-of-function	activation	crizotinib	case report	emerging	377	256	resistance
84	gain-of-function	activation	crizotinib	preclinical	emerging	379	243	sensitivity
85	switch-of-function	activation	IDH inhibitors	preclinical	emerging	396	414	sensitivity
86	gain-of-function	activation	lapatinib	preclinical	emerging	400	416	sensitivity
87	gain-of-function	activation	lapatinib	preclinical	emerging	401	416	sensitivity
88	gain-of-function	activation	lapatinib	preclinical	emerging	402	416	sensitivity
89	gain-of-function	activation	lapatinib	preclinical	emerging	403	416	sensitivity
90	gain-of-function	activation	lapatinib	preclinical	emerging	404	416	sensitivity
91	gain-of-function	activation	lapatinib	preclinical	emerging	405	416	sensitivity
92	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	412	419	resistance
93	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	413	419	resistance
94	gain-of-function	activation	JAK inhibitors	preclinical	emerging	415	421	sensitivity
95	gain-of-function	activation	bortezomib	preclinical	emerging	483	439	resistance
96	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	483	440	sensitivity
97	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	484	440	resistance
98	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	488	444	sensitivity
99	gain-of-function	activation	crenolanib	preclinical	emerging	489	444	sensitivity
100	gain-of-function	activation	imatinib	preclinical	emerging	489	444	resistance
101	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	493	444	sensitivity
102	gain-of-function	activation	imatinib, sunitinib	late trials, preclinical	emerging	498	107	resistance
103	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	498	109	sensitivity
104	gain-of-function	activation	crenolanib	preclinical	emerging	498	110	sensitivity
105	gain-of-function	activation	dasatinib	preclinical	emerging	498	109	sensitivity
106	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	500	444	sensitivity
107	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	502	444	sensitivity
108	gain-of-function	activation	imatinib	case report	emerging	508	328	response
109	gain-of-function	activation	sunitinib	case report	emerging	508	329	response
110	gain-of-function	activation	imatinib	preclinical	emerging	515	99	resistance
111	gain-of-function	activation	imatinib	preclinical	emerging	517	99	resistance
112	gain-of-function	activation	imatinib	case report	emerging	520	333	response
113	gain-of-function	activation	imatinib	preclinical	emerging	530	102	decreased sensitivity
114	gain-of-function	activation	imatinib	preclinical	emerging	530	99	resistance
115	gain-of-function	activation	imatinib	preclinical	emerging	534	99	resistance
116	gain-of-function	activation	imatinib	case report	emerging	534	103	resistance
117	gain-of-function	activation	sunitinib	preclinical	emerging	535	332	sensitivity
118	gain-of-function	activation	imatinib	preclinical	emerging	539	99	resistance
119	gain-of-function	activation	dasatinib	case report	emerging	539	158	response
120	gain-of-function	activation	quizartinib	preclinical	emerging	539	121	resistance
121	gain-of-function	activation	imatinib	case report	emerging	541	487	response
122	gain-of-function	activation	dasatinib	early trials	emerging	542	324	response
123	gain-of-function	activation	sorafenib	case report	emerging	543	338	response
124	gain-of-function	activation	imatinib	preclinical	emerging	544	99	resistance
125	gain-of-function	activation	dasatinib	preclinical	emerging	545	159	sensitivity
126	gain-of-function	activation	dasatinib	preclinical	emerging	546	159	sensitivity
127	gain-of-function	activation	imatinib	preclinical	emerging	547	99	resistance
128	gain-of-function	activation	imatinib	preclinical	emerging	549	99	resistance
129	gain-of-function	activation	ruxolitinib (in SH2B3 deleted)	preclinical	emerging	551	10	sensitivity
130	gain-of-function	activation	mTOR inhibitors  (in SH2B3 deleted)	preclinical	emerging	551	11	sensitivity
131	gain-of-function	activation	imatinib	preclinical	emerging	581	350	sensitivity
132	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	588	341	sensitivity
133	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	589	341	sensitivity
134	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	590	341	sensitivity
135	gain-of-function	activation	crizotinib	case report	emerging	591	262	resistance
136	gain-of-function	activation	anti-estrogens	early trials	emerging	592	491	resistance
137	gain-of-function	activation	anti-estrogens	early trials	emerging	595	491	resistance
138	gain-of-function	activation	anti-estrogens	early trials	emerging	596	491	resistance
139	gain-of-function	activation	erlotinib	preclinical	emerging	602	495	sensitivity
140	gain-of-function	activation	erlotinib	preclinical	emerging	603	495	sensitivity
141	gain-of-function	activation	erlotinib	preclinical	emerging	604	495	sensitivity
142	gain-of-function	activation	cetuximab	case report	emerging	605	61	resistance
143	gain-of-function	activation	panitumumab	case report	emerging	605	61	response
144	gain-of-function	activation	cetuximab	case report	emerging	606	496	response
145	gain-of-function	activation	erlotinib	preclinical	emerging	607	495	sensitivity
146	gain-of-function	activation	lapatinib	case report	emerging	608	343	response
147	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	609	276	response
148	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	609	277	sensitivity
149	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	610	276	response
150	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	610	277	sensitivity
151	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	611	276	response
152	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	611	277	sensitivity
153	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	612	276	response
154	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	612	277	sensitivity
155	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	620	276	response
156	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	620	277	sensitivity
157	gain-of-function	activation	cetuximab plus sirolimus	case report	emerging	623	512	response
158	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	626	276	response
159	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	626	277	sensitivity
160	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	628	277	sensitivity
161	gain-of-function	activation	gefitinib	case report	emerging	631	522	no response
162	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	635	276	response
163	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	635	277	sensitivity
164	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	637	276	response
165	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	637	277	sensitivity
166	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	638	276	response
167	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	638	277	sensitivity
168	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	639	276	response
169	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	639	277	sensitivity
170	gain-of-function	activation	crizotinib	preclinical	emerging	640	524	sensitivity
171	gain-of-function	activation	crizotinib	preclinical	emerging	641	524	sensitivity
172	gain-of-function	activation	crizotinib	preclinical	emerging	642	524	sensitivity
173	gain-of-function	activation	MET inhibitors	early trials	emerging	644	249	response
174	gain-of-function	activation	crizotinib	preclinical	emerging	646	524	reduced sensitivity
175	gain-of-function	activation	crizotinib	preclinical	emerging	647	524	reduced sensitivity
176	gain-of-function	activation	MET inhibitors	case report	emerging	648	250	response
177	gain-of-function	activation	crizotinib	preclinical	emerging	649	524	sensitivity
178	gain-of-function	activation	crizotinib	preclinical	emerging	650	524	sensitivity
179	gain-of-function	activation	crizotinib	preclinical	emerging	651	524	sensitivity
180	gain-of-function	activation	vismodegib	case report	emerging	652	352	resistance
181	gain-of-function	activation	MEK inhibitors	case report	emerging	658	366	response
182	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	664	49	resistance
183	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	early trials	emerging	664	51	response
184	gain-of-function	activation	BRAF inhibitors + EGFR inhibitors	preclinical	emerging	664	46	sensitivity
185	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	664	52	sensitivity
186	gain-of-function	activation	proteosome inhibitors	preclinical	emerging	664	54	sensitivity
187	gain-of-function	activation	preclinical	preclinical	emerging	664	55	mTOR inhibitors + BH3 mimetics
188	gain-of-function	activation	dabrafenib	case report	emerging	664	98	response
189	gain-of-function	activation	BRAF inhibitors	case report	emerging	664	51	response
190	gain-of-function	activation	MEK inhibitors	preclinical	emerging	664	356	sensitivity
191	gain-of-function	activation	dabrafenib	case report	emerging	664	51	response
192	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	664	379	sensitivity
193	gain-of-function	activation	BRAF inhibitors + HSP90 inhibitors	preclinical	emerging	664	381	sensitivity
194	gain-of-function	activation	BRAF inhibitors + CDK2/4 inhibitors	preclinical	emerging	664	382	sensitivity
195	gain-of-function	activation	preclinical	preclinical	emerging	664	383	ERK inhibitors
196	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	664	51	response
197	gain-of-function	activation	MEK inhibitors	early trials	emerging	664	532	response
198	gain-of-function	activation	MEK-enhanced radioiodine uptake	early trials	emerging	664	403	response
199	gain-of-function	activation	EGFR TKIs	case report	emerging	664	260	resistance
200	gain-of-function	activation	dabrafenib	early trials	emerging	664	533	response
201	gain-of-function	activation	vemurafenib	case report	emerging	664	534	response
202	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	preclinical	emerging	664	535	sensitivity
203	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	664	541	sensitivity
204	gain-of-function	activation	vemurafenib	case report	emerging	664	545	response
205	gain-of-function	activation	BRAF inhibitors	early trials	emerging	665	384	response
206	gain-of-function	activation	MEK inhibitors	case report	emerging	665	366	response
207	gain-of-function	activation	vemurafenib	late trials	emerging	666	368	response
208	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	671	370	response
209	gain-of-function	activation	BRAF inhibitors	case report	emerging	671	548	response
210	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	672	370	response
211	gain-of-function	activation	BRAF inhibitors	case report	emerging	672	548	response
212	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	673	370	response
213	gain-of-function	activation	BRAF inhibitors	case report	emerging	673	548	response
214	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	674	370	response
215	gain-of-function	activation	BRAF inhibitors	case report	emerging	674	548	response
216	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	683	551	sensitivity
217	reduced kinase activity	activation	dasatinib	case report	emerging	695	543	response
218	gain-of-function	activation	EGFR TKIs	case report	emerging	698	260	resistance
219	gain-of-function	activation	EGFR TKIs + MEK inhibitors in EGFR mutant	preclinical	emerging	698	260	sensitivity
220	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	699	551	sensitivity
221	reduced kinase activity	activation	dasatinib	preclinical	emerging	704	543	sensitivity
222	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	712	561	sensitivity
223	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	713	561	sensitivity
224	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	713	562	sensitivity
225	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	714	561	sensitivity
226	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	715	561	sensitivity
227	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	716	561	sensitivity
228	gain-of-function	activation	ruxolitinib	early trials	emerging	725	156	response
229	gain-of-function	activation	JAK inhibitors (alone or in combination)	preclinical	emerging	725	148	response
230	gain-of-function	activation	ruxolitinib	preclinical	emerging	726	17	sensitivity
231	gain-of-function	activation	ruxolitinib	preclinical	emerging	727	17	sensitivity
232	gain-of-function	activation	ruxolitinib	preclinical	emerging	728	17	sensitivity
233	gain-of-function	activation	ruxolitinib	preclinical	emerging	729	17	sensitivity
234	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	741	566	response
235	gain-of-function	activation	PKC inhibitor	preclinical	emerging	741	567	sensitivity
236	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	742	566	response
237	gain-of-function	activation	PKC inhibitor	preclinical	emerging	742	567	sensitivity
238	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	743	566	response
239	gain-of-function	activation	PKC inhibitor	preclinical	emerging	743	567	sensitivity
240	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	745	210	response
241	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	752	210	response
242	gain-of-function	activation	nilotinib, ponatinib	NCCN guidelines	consensus	757	210	response
243	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	758	210	response
244	gain-of-function	activation	ponatinib	NCCN guidelines	consensus	759	210	response
245	gain-of-function	activation	AURK inhibitors + BCR-ABL1 inhibitors	case report	emerging	759	5	response
246	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	760	210	response
247	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	761	210	response
248	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	762	210	response
249	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	763	210	response
250	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	764	210	response
251	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	767	210	response
252	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	768	210	response
253	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	770	210	response
254	gain-of-function	activation	vandetanib	FDA-approved	consensus	777	575	response
255	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	777	576	sensitivity
256	gain-of-function	activation	RET inhibitors	preclinical	emerging	777	577	sensitivity
257	gain-of-function	activation	vandetanib	FDA-approved	consensus	781	575	response
258	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	781	576	sensitivity
259	gain-of-function	activation	RET inhibitors	preclinical	emerging	781	577	sensitivity
260	gain-of-function	activation	dovitinib	preclinical	emerging	792	344	resistance
261	gain-of-function	activation	ponatinib	preclinical	emerging	792	344	sensitivity
262	gain-of-function	activation	dovitinib	preclinical	emerging	794	344	resistance
263	gain-of-function	activation	ponatinib	preclinical	emerging	794	344	sensitivity
264	gain-of-function	activation	dovitinib	preclinical	emerging	795	344	resistance
265	gain-of-function	activation	ponatinib	preclinical	emerging	795	344	sensitivity
266	gain-of-function	activation	dovitinib	preclinical	emerging	796	344	resistance
267	gain-of-function	activation	ponatinib	preclinical	emerging	796	344	sensitivity
268	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	797	345	sensitivity
269	gain-of-function	activation	dovitinib	preclinical	emerging	797	344	resistance
270	gain-of-function	activation	ponatinib	preclinical	emerging	797	344	sensitivity
271	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	798	345	sensitivity
272	gain-of-function	activation	dovitinib	preclinical	emerging	798	344	resistance
273	gain-of-function	activation	ponatinib	preclinical	emerging	798	344	sensitivity
274	gain-of-function	activation	dovitinib	preclinical	emerging	799	344	resistance
275	gain-of-function	activation	ponatinib	preclinical	emerging	799	344	sensitivity
276	gain-of-function	activation	dovitinib	preclinical	emerging	800	344	resistance
277	gain-of-function	activation	ponatinib	preclinical	emerging	800	344	sensitivity
278	gain-of-function	activation	dovitinib	preclinical	emerging	801	344	resistance
279	gain-of-function	activation	ponatinib	preclinical	emerging	801	344	sensitivity
280	gain-of-function	activation	dovitinib	preclinical	emerging	802	344	resistance
281	gain-of-function	activation	ponatinib	preclinical	emerging	802	344	sensitivity
282	gain-of-function	activation	dovitinib	preclinical	emerging	803	344	resistance
283	gain-of-function	activation	ponatinib	preclinical	emerging	803	344	sensitivity
284	gain-of-function	activation	dovitinib	preclinical	emerging	804	344	resistance
285	gain-of-function	activation	ponatinib	preclinical	emerging	804	344	sensitivity
286	gain-of-function	activation	dovitinib	preclinical	emerging	805	344	resistance
287	gain-of-function	activation	ponatinib	preclinical	emerging	805	344	sensitivity
288	gain-of-function	activation	dovitinib	preclinical	emerging	806	344	resistance
289	gain-of-function	activation	ponatinib	preclinical	emerging	806	344	sensitivity
290	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	810	322	sensitivity
291	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	812	322	sensitivity
292	gain-of-function	activation	pazopanib	case report	emerging	813	322	response
293	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	832	349	sensitivity
294	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	833	349	sensitivity
295	gain-of-function	activation	cetuximab	late trials	emerging	852	70	response
296	gain-of-function	activation	MEK inhibitors + PI3K pathway inhibitors	preclinical	emerging	852	72	sensitivity
297	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	862	364	sensitivity
298	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	863	364	sensitivity
299	gain-of-function	activation	trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	864	364	sensitivity
300	gain-of-function	activation	quizartinib	preclinical	emerging	866	121	resistance
301	gain-of-function	activation	ponatinib	preclinical	emerging	866	122	resistance
302	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	866	123	sensitivity
303	gain-of-function	activation	quizartinib	preclinical	emerging	867	121	resistance
304	gain-of-function	activation	ponatinib	preclinical	emerging	867	122	resistance
305	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	867	123	sensitivity
306	gain-of-function	activation	quizartinib	preclinical	emerging	872	121	resistance
307	gain-of-function	activation	ponatinib	preclinical	emerging	872	122	resistance
308	gain-of-function	activation	sorafenib	case report	emerging	872	16	resistance
309	gain-of-function	activation	midostaurin	case report	emerging	872	134	response
310	gain-of-function	activation	lestaurtinib	case report	emerging	872	135	response
311	gain-of-function	activation	quizartinib	preclinical	emerging	873	121	resistance
312	gain-of-function	activation	ponatinib	preclinical	emerging	873	122	resistance
313	gain-of-function	activation	sorafenib	case report	emerging	873	16	resistance
314	gain-of-function	activation	midostaurin	case report	emerging	873	134	response
315	gain-of-function	activation	lestaurtinib	case report	emerging	873	135	response
316	gain-of-function	activation	quizartinib	preclinical	emerging	875	121	resistance
317	gain-of-function	activation	ponatinib	preclinical	emerging	875	122	resistance
318	gain-of-function	activation	sorafenib	case report	emerging	875	16	resistance
319	gain-of-function	activation	midostaurin	case report	emerging	875	134	response
320	gain-of-function	activation	lestaurtinib	case report	emerging	875	135	response
321	gain-of-function	activation	quizartinib	preclinical	emerging	876	121	resistance
322	gain-of-function	activation	ponatinib	preclinical	emerging	876	122	resistance
323	gain-of-function	activation	sorafenib	case report	emerging	876	16	resistance
324	gain-of-function	activation	midostaurin	case report	emerging	876	134	response
325	gain-of-function	activation	lestaurtinib	case report	emerging	876	135	response
326	gain-of-function	activation	quizartinib	preclinical	emerging	877	121	resistance
327	gain-of-function	activation	quizartinib	preclinical	emerging	878	121	resistance
328	gain-of-function	activation	ponatinib	preclinical	emerging	878	122	resistance
329	gain-of-function	activation	sorafenib	case report	emerging	878	16	resistance
330	gain-of-function	activation	midostaurin	case report	emerging	878	134	response
331	gain-of-function	activation	lestaurtinib	case report	emerging	878	135	response
332	gain-of-function	activation	quizartinib	preclinical	emerging	879	121	resistance
333	gain-of-function	activation	ponatinib	preclinical	emerging	879	122	resistance
334	gain-of-function	activation	sorafenib	case report	emerging	879	16	resistance
335	gain-of-function	activation	midostaurin	case report	emerging	879	134	response
336	gain-of-function	activation	lestaurtinib	case report	emerging	879	135	response
337	gain-of-function	activation	quizartinib	preclinical	emerging	880	121	resistance
338	gain-of-function	activation	ponatinib	preclinical	emerging	880	122	resistance
339	gain-of-function	activation	sorafenib	case report	emerging	880	16	resistance
340	gain-of-function	activation	midostaurin	case report	emerging	880	134	response
341	gain-of-function	activation	lestaurtinib	case report	emerging	880	135	response
342	gain-of-function	activation	quizartinib	preclinical	emerging	881	121	resistance
343	gain-of-function	activation	quizartinib	preclinical	emerging	882	121	resistance
344	gain-of-function	activation	quizartinib	preclinical	emerging	883	121	resistance
345	gain-of-function	activation	ponatinib	preclinical	emerging	883	122	resistance
346	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	883	123	sensitivity
347	gain-of-function	activation	quizartinib	preclinical	emerging	884	137	resistance
348	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	884	123	sensitivity
349	gain-of-function	activation	quizartinib	preclinical	emerging	885	137	resistance
350	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	885	123	sensitivity
351	gain-of-function	activation	quizartinib	preclinical	emerging	886	121	resistance
352	gain-of-function	activation	ponatinib	preclinical	emerging	886	122	resistance
353	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	886	123	sensitivity
354	gain-of-function	activation	quizartinib	preclinical	emerging	887	121	resistance
355	gain-of-function	activation	ponatinib	preclinical	emerging	887	122	resistance
356	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	887	123	sensitivity
357	gain-of-function	activation	quizartinib	preclinical	emerging	888	121	resistance
358	gain-of-function	activation	ponatinib	preclinical	emerging	888	122	resistance
359	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	888	123	sensitivity
360	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	900	365	resistance
361	gain-of-function	activation	allosteric AKT inhibitors	preclinical	emerging	901	610	sensitivity
362	gain-of-function	activation	neratinib	preclinical	emerging	903	619	sensitivity
363	gain-of-function	activation	vemurafenib	case report	emerging	906	390	resistance
364	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	906	621	resistance
365	gain-of-function	activation	vemurafenib	case report	emerging	907	390	resistance
366	gain-of-function	activation	MEK inhibitors	case report	emerging	908	622	resistance
367	gain-of-function	activation	MEK inhibitors	case report	emerging	909	622	resistance
368	gain-of-function	activation	MEK inhibitors	preclinical	emerging	911	621	resistance
369	gain-of-function	activation	MEK inhibitors	preclinical	emerging	912	621	resistance
370	gain-of-function	activation	ERK inhibitors	preclinical	emerging	912	383	sensitivity
371	gain-of-function	activation	MEK inhibitors	preclinical	emerging	913	621	resistance
372	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	914	623	sensitivity
373	gain-of-function	activation	MEK inhibitors	preclinical	emerging	915	621	resistance
374	gain-of-function	activation	MEK inhibitors	preclinical	emerging	916	621	resistance
375	gain-of-function	activation	MEK inhibitors	preclinical	emerging	917	621	resistance
376	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	919	624	resistance
377	gain-of-function	activation	novel MEK inhibitors	preclinical	emerging	919	625	sensitivity
378	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	920	623	sensitivity
379	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	921	621	resistance
380	gain-of-function	activation	MEK inhibitors	preclinical	emerging	922	621	resistance
381	gain-of-function	activation	MEK inhibitors	preclinical	emerging	923	621	resistance
382	gain-of-function	activation	ERK inhibitors	preclinical	emerging	923	383	sensitivity
383	gain-of-function	activation	vemurafenib	case report	emerging	924	390	resistance
384	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	924	621	resistance
385	gain-of-function	activation	MEK inhibitors	preclinical	emerging	925	621	resistance
386	gain-of-function	activation	MEK inhibitors	preclinical	emerging	926	621	resistance
387	gain-of-function	activation	ERK inhibitors	preclinical	emerging	926	383	sensitivity
388	gain-of-function	activation	ibrutinib	early trials	emerging	935	630	resistance
389	gain-of-function	activation	ibrutinib	early trials	emerging	936	630	resistance
390	gain-of-function	activation	ibrutinib	early trials	emerging	937	630	resistance
391	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	950	261	sensitivity
392	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	951	619	sensitivity
393	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	952	261	sensitivity
394	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	953	261	sensitivity
395	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	956	619	sensitivity
396	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	957	619	sensitivity
397	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	961	619	sensitivity
398	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	964	619	sensitivity
399	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	965	619	sensitivity
400	loss-of-function	activation	everolimus	case report	emerging	978	640	response
401	loss-of-function	activation	everolimus	case report	emerging	979	640	response
402	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	985	566	response
403	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	986	566	response
404	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	987	643	resistance
405	gain-of-function	activation	ERK inhibitors	preclinical	emerging	987	643	sensitivity
406	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	988	643	resistance
407	gain-of-function	activation	ERK inhibitors	preclinical	emerging	988	643	sensitivity
408	gain-of-function	activation	BRAF + MEK inhibitors	case report	emerging	989	644	resistance
409	gain-of-function	activation	ERK inhibitors	preclinical	emerging	989	644	sensitivity
410	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	990	643	resistance
411	gain-of-function	activation	ERK inhibitors	preclinical	emerging	990	643	sensitivity
412	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	991	643	resistance
413	gain-of-function	activation	ERK inhibitors	preclinical	emerging	991	643	sensitivity
414	gain-of-function	activation	JAK inhibitors	preclinical	emerging	993	182	sensitivity
415	gain-of-function	activation	JAK inhibitors	preclinical	emerging	995	182	sensitivity
416	gain-of-function	activation	JAK inhibitors	preclinical	emerging	996	182	sensitivity
417	gain-of-function	activation	JAK inhibitors	preclinical	emerging	998	182	sensitivity
418	loss-of-function	activation	mTOR inhibitors	preclinical	emerging	999	348	sensitivity
419	gain-of-function	activation	JAK inhibitors	preclinical	emerging	1003	649	sensitivity
420	gain-of-function	activation	JAK inhibitors	preclinical	emerging	1004	649	sensitivity
421	gain-of-function	activation	JAK inhibitors	preclinical	emerging	1005	649	sensitivity
422	gain-of-function	activation	sorafenib	case report	emerging	1017	259	response
423	gain-of-function	activation	ibrutinib	early trials	emerging	1018	630	resistance
424	gain-of-function	activation	ibrutinib	early trials	emerging	1019	630	resistance
\.


--
-- Name: drug_interactions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('drug_interactions_id_seq', 424, true);


--
-- Name: genes_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('genes_id_seq', 110, true);


--
-- Name: locations_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('locations_id_seq', 554, true);


--
-- Name: mutation_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('mutation_types_id_seq', 6, true);


--
-- Data for Name: schema_migrations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY schema_migrations (version) FROM stdin;
20140224185736
20140307221921
20140328160937
20140328183844
20140401211108
20140402163345
20140709150748
20140908201835
20140909212322
20140910203359
20140917182544
20140917193015
20140917201703
20140924205020
20140925154732
20150206205847
20150617174045
20150715153937
20151209194223
20160203194352
20160203214847
20160209164657
\.


--
-- Name: sources_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('sources_id_seq', 649, true);


--
-- Name: transcripts_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('transcripts_id_seq', 76, true);


--
-- Name: variant_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variant_types_id_seq', 4, true);


--
-- Name: variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variants_id_seq', 1019, true);


--
-- Name: versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('versions_id_seq', 2, true);


--
-- PostgreSQL database dump complete
--

